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This thesis includes a systematic literature review, a research outcome paper and a critical 
appraisal. 
      The systematic literature review summarises 20 outcome papers that explore the use of 
Mentalisation-Based Treatment (MBT) in participants with different mental health 
presentations. The results suggest that MBT has strong evidence in the treatment of people 
with a diagnosis of Borderline Personality Disorder (BPD) and that MBT has the potential of 
improving clinical outcomes in people with diagnoses of eating disorders and depression, 
adolescents who self-harm and mothers enrolled in substance misuse treatments. As 
compared to other interventions, MBT yielded positive outcomes that were maintained over 
long follow-ups and thus should be increasingly available for people with a diagnosis of 
BPD. Future research addressing treatment fidelity, confounding and assessor‘s blindness 
bias is required. 
The outcome paper explores the mental health of adult caregivers of asthmatic 
children living in the United Kingdom. Using an online designed questionnaire, the study 
collected information regarding participants´ socio-demographic characteristics, mentalising 
ability, family functioning, anxiety, depression and hypomanic symptoms. The aim was to 
further explore the association between caregivers´mentalising capacity and self-reported 
mental health symptoms. Sequential linear regression models showed that mentalising on its 
own was associated with 16%, and 14% of depressive and anxiety symptoms respectively. 
On the contrary, family functioning was not significantly associated with the independent 
variables in any of the regression models after mentalising was included. Psychological 
interventions targeting mentalising might be helpful in reducing anxiety and depression 
symptoms in this population. The critical appraisal includes the author´s personal reflections 
on the journey of writing a doctorate thesis along with the implications of the findings.
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1. Section One: Systematic Literature Review 
Mentalisation-Based Treatment (MBT) and its Evidence-Base Status: A 
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Purpose: This study has reviewed the evidence-base status of mentalisation-based 
treatment (MBT), along with its methodological quality, strengths and limitations. MBT is 
a manualised, time limited and attachment rooted psychotherapy. The aim was to pave the 
way for further MBT research.  
Method: An electronic database search of papers published between 1999 and 2017 was 
conducted. Studies of any methodology and design that included pre and post outcome 
quantitative results were included. The quality of the studies and the risk of bias were 
determined using two validated checklist. 
Results: Twenty studies were included in the review. This included seven randomised 
controlled trials, six uncontrolled pre-post effectiveness studies, three retrospective cohort 
studies, two uncontrolled randomised trials and two case studies. The methodological 
quality of almost half of the papers was assessed as fair (45%), followed by good (30%), 
poor (20%) and excellent (5%) ratings. Nevertheless, the review identified a risk of 
confounding bias across the majority of studies (70%), and fidelity to treatment was 
poorly reported in over half of the studies (40%). Most of the studies focused on 
borderline personality disorder (BPD) treatment, and the evidence base for other 
presentations was still developing. MBT produced positive clinical outcomes across all the 
presentations. The treatment of adolescents who self-harm and at-risk mothers in 
substance misuse treatment showed promising results, as these are client groups that had 
previously shown limited positive response to psychological interventions.  
Conclusions: MBT has the potential of becoming an effective intervention for different 
clinical presentations, but further research should focus on increasing the quality and the 
quantity of the MBT evidence outside the treatment of BPD.  
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1.MBT can be a particularly effective intervention for the treatment of adults with a diagnosis 
of BPD, adolescents who self-harm and mothers enrolled in substance misuse treatments. 
2.MBT can be an effective intervention for depression and eating disorders but the evidence 
is currently limited. 
3.Professionals supporting mothers in substance misuse treatment may benefit from receiving 
training in the principles of MBT.   
                                                     
1 Requirement of the target journal 
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Mentalisation-Based Treatment (MBT) and its Evidence-Base Status: A Systematic 
Literature Review 
 
The concept of mentalisation was first described by Fonagy (1989) as an ability that helps 
make sense of one‘s own and others‘ states of mind regarding desires, intentions, thoughts, 
feelings and behaviour. An example of mentalising difficulty is becoming upset with 
someone else‘s behaviour and developing quick assumptions about their thoughts and 
intentions. Conversely, good mentalising would involve putting yourself in the other‘s 
position and thinking about alternative reasons for their behaviour (Fonagy & Luyten, 
2009). Given that difficulties in mentalising seem to be present in people with a diagnosis 
of borderline personality disorder (BPD) (Bateman & Fonagy, 2010), this theory has 
strongly influenced a partial-hospitalisation psychoanalytic treatment programme for 
clients with BPD diagnoses (Bateman & Fonagy, 1999). The programme was manualised, 
labelled mentalisation-based treatment (MBT) and tested in a randomised controlled trial 
(RCT), which constituted the first published paper on MBT (Bateman & Fonagy, 1999).  
MBT: Theoretical Foundations and Mentalising Practice 
 MBT is a time-limited psychodynamic treatment rooted in attachment, cognitive and 
neuropsychology principles (Bateman & Fonagy, 2016). One of the main strengths of 
MBT is its strong links with the neurosciences, as evidenced by the publication of a wide 
range of neuroimaging studies exploring the neuroanatomical correlates of mentalising 
(Denny et al., 2012; Frith & Frith, 2006; Stuss et al., 2001). For instance, Lombardo, 
Chakrabarti, Bullmore and Wheelwright (2010) demonstrated that overlapping neural 
circuits were involved in the process of mentalising of both self and others. Moreover, 
Nolte et al. (2013) concluded that when presenting healthy adult participants with an 
attachment-related stress condition, there was a reduction in the activation of the areas of 
the brain that collaborate in the process of mentalising, such as the superior temporal 
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sulcus, left inferior frontal gyrus and left temporo-parietal junction. Therefore, the 
theoretical principles of the model tap into complex levels of functioning that can be 
measured. This offers the possibility of widening the currently limited understanding of 
the biological pathways of therapeutic change.  
A central assumption of MBT is that mentalising is a skill that develops as a result 
of early interactions with caregivers, and that it is a main contributor to the ability of 
orchestrating affect regulation and to the development of a sense of self (Fonagy, 1998). In 
order to develop full mentalising, Bateman and Fonagy (2016) ―particularly emphasize the 
importance of marked mirroring‖ (p. 6) of attentive adults who are able to convey, hold 
and understand a baby‘s affect, states of mind and intentions. In contrast, neglectful, 
abusive or dysfunctional attachment experiences are likely to impair the development of 
robust mentalising, which could, in turn, lead to impulsivity, affect dysregulation, self-
harm or anxiety, among other effects (Bateman & Fonagy, 2011; 2012; 2016).  
Initially, there were two different MBT treatment modalities, with different 
intensities. The first was implemented in the context of day hospital programmes, where 
service users received treatment for five days a week (Bateman & Fonagy, 2005) and the 
maximum length of the treatment ranged between 18 and 24 months. However, the 
intensive day hospital MBT approach is not currently offered in the UK (Bateman & 
Fonagy, 2016). One of the reasons is that over the last decade, mental healthcare provision 
in the UK has experienced major cuts (Davis, Lister & Wrigley, 2015; Lymbery, 2010), 
with a significant amount of day centres closing down as a result of the austerity policies 
(Pitt, 2010). Another reason is that outpatient, less intensive MBT has also proven to be 
efficacious (Bateman & Fonagy, 2009). Thus, in the UK service users receive the second 
type of MBT treatment, which consists of 18-month outpatient treatment with 50-minute 
individual and 75-minute group sessions each week (Bateman & Fonagy, 2016). The 
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structure of MBT can be divided in the following categories: assessment of mentalising 
difficulties, diagnosis and formulation, crisis plan and risk management, therapeutic 
contract and psychoeducation. A typical MBT session would involve a not-knowing 
therapeutic stance, where the therapist´s uses questions to promote reflective dialogue 
(Bateman & Fonagy, 2016). It would also include supporting the client to mentalise the 
narrative by using techniques such as ―stop, re-wind, explore‖ in which the aim is to 
generate multiple perspective, to clarify how situations are felt and understood and how 
this is related with the attachment/relational patterns of the client (Bateman & Fonagy, 
2016). Other MBT techniques include a constant focus on the client´s mind, monitoring 
relational misunderstandings and balancing the arousal levels with empathic validation 
and behavioural interventions (Bateman & Fonagy, 2016).  
The main differences from other psychological interventions commonly 
implemented in the UK, such as cognitive behavioural therapy (CBT) or third wave CBT 
such as acceptance and commitment therapy (ACT), are that MBT is often more intensive 
(biweekly), has a longer duration, is well-integrated with other services available to the 
client, and uses both problem-solving skills and a specific focus on the therapeutic 
relationship as mediums of therapeutic change (Jørgensen et al., 2013; Ramires, Schwan & 
Midgley, 2012).  
Clinical Implementation of MBT 
 In the last two decades, MBT has captured the interest of researchers and clinicians due 
to its novelty and ability to simplify and integrate attachment, psychodynamic and 
cognitive principles. According to the Thompson Reuter search tool Web of Science, the 
use of the term ―mentalisation" increased from 7 to 844 between 1991 and 2017 (Web of 
Science, 2017).  
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Mental health professionals in particular have embraced MBT and have started to 
implement it for a wide range of clinical presentations (Bateman & Fonagy, 2013), such as 
eating disorders (Balestrieri et al., 2015; Robinson et al., 2016), depression (Jakobsen et 
al., 2014) and adolescents who self-harm (Rossouw & Fonagy, 2012), among others. 
Although some evidence has supported the efficacy of MBT in the treatment of BPD 
(Bateman & Fonagy, 1999; 2008; 2009; Jørgensen et al., 2013), it is still not 
recommended as a first-line treatment for personality disorders (PD) in the National 
Institute for Health and Care Excellence guidelines (NICE, 2009), and its evidence base 
for other psychological difficulties is still developing.  
    The charity Mind (2013) conducted a survey in the United Kingdom (UK) in which 
1,639 adults with mental health difficulties who had accessed psychological therapies over 
the past two years took part. The survey indicated that CBT was the most commonly 
offered psychological intervention, accounting for 43% of all types of therapy. Given that 
specific MBT percentages were not reported and that psychodynamic therapies were 
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mainstream mental health services. These differences can be understood in the context of a 
significantly larger amount of published evidence in favour of CBT across a wide range of 
presentations (Hofman, Asnaani, Vonk, Sawyer & Fang, 2012) and the fact that MBT is 
often offered as a specialised intervention for PDs in the National Health Service (NHS).  
     Additionally, the Mind (2013) report also highlighted that 58% of the participants 
were not given a choice in the type of psychological intervention they accessed. These 
figures contrast with the Health and Social Care Act (2012) and with the Department of 
Health (2011) initiative of ―no health without mental health‖, which prioritised the 
increase of service users‘ choice of treatment as a way of putting mental health on an 
equal footing with physical health, where choice of treatment is often available (Health 
and Social Care Information Centre, 2013). A plausible explanation is that the NICE 
guidelines are often dominated by widely established therapies such as CBT, which often 
means that service users lack the opportunity to choose between different therapeutic 
approaches (Mind, 2013).  
    Thus, in order to provide service users with the opportunity to make informed 
decisions around their choice of psychological treatments, clinical researchers have the 
responsibility of summarising and integrating the available outcome evidence for 
interventions that might be underrepresented in the guidelines and in current routine NHS 
provision, such as MBT.  
Integrating New Evidence 
 In an attempt to coordinate and integrate the evidence base of psychological therapies, 
previous literature has proposed a wide range of models, such as the ―hourglass model‖ 
(Salkovksis, 1995). The aim of the model is to provide an overarching framework that 
helps to establish whether the published literature around a specific psychological 
intervention includes efficacy and effectiveness studies (Barkham & Mellor-Clark, 2000). 
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Efficacy studies refer to those that are implemented under rigorous scientific conditions, 
such as RCTs (Barkhman & Mellor-Clark, 2000), and effectiveness studies refer to those 
implemented in standard settings with clinically representative populations. Although 
efficacy RCTs are considered to be the gold standard measure in assessing the evidence 
base of any psychological therapy, relatively few attempts have been made to translate and 
replicate the findings of controlled trials into routine clinical practice (Barkham & Mellor-
Clark, 2000; Tajika, Ogawa, Takeshima, Hayasaka & Furukawa, 2015).  
        The ―hourglass model‖ uses a three-stage evaluation process to examine the 
efficacy–effectiveness continuum. The first stage occurs when a new theoretical 
framework is proposed as a new alternative for treating a clinical problem that concerns a 
large number of practitioners (Barkham & Mellor-Clark, 2000; 2010). This approach is 
initially tested with small-scale methods such as case studies. The findings are then 
translated to the second stage, where more stringent methodology, such as RCTs, is 
employed as a way of testing the efficacy of the intervention (Barkham & Mellor-Clark, 
2000). In the third stage, the treatment is implemented in settings that are closer to 
standard clinical practice to assess its effectiveness and external validity (Barkham & 
Mellor-Clark, 2000; Calvert & Kellet, 2014).  
Current Review 
 Despite the novelty and limited implementation of MBT in routine clinical practice, 
there is a substantial amount of research on treatment efficacy and effectiveness that 
deserves attention. The efficacy and effectiveness of MBT treatment has so far only been 
systematically synthesised in literature reviews of PD treatment (Stoffers-Winterling et al., 
2012). To date, no systematic review has focused on exploring the evidence base of MBT 
for other mental health presentations, such as eating disorders or depression.  
Therefore, this review has three main objectives. First, it aims to describe and integrate all 
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of the published MBT outcome evidence, using the ―hourglass model‖ as a framework to 
determine the status of such evidence. Second, it aims to establish whether MBT 
interventions lead to clinical improvements across different mental health presentations. 
Third, it attempts to assess the quality of such evidence and pave the way for further 
research in the field.   
Method 
 This systematic review adheres to the guidelines specified by the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) (Liberati et al., 2009; 
Moher, Liberati, Tetzlaff & Altman, 2010). 
Identification of Studies and Inclusion/Exclusion Criteria 
 The search was conducted with the support of a staff member of the academic liaison 
service of Lancaster University library. Papers were identified by searching six relevant 
databases: Medline, CINAHL, Psychinfo, Embase, Scopus and Web of Science. Databases 
were searched for studies published between 1999 (when the first MBT paper was 
published) and September 2017. All databases were searched using terms related to the 
treatment approach. Four terms relating to the same concept were combined using the 
Boolean operator ―OR‖ (―Mentalis*ation based treatment‖ OR ―Mentalis*ation based 
therapy‖ OR ―Mentaliz*ation based treatment‖ OR ―Mentaliz*ation based therapy‖). 
These terms were searched for in the titles, abstracts and keywords of articles in the six 
databases, and full texts of relevant articles were retrieved accordingly. Furthermore, the 
reference lists of the retrieved articles were searched by hand in order to find any relevant 
articles not already included in the search.  
           Studies were deemed eligible based on the following criteria: 1) papers that 
reported pre- and post-outcome data; 2) published in English or Spanish in peer-reviewed 
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journals between 1999 and 20 September 2017; 3) participants received an intervention 
primarily informed by the main components of MBT; 4) papers both with and without 
comparison groups; 5) populations with any type of mental health presentation, including 
children, adolescents, adults, older adults and caregivers; 6) studies conducted within all 
types of healthcare settings; 7) at least one psychometric measure showing quantitative 
outcomes.  
Papers were excluded from the current literature review according to the following 
criteria: 1) qualitative papers; 2) study protocols, theoretical discussions, unpublished 
articles, theses, dissertations or abstracts; 3) papers where MBT was limited to an adjunct 
component of another primary intervention (for example, a CBT intervention that had 
incorporated some MBT components).  
Data Extraction and Methodological Quality Assessment 
 The present literature review employed a data extraction tool (see Appendix 1-A), 
which the author adapted from the data collection checklist of the ―Cochrane Effective 
Practice and Organisation of Care Review Group‖ (EPOC, 2002).  
The review employed a methodological quality assessment tool (Downs & Black, 1998) 
and a risk of bias assessment tool (Viswanathan et al., 2012). The methodological quality 
of each study was assessed using Trac et al.‘s (2016) adaptation of the Downs and Black 
(1998) checklist tool.  This 27- item instrument (Appendix 1-B) is considered as suitable 
for use in systematic reviews (Deeks et al., 2003) and allowed the calculation of a score 
that reflected the quality of each study, ranging from 0 to 28. Following the guidelines of a 
recently published comparative study (O‘Connor et al., 2015) of the Downs and Black 
checklist tool (1998), the current review assessed the methodological quality of the 
included papers as follows: poor (<14 points), fair (14–18 points), good (19–23 points) or 
excellent (24–28 points).  Five randomly selected papers also received scores from both 
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the author of this review and from an independent blind rater, which allowed for a 
calculation of an inter-rater reliability score.   
 However, methodological quality assessment tools use a single numerical value, which 
includes different elements such as ethical issues, statistical analyses or reporting strategy. 
These factors are not always directly associated with risk of bias (Wood et al., 2008) and 
thus papers with significant bias can receive high quality ratings if they are well reported. 
 In order to overcome this, the review also assessed the risk of bias, which plays an 
important role in establishing the robustness of evidence (Viswanathan et al., 2012) and is 
a requirement of the PRISMA guidelines (Liberati et al., 2009). The tool employed was 
developed by the Agency for Healthcare Research and Quality (AHRQ) (Viswanathan et 
al., 2012) and was constructed following the principles of the Cochrane ―risk of bias‖ tool 
(Higgins & Green, 2011). Although independent ratings were not provided for this tool, 
the author clarified inconsistencies in the scoring with research supervisors. 
Results 
 Figure 1 shows a flow diagram of the search process, which was divided into four 
separate stages: identification, screening, eligibility and inclusion (Moher et al., 2010). In 
the identification stage, the search generated 1,136 citations. These were exported to 
EndNote
TM
, and screening identified 651 citations as duplicates, which were then 
removed. Subsequently, the titles and abstracts of the remaining 485 citations were 
screened.  
  Of these 485 citations, 463 were removed, and thus 22 studies were deemed 
appropriate for the eligibility stage. Full texts were retrieved and they were assessed, 
attending to the exclusion and inclusion criteria of the present review. After scrutiny, two 
articles were finally excluded from the present review according to the reasons presented 
in Figure 1.  
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 An additional search of the 20 papers‘ reference lists was then conducted, and four new 
studies were identified (Bateman & Fonagy, 1999; 2008; Kvarstein et al., 2015; Suchman 
et al., 2010). Out of those 24 studies, three (Bateman & Fonagy, 2001; 2008; Jørgensen et 
al., 2014) were combined due to providing follow-up data for original trials (Bateman & 
Fonagy, 1999; Jørgensen et al., 2013), and one (Bateman, O‘Connell, Lorenzini, Gardner 
& Fonagy, 2016) for presenting extended analyses of an original dataset from another 
article in this review (Bateman & Fonagy, 2009). Therefore, as presented in Figure 1, 20 
studies were included in the current systematic review.  
Data Synthesis  
 The papers are summarised in Table 1, which clusters them according to their design, 
consistent with the different stages of the ―hourglass model‖ (Salkovskis, 1995). Given 
that this was the first systematic literature review of the evidence base of MBT, meta-
analysis was discarded as only the studies concerning the treatment of BPD had enough 
number of trials for this approach, and a meta-analysis of the treatment BPD has already 
been conducted elsewhere (Stoffers-Winterling et al., 2012). On the contrary, this review 
aimed to synthesize the evidence of the treatment for the different mental health 
presentations, and thus narrative synthesis was employed, as recommended by the 
Cochrane guidelines (Ryan, 2014).  
Study and Participant Characteristics 
 The N=20 studies were published between 1999 and 2017 and consisted of seven 
RCTs, six uncontrolled pre–post effectiveness studies, three retrospective cohort studies, 
two uncontrolled randomised trials and two case studies. These studies were conducted in 
a wide variety of countries, including the UK (N=6), Denmark (N=4), Netherlands (N=4), 
USA (N=2), Norway (N=2), Italy (N=1) and Brazil (N=1)  
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The total sample across the 20 studies was n=1,724. All the studies consistently reported a 
high proportion of female (ranging between 47% and 100%) and Caucasian (ranging 
between 68% and 85%) participants. The mean age ranged between 15.4 and 38.5. 
Although there was a relative degree of diversity in psychiatric diagnoses, a significant 
number of the studies (N=9) were focused on borderline personality disorder (BPD).  
Intervention Characteristics 
 Almost half of the studies (N=9) followed the original 18-month MBT manualised 
approach (Bateman & Fonagy, 2004) and two of them (Balestrieri et al., 2015; Robinson 
et al., 2016) included the adaptations relevant for the treatment of eating disorders (MBT-
ED). One study (Bateman & Fonagy, 1999) followed psychodynamic and mentalising 
principles but did not adhere to a treatment manual, as this was not available at the time. 
Similarly, another study adapted elements of the MBT treatment manual for adults in an 
intervention for maltreated children (Ramires et al., 2016). Two studies described shorter 
MBT interventions that lasted five and six months respectively (Jakobsen et al., 2014; 
Thomsen, Ruocco, Uliaszek, Mathiesen & Simonsen, 2017). Three studies explored the 
effectiveness of a one-year manualised MBT intervention for adolescents (MBT-A) (Bo et 
al., 2016; Laurenssen et al., 2014; Rossouw & Fonagy, 2012). One study (Griffiths, Noble, 
Duffy & Schwannauer, 2017) reported on the service utilisation of adolescent 
mentalisation-based integrative treatment (AMBIT), a systemic multi-agency liaison 
intervention organised around the concept of mentalising, which was originally developed 
to work with young service users that usually experience difficulties in accessing mental 
health services (Bevington, Fuggle, Fonagy, Target & Asen, 2013). Three studies 
described the adaptation of a short-term three-month MBT intervention for parents 
(Hertzmann et al., 2016; Suchman et al., 2010; 2017). The average number of offered 
clinical contacts varied significantly from six to 92 sessions.  
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Clinical Outcomes of MBT treatment 
 Table 1 presents the main clinical outcomes of MBT across different mental health 
presentations.  
Personality Disorders 
 The status of evidence for MBT according to the hourglass model indicates one case 
study corresponding to stage one, two RCTs corresponding to stage two and six studies 
corresponding to stage three.  
 The first MBT published study (Bateman & Fonagy, 1999) tested treatment efficacy 
when applied to participants with a BPD diagnosis in a partially hospitalised setting 
(N=44). Self-harming behaviours were reduced significantly in the MBT arm [Kendall’s 
W=0.21, x
2
(3)=11.9, p<.008]. Furthermore, suicide attempts significantly decreased, from 
95% at baseline to 5.3% at 18 months post-treatment (Bateman & Fonagy, 2001) in the 
MBT group [Kendall’s W=.59, x2(3)=33.5, p<.001], and they did not decrease 
significantly in the control group [Kendall’s W=.04, x2(3)=2.4, p>.05]. Medical record 
examinations at five years follow-up showed that the MBT group maintained a 
significantly lower suicidality (23% vs 74%), less access to psychiatric services and higher 
global assessment functioning (GAF) scores than the control group (Bateman & Fonagy, 
2008). Although the five-year follow-up included records from all the participants (0% 
attrition), the study had a relatively small simple size (N=44) and did not follow a 
manualised approach.  
 In a subsequent RCT, Bateman and Fonagy (2009) examined the effectiveness of an 
outpatient MBT intervention when compared with structured clinical management (SCM, 
detailed in Bateman & Fonagy, 2009) in participants with diagnoses of antisocial PD 
(APD) and BPD. This paper employed a larger sample size (N=134) and included a 
manualised MBT intervention, which reduced performance bias. The results showed 
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medium and modest effect sizes for the reduction in rates of suicide attempts (d=.65, 95%, 
CI=.58-0.73), self-harming behaviours (d=.62, 95% CI=.28-.97) and depressive 
symptoms (d=.45, 95%, CI=.10-.79) in the MBT group as compared with SCM. Results 
also showed significantly greater decreases in antisocial related features, such as anger 
(t=2.05, p<.05), paranoia (t=3.06, p<.01) and hostility (t=3.53, p<.001) in the MBT arm.  
Subsequently, a research group separate to the original authors of MBT (Jørgensen et al., 
2013) developed the first uncontrolled clinical trial testing the effectiveness of MBT 
outside of the UK. This trial compared a two-year manualised MBT intervention with two 
years of supportive group therapy in Denmark (N=111). The pre–post analyses suggested 
that the psychiatric symptoms of both groups decreased significantly (d=.50–2.1, p<.001), 
although the differences between the two treatments were not statistically significant 
(Fs<2.9, all ps>.13). Although the therapists were not blind to the treatment condition, 
their ratings were compared with those of an independent assessor, showing very high 
reliability scores (Cronbach’s alpha=.97 GAF-F and .95 GAF-S).  
The number of participants without BPD diagnoses was significantly lower in the MBT 
arm (d=.58, p<.046) and although no significant changes were found between post-
treatment and 18-month follow-up, the positive changes reported post-treatment were still 
maintained (Jørgensen et al., 2014). The study benefited from strong external validity, but 
internal validity was threatened because the same therapists delivered both interventions.  
 A prospective cohort study conducted by Bales et al. (2012) tested the applicability of a 
manualised MBT intervention in a day hospital setting in the Netherlands. The scores of 
depression, general symptom distress and quality of life improved significantly (p<.05) at 
18 months posttreatment. This research study offered promising evidence regarding the 
generalisability of the results but lacked a control comparison group, which hinders the 
possibility of drawing conclusions about the efficacy of MBT. 
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 Morken et al., (2014) reported on a case study from a clinic in Norway, which 
attempted to use MBT as part of a substance misuse treatment. The client, described by the 
authors as a 28-year-old female with features of borderline, schizotypal and avoidant PDs 
seemed to benefit from the treatment, although the only conclusion that can be 
extrapolated is that the intervention was helpful for that particular client.  
 Bales et al. (2015) developed a matched control study (N=204) for participants with a 
diagnosis of BPD. This paper compared a manualised MBT intervention with a 
heterogeneous group referred to as ―other psychological treatments‖ (OPT), which 
included a wide range of therapeutic approaches, lengths and settings. Results suggested 
that psychiatric symptoms decreased in both groups post-treatment and after 18 months 
follow-up. Nevertheless, these improvements were higher in the MBT arm, as showed by 
the greater within-effect sizes (d=-1.06 post-treatment and d=-1.42 18 months follow-up) 
than in the OPT group (d=-.35 post-treatment and d=-.57 18 months follow-up). The 
superiority of MBT was confirmed when exploring the large between-group effect sizes (-
.71 post-treatment and -.85 at 18 months follow-up).  
 Similarly, a retrospective cohort study (Kvarstein et al., 2015) compared MBT (N=68) 
with psychodynamic psychotherapy (N=281) in Norway. The MBT group followed the 
Norwegian manual for the treatment (Karterud & Bateman, 2010), and the frequencies of 
self-harm, hospitalisation and suicide attempts decreased in both groups, whilst between 
group differences were not significant (p>.05). In MBT, pre–post analyses indicated that 
self-harm frequencies decreased from 89% to 27% and suicide attempts from 35% to 6% 
post-treatment. However, the long-term decrease of scores in the Brief Symptom 
Inventory (BSI) was significantly (p<.001) greater in the MBT group. The same pattern 
emerged for improvements in the GAF and in the circumplex of interpersonal problems 
(CIP) inventory (p<.001).   
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Thomsen et al. (2017) developed the first study testing neurocognitive functioning 
before and after an MBT intervention. This matched control study reported on the 
differences between an MBT group (N=18) of participants with a BPD diagnosis and a 
non-psychiatric control group (N=28), matched on parental education. Results showed a 
significant decrease in the Zanarini-BPD scale [t(17)=5.19, p<.05] and the Hamilton 
depression rating scale (HDRS) [t(17)=2.71, p<.05] post-treatment. Moreover, significant 
time X group interactions emerged for attention [F (1,44)=8.98, p<.01, n
2
p =.17] and 
perceptual reasoning [F(1,44)=19.92, p<.001, n
2
p=.31], such as that MBT improved more 
in perceptual reasoning [t(44)=2.09,p<.05, d=0.61], and that baseline group differences in 
attention were no longer significant post-treatment. Whilst improvements in episodic 
memory were associated with reductions in affective symptoms (Spearman r=-.50, 
p<.05), improvements in perceptual reasoning were correlated with improvements in 
interpersonal functioning (Spearman r=.49, p<.04). Although the results suggest that 
neuropsychological functioning can be associated with improvements in BPD-related 
symptoms, the non-controlled nature of the study does not allow attributing such 
improvements to MBT.  
 Finally, Bales et al. (2017) reported on the effectiveness of MBT in the treatment of 
BPD before and after a large reorganisation process. This retrospective cohort study 
(N=46) showed that psychiatric symptoms were reduced and personality functioning 
improved at 18 months follow-up for both groups (p<.05).  
 Overall, the summarised evidence corresponded to the three stages of the ―hourglass 
model‖ and suggested that MBT has the potential of improving the clinical outcomes of 
people with a PD diagnosis, particularly BPD.  
Depression 
 The status of MBT for the treatment of depression indicates that only evidence from the 
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second stage of the hourglass model is currently available. This review only identified one 
study exploring the benefits of MBT in depression. Jakobsen et al. (2014) developed a 
RCT (N=44) that compared the benefits of five months‘ third wave (non-specified) 
cognitive therapy (CT) with five months‘ MBT. The mean depression and psychiatric 
symptoms decreased for both conditions but the analyses indicated that the third wave CT 
group achieved significantly greater reduction in the scores of the HDRS than the MBT 
group (p=.039). Nevertheless, the treatment offered in this trial was limited to five months 
and only recruited 52% of the sample size that was estimated in the original power 
calculation. Thus, currently there is not enough available evidence of MBT outcomes in 
the treatment of depression. 
Eating Disorders 
 The reviewed evidence of MBT for the treatment of eating disorders accumulated one 
study from the second, and one from the third stage of the hourglass model. Balestrieri et 
al. (2015) described the results of the first MBT matched control study (N=24) for eating 
disorders (MBT-ED). The paper compared the effectiveness of an 18-month manualised 
MBT-ED with a psychodynamic intervention, and the results indicated that all symptoms 
were reduced significantly in both groups (ps<.05), and the only significant between-
group effects emerged in the GAF scores (p<.01), which favoured the MBT group.  
 A year later, Robinson et al. (2016) developed a RCT (N=68) that compared the 
outcomes of MBT-ED with an eating-disorders-adapted structural clinical management 
group (SCM-ED). The global scores in the eating disorder examination (EDE) improved at 
post-treatment, with a 1.2 point reduction in the MBT-ED condition (95% CI -1.81 to -.56, 
p<.001). Furthermore, the MBT-ED group showed a significantly (p<.05) greater 
reduction in shape concern and weight concern post-treatment than SSCM-ED. Given the 
limited available evidence, it is currently challenging to extrapolate conclusions regarding 
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the MBT outcomes in the treatment of eating disorders.  
Children and Adolescents 
 The evidence of MBT for the treatment of children and adolescents accumulated five 
studies. Two corresponded to the first and second stage respectively, and three to the third 
stage of the hourglass model.  A case study conducted by Ramires et al. (2012) reported 
on the outcomes of a six-month MBT intervention for a seven-year-old boy who had 
experienced early abuse and neglect in Brazil. The results showed a significant decrease in 
the child depression inventory (CDI), from 40 at baseline to 5 after six months of 
treatment. Despite the encouraging results for that individual at that particular time, no 
further conclusions can be drawn from this study. 
 Rossouw and Fonagy (2012) developed the first one-year manualised MBT 
intervention for adolescents (MBT-A), and tested its efficacy in the treatment of self-harm. 
This RCT (N=80) compared MBT-A with treatment as usual (TAU). Results post-
treatment suggested significantly higher decreases in self-harming behaviour (p<.01), 
depression (p<.04) and self-reported BPD-related symptoms (p<.05) in the MBT-A arm 
than in the TAU arm. Moreover, mentalising was also enhanced in the MBT-A group 
(d=.36), whereas significant changes did not emerge in the TAU condition.  
 Laurenssen et al. (2014) further tested the implementation of MBT with adolescents in 
a practice-based effectiveness study. This uncontrolled research showed that adolescents 
from an inpatient unit benefited from a one-year MBT-A intervention. The findings 
indicated that scores in the Brief Symptom Inventory (BSI) decreased significantly 
(p<.001, d=1.46) and quality of life and personality functioning improved (ps<.001).  
 In a similar study, Bo et al. (2016) reported results from a fair-quality, uncontrolled, 
practice-based study. Their findings showed that after a one-year MBT group 
intervention, participants reported significant (ps< .01) reductions of general 
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psychopathology and depressive symptoms, as well as improved mentalising and peer and 
parent attachment.  
 More recently, Griffiths et al. (2017) reported on the implementation of the adolescent 
mentalisation-based integrative therapy (AMBIT) approach with regard to a tier-4 child 
and adolescent mental health service (CAMHS). This retrospective cohort study (N=302) 
showed consistently significant reductions in psychiatric symptoms (ps<.05) between 
admission and discharge. Furthermore, results suggested high overall attendance rates 
(80%) and higher professional involvement (x
2
=5.26, p<.05) with those participants who 
experienced difficulties with engaging. Although the positive outcomes are consistent 
with the theoretical principles of AMBIT, whose principal aim is to be able to engage 
with young service users that are traditionally difficult to reach through services 
(Bevington et al., 2013), changes cannot be attributed to the implementation of AMBIT, 
since the design did not control for natural fluctuations in the self-reported distress.  
 Overall, currently there is promising evidence in the effectiveness of MBT-A for the 
reduction of self-harming behaviour, but the evidence for the treatment of children and 
other clinical presentations of adolescence still lacks robustness.  
Parental Interventions 
 The reviewed evidence status of MBT parental interventions accumulated three studies 
and all of them corresponded to the second stage of the hourglass model. In line with 
prior research focused on attachment-based interventions with at-risk mothers, Suchman 
et al. (2010) developed the first MBT-based parental intervention (MIO). Its efficacy was 
tested in a RCT (N=47) that compared the effects of MIO with a control parent education 
(PE) group. The sample was comprised of mothers enrolled in a substance misuse 
treatment with children between birth and three years of age. The results were promising, 
with a significantly greater increase (p<.05) in reflective functioning (mentalising) 
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(d=.56) and caregiving behaviour (d=.41) in the MIO arm. Furthermore, the fidelity to 
the MIO intervention was correlated with improvements in reflective functioning, and 
small effect sizes suggested that the MIO group reported fewer psychiatric symptoms 
post-treatment. A subsequent RCT (N=87) developed by Suchman et al. (2017) further 
tested the efficacy of MIO in a sample of mothers enrolled in substance abuse treatment 
with children between one and five years of age. Similar results emerged, with higher 
reflective functioning (d=.36), mental coherent representation scores (d=.41) and 
engagement with their children (d=.21) in the MIO group than in the control PE group 
post-treatment. These two RCTs showed that a short (12 weeks) MBT intervention could 
reduce psychiatric symptoms as well as improve mentalising and caregiving behaviours 
in highly at-risk and vulnerable mothers presenting with substance misuse difficulties.  
 In addition, Hertzmann et al. (2016) reported on the only non-clinical study included in 
this review. This RCT compared the efficacy of an MBT-adapted intervention for parents 
in separation (entrenched) conflict (N=30) with a control parent group (PG). Although 
parental alliance and mentalising did not change significantly post-treatment, parents in 
both groups showed reduced scores in anger, stress and depression.  
 Hence, the studies summarised show that there is promising evidence for the use of 
MBT adapted parental interventions.  
Methodological Quality and Risk of Bias  
 Methodological quality scores are presented in Table 1, and risk of bias judgements are 
described in Table 2. Regarding methodological quality, the two case studies were 
assessed as poor (M=5.5, range 4–7). Of a total of seven RCTs, five were rated as good, 
one as excellent and one as fair (M=20, range 17–24). Of a total of 11 practice-based 
effectiveness studies, eight were assessed to be fair, one as good and two as poor (M=14.9, 
range 11–19). Therefore, 45% of the included MBT studies (9/20) were considered to have 
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fair methodological quality, 30% good (6/20), 20% poor (4/20) and 5% excellent (1/20). 
An independent rater assessed five randomly selected papers with the Downs and Black 
(1998) checklist tool and the intraclass correlation coefficient was 0.82 (95% CI=.053-
.98), suggesting excellent inter-rater reliability (Cichetti, 1994).  
 Similarly, selection bias ratings showed that five of the nine (55%) studies that 
conducted randomisation processes had low risk of bias, and that 11 studies had low risk 
of recruitment bias (55%). However, risk of confounding bias was present in 14 studies 
(70%). Performance risk of bias showed that eight studies (40%) had an unclear or high 
risk of fidelity to treatment bias. In contrast, the risk of bias due to attrition was assessed 
as low in 14 studies (70%). Judgments of detection bias showed that assessors‘ blindness 
was unclear for 13 papers (65%). All studies  employed valid and reliable self-report 
measures, and 80% of the studies were rated with low risk of bias around their use of 
clinician- rated measures. In addition, almost half of the studies (45%) showed unclear risk 
of reporting bias.  
Discussion 
 This systematic review is the first to analyse the outcome evidence base of published 
MBT studies. The review sought to achieve three main objectives. First, it aimed to 
describe the integration of MBT outcome evidence following the different stages of the 
―hourglass model‖ (Salkovskis, 1995). Second, it attempted to explore the potential of 
MBT to produce clinical improvements across different presentations, settings and 
populations. Third, this study sought to establish the quality of the published evidence for 
MBT.  
Coherence of MBT Research 
 The ´hourglass model´ framework suggests that papers that measured treatment effects 
of MBT on participants with a diagnosis of BPD and on children and adolescents provide 
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evidence from the three stages of the model. Furthermore, MBT for eating disorders 
accumulated evidence from stages two and three. This indicates that MBT treatment for 
BPD, eating disorders and children and adolescents has accumulated evidence from 
highly controlled settings (Bateman & Fonagy, 1999; 2008; 2009; Jørgensen et al., 2013; 
Robinson, 2016, Rossouw & Fonagy, 2012), practice-based settings (Balestrieri et al., 
2013; Bales et al., 2012; 2015; Kvarstein et al., 2015) and large service evaluations (Bales 
et al., 2017). On the contrary, studies on MBT treatment for depression and parental 
interventions failed to progress through the three stages of the model and only provided 
evidence from the second stage with studies in highly controlled settings (Jakobsen, 2013; 
Suchman et al., 2010; 2017). 
 Given that RCTs often assess psychological treatments in ideal conditions (Barkham, 
Hardy & Mellor-Clark, 2010), future research should aim to retrieve both efficacy and 
effectiveness evidence. This would help to clarify whether results obtained using MBT in 
highly controlled environments can be translated to the highly complex and 
heterogeneous population encountered in standard clinical practice and vice versa. By 
doing this, MBT can lay the foundations of accumulating a more consistent and robust 
evidence that attracts policy makers´ attention and funding. 
Quality of MBT and Clinical Findings 
 The majority of published MBT evidence was assessed to be of fair quality (45%) or 
good quality (30%), with similar mean ratings for RCTs (M= 20) and practice-based 
effectiveness studies (M=15) to those reported by Calvert and Kellett (2014) when 
assessing the quality of Cognitive Analytic Therapy ([CAT] M=22 and M=16, 
respectively) with the same tool. However, quality checklist tools that rely on single 
numerical scales often fail to identify studies with increased risk of bias (O‘Connor et al., 
2015), and therefore this review also employed a risk-of-bias assessment tool. In fact, 
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reporting and attrition bias remained consistently low across the reviewed papers, although 
assessors‘ blindness was not clearly reported in 65% of the papers. Additionally, almost 
half of the studies presented with unclear or high risk of treatment fidelity bias (40%), risk 
of confounding bias were identified in a substantial amount of the included studies (70%) 
and almost half of the studies showed unclear risk of reporting bias.  
 This suggests that a substantial number of papers did not report adherence scales to the 
treatment manual, and that it was not clear whether the potential outcomes were pre-
specified by researchers. It should be acknowledged that although some papers did not 
report the adherence scale results, they met inclusion criteria because they described 
clearly the MBT components employed. Additionally, they included live supervision by 
senior therapists, who assessed whether the interventions had the essential components to 
be defined as MBT. 
 Future studies would benefit from addressing these issues and from providing a clear 
description of the assessment procedure, with special attention to whether those involved 
in the assessment were blinded to the treatment condition or exposure status of 
participants, as this was also poorly described. Finally, a substantial amount of papers did 
not describe clearly whether the distribution of confounders in each group could affect the 
interpretation of the results, which requires attention.  
Despite these methodological issues, the reported findings suggest that MBT was 
associated with positive clinical outcomes across the 20 studies and was superior to 
comparison groups, with the exception of supportive therapy and third wave CT 
(Jørgensen et al., 2013; Jakobsen et al., 2014). This was of particular relevance for BPD, 
as the therapy gains were maintained after long follow-up periods (Bateman & Fonagy, 
1999; 2001; 2008). To date, no other psychological intervention has reported 
improvements of such endurance in the treatment of BPD (Levy, Ablon & Kächele, 
MBT And Its Evidence-Base Status       




2011). Although some of the studies reported particularly long follow-ups, 65% of the 
papers did not report any follow-up periods, and future studies should address this issue 
as positive therapy outcomes could dissipate after therapy terminated.  
Nevertheless, the positive outcomes obtained by Bateman and Fonagy (2009; 2016) in the 
treatment of antisocial PD (APD) are also noteworthy given the very limited available 
evidence showing positive treatment results with this population (Gibbon et al., 2010; 
Yakeley & Williams, 2014). Despite the promising nature of the results, a note of caution 
should be made since some of these papers presented with limitations, such as unclear 
treatment fidelity or being underpowered. Nevertheless, it is important to take into 
account that three of the included studies (Hertzmann et al., 2016, Laurenssen et al., 2014 
& Suchman et al., 2010) were feasibility studies with small sample sizes, because their 
aims were not to provide generalizable results but to determine whether a larger scale trial 
was warranted.  
 Regarding depression, a RCT demonstrated that participants receiving MBT improved 
in all the self-reported symptoms, although the improvements were greater for those 
receiving third wave CT. However, this trial lacked statistical power as it only included 
52% of the originally calculated sample size and used the HDRS as the primary outcome 
measure, whose validity and ability to predict suicide attempts has been extensively 
questioned (Bagby, Ryder, Schuller & Marshall, 2004; Chakraborty & Chatterjee, 2006; 
Jakobsen et al., 2013). Additionally, the paper did not include any measure of 
mentalising, which is of particular relevance given that a previous paper identified 
mentalising deficits in female inpatient service users with diagnoses of major depressive 
disorder (Fischer-Kern et al., 2013). Therefore, more randomised trials that assess the 
efficacy of MBT in depression and that include measurements of mentalising are needed.  
 Similarly, the development of a new protocol of MBT for eating disorders (MBT-ED) 
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yielded positive results (Balestrieri et al., 2015; Robinson et al., 2016). In the trial of 
Robinson et al. (2016), changes in participants with  a diagnosis of bulimia in the EDE 
instrument showed a mean effect size of 1.2, which is comparable to those reported by 
CBT-E (Fairburn et al., 2009; Mitchell et al., 2011), a first line treatment recommended in 
the NICE guidelines (2004). Despite the fact that this trial was well-designed, employed 
blind independent assessors and treatment adherence scales, the study lacked statistical 
power and the dropout rates were very high, with 70% of participants in the MBT-ED not 
finishing the treatment. Although the reasons for this were not apparent, the participants 
were described as highly complex and it was hypothesised that they might have found the 
trial very stressful. Thus, although the results were promising for those who remained in 
the trial, high levels of attrition limited the conclusions on the efficacy of MBT treatment 
for eating disorders.  
 The research concerning interventions with adolescents was ground breaking, with the 
MBT version for adolescents (MBT-A) (Rossouw & Fonagy, 2012) being one of the few 
psychological treatments that demonstrated to be efficacious in reducing self-harm among 
adolescents (Ougrin, Tranah, Leigh, Taylor & Asarnow, 2012). Although further research 
in standard clinical practices expanded on the effectiveness of MBT-A (Bo et al., 2016; 
Laurenssen et al., 2014) in outpatient and inpatient services, more randomised trials and 
practice-based effectiveness studies are required to draw definite conclusions.  
 Ultimately, the MBT intervention for parents with separation (entrenched) conflicts 
(Hertzmann et al., 2016) and mothers (MIO) (Suchman et al., 2010; 2017) at risk showed 
promising evidence. The results with mothers at risk in substance abuse treatment are 
deeply encouraging, as this is a population that has previously been overlooked by other 
programmes such as ―The incredible years‖ (Webster-Stratton & Reid, 2010), and for 
whom treatment dropouts and lack of positive outcomes are very common (Kerwin, 2005; 
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Suchman et al., 2017). The next step could be to provide MBT training for professionals 
involved in the care and support of this population as well as to recognise the importance 
of including mentalising enhancement as one of the main treatment targets.  
 In addition, caution should be taken when interpreting the results. MBT is a long-term 
and intensive intervention, and therefore non-specific factors such as the treatment length 
could account for the positive outcomes. In order to overcome this, future literature 
should aim to establish whether positive treatment outcomes correlated with increasing 
mentalising function, as measured by validated mentalising scales. Participants in these 
studies were largely Caucasian female, which gives rise to questioning whether the same 
results would apply to male and ethnic minority service users. It is also noteworthy that 
few studies used a mentalising or reflective functioning measure, which hinders the 
ability to draw conclusions on the mechanisms of change. In spite of this, most of the 
participants included in this review presented with high diagnostic comorbidity, as MBT 
studies were often designed with very few exclusion criteria. Furthermore, research was 
conducted in a variety of countries, including the UK, Norway, Netherlands, Denmark, 
Brazil, Italy and the USA. The original authors were only involved in three studies (15%), 
suggesting that risk of research allegiance was minimal.  
 Taken together, these findings suggest that MBT is a favourable intervention across 
different presentations. Nevertheless, future research should address the risk of biases 
identified in this review, expand the selection of participants to male and minority client 
groups and increase the outcome evidence across all the presentations, especially for 
depression and eating disorders.  
Strengths and Limitations of the Review 
 There are some limitations to this review. First, it was limited to articles written in 
English and Spanish, which could have impacted on the findings of this review, 
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particularly given the increasing body of MBT research conducted in Scandinavian 
countries (Bo et al., 2016; Jørgensen et al., 2013; 2014; Jakobsen et al., 2014; Kvarstein 
et al., 2015). Additionally, papers with non-significant results are less likely to be 
published in peer reviewed journals, or if they are published, is more likely to be in non-
English journals (Egger et al., 1997), suggesting that this review might contribute to 
publication bias by not including such studies. Second, although inter-rater reliability was 
employed in the quality assessment, the review was primarily conducted by a single 
author, which could have impacted on the risk of bias rating, database search, inclusion 
and exclusion criteria assessment, as well as on the extraction of relevant data. In spite of 
this, the review presents with several strengths, such as including two well established 
and validated risk of bias and quality assessment tools. Moreover, the review adhered to 
the PRISMA guidelines and a priori identified the search strategy, as well as inclusion 
and exclusion criteria. Finally, this is the first review to systematically integrate the 
outcome evidence of MBT treatment and to employ the ―hourglass model‖ as a 
framework to assess the status of such evidence.  
Conclusions 
 In summary, although the studies included in this review suggest that MBT is a 
promising intervention for a wide range of presentations, there is currently insufficient 
evidence to consider MBT as a first line treatment. The reviewed evidence is of 
acceptable quality, but relevant risk of treatment, confounding and detection biases have 
been identified and should be taken into account in future studies. However, the results 
are promising and suggest that MBT has the potential to be a useful intervention for 
service users that have multifaceted presentations and high comorbidities and that often 
do not fit into a specific diagnostic category, making the treatment of choice difficult. In 
fact, MBT often provides long-term positive outcomes, which are often absent in other 
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established psychotherapies. Future research should aim to expand the currently available 
evidence on the effectiveness and efficacy of MBT across different presentations, with 
special emphasis on increasing the available number of controlled trials in BPD so that 
this treatment can be included in the future revision of NICE guidelines (2009) for the 


























Aber, J., Slade, A., Berger, B., Bresgi, I., & Kaplan, M. (1985). The parent development 
interview: Interview protocol (Unpublished manuscript, Barnard College, Columbia 
University, New York). 
Abidin, R. R., & Konold, T. R. (1999). Parenting alliance measure professional manual. Odessa, 
FL: Psychological Assessment Resources.  
Achenbach, T. M. (1991). Manual for the youth self-report and profile. Burlington, VT: 
University of Vermont, Department of Psychiatry. 
Ainsworth, M. D. S., & Bell, S.M. (1970). Attachment, exploration and separation: illustrated by 
the behavior of one-year-olds in a strange situation. Child Development, 41(1), 49–67. Doi: 
10.2307/1127388 
Angold, A., Costello, E., Pickles E., & Winder, F. (1987). The development of a questionnaire for 
use in epidemiological studies of depression in children and adolescents. London: Medical 
research Council. 
Armsden, G. C., & Greenberg, M. T.  (1987). The inventory of parent and peer 
attachment:  Relationships to well-being in adolescence.  Journal of Youth and Adolescence, 
16(5), 427–454. Doi:10.1007/BF02202939  
Arntz, A. (1999). Borderline personality disorder severity index, version IV. Revision of Weaver 
& Clum, 1993. Maastricht: Department Medical, Clinical and Experimental Psychology, 
University of Maastricht. 
Bagby, R. M., Parker, J. D. A., & Taylor, G. J. (1994). The twenty item Toronto alexithymia scale 
I. Item selection and cross validation of the factor structure. Journal of Psychosomatic 
Research, 38, 23–32. Doi:10.1016/0022-3999(94)90005-1  
Bagby, R. M., Ryder, A. G., Schuller, D. R., & Marshall, M.B. (2004). The Hamilton Depression 
Rating Scale: Has the gold standard become a lead weight? American Journal of  Psychiatry, 





Bales, D. J., Van Beek, N., Smits, M., Busschbach, J., Andrea, H., Willemsen, S., & Verheul, R. 
(2012). Treatment outcome of 18-month, day hospital Mentalization-Based Treatment (MBT) 
in patients with severe borderline personality disorder in the Netherlands. Journal of 
Personality Disorders, 26(4), 568–582. Doi:10.1521/pedi.2012.26.4.568   
Bales, D. L., Timman, R., Andrea, H., Busschbach, J. J., Verheul, R., & Kamphuis, J. H. (2014). 
Effectiveness of day hospital mentalization-based treatment for patients with severe 
borderline personality disorder: A matched control study. Clinical Psychology and 
Psychotherapy, 22, 409–417. Doi: 10.1002/cpp.1914  
Bales, D. L., Timman, R., Luyten, P., Busschback, J., Verheul, R., & Hutsebaut, J. (2017). 
Implementation of evidence-based treatments for borderline personality disorder: The impact 
of organizational changes on treatment outcome of mentalization-based treatment. 
Personality and Mental Health, 11(4). Doi: 10.1002/pmh.1381 
Balestrieri, M., Zuanon, S., Pellizzari, J., Zappoli-Thyrion, E., & Ciano, R. (2015). Mentalization 
in eating disorders: A preliminary trial comparing mentalization-based treatment (MBT) with 
a psychodynamic-oriented treatment. Eating and Weight Disorders – Studies on Anorexia, 
Bulimia and Obesity, 20(4), 525–528. Doi: 10.1007/s40519-015-0204-1  
Barkham, M., & Mellor-Clark, J. (2000). Rigour and relevance: The role of practice based 
evidence in psychological therapies. In: N. Rowland & S. Goss (Eds.), Evidence-base 
counseling and psychological therapies: Research and application (pp. 127–144). London: 
Routledge. 
Barkham, M., Hardy, G., & Mellor-Clark, J. (2010). Developing and delivering practice-based 
evidence: A guide for the psychological therapies: Effectiveness research in counselling and 
the psychological therapies. (1st ed.). Oxford: Willey-Blackwell.  
Barnard, K. E., & Eyres, S. J. (1979). Child health assessment, part 2: The first year of life. U.S. 




Government. Printing Office: Washington, D.C. 
Bateman, A., & Fonagy, P. (1999). The effectiveness of partial hospitalization in the treatment of 
Borderline Personality Disorder – A randomised controlled trial. American Journal of 
Psychiatry, 156(10), 1563–1569. 
Bateman, A., & Fonagy, P. (2001). Treatment of Borderline Personality Disorder with 
psychoanalytically oriented partial hospitalization: An 18 month follow-up. American 
Journal of Psychiatry, 158(1), 36–42.  
Bateman, A. W., & Fonagy, P. (2004). Psychotherapy for borderline personality disorder: 
Mentalization based treatment (1st ed.). Oxford: Oxford University. 
Bateman, A. (2005). Day hospital treatment of borderline personality disorder. In: M. C. Zanarini 
(Ed.). Borderline personality disorder (pp. 281–304). Boca Raton, FL: Taylor & Francis.  
Bateman, A., & Fonagy, P. (2008). 8 year follow-up of patients treated for borderline personality 
disorder: Mentalization-based treatment versus treatment as usual. American Journal of 
Psychiatry, 165 (5), 631–638.  
Bateman, A., & Fonagy, P. (2009). Randomized controlled trial of outpatient mentalization-based 
treatment versus structured clinical management for borderline personality disorder. 
American Journal of Psychiatry, 166(12), 1355–1364. Doi: 10.1176/appi.ajp.2009.09040539 
Bateman, A., & Fonagy, P. (2010). Mentalization based treatment for borderline personality 
disorder. World Psychiatry, 9(1), 11–15. Doi:10.1002/j.2051-5545.2010.tb00255.x  
Bateman, A. W., & Fonagy, P. (2011). Mentalization based treatment. Psychoanalytic Inquiry, 33 
(6), 595–613. Doi: 10.1080/07351690.2013.835170 
Bateman, A., & Fonagy, P. (2012). Handbook of mentalizing in mental health practice. (1st ed.). 
Washington, DC: American Psychiatric Publishing.  
Bateman, A., & Fonagy, P. (2013). Mentalization-Based Treatment. Psychoanalytic Inquiry, 
33 (6), 595–613.   




Bateman, A., & Fonagy, P. (2016). Mentalization-based treatment for personality disorders: A 
practical guide. (1st ed.). Oxford: Oxford University Press.  
Bateman, A., & Krawitz, R. (2013). Borderline personality disorder: An evidence-based guide for 
generalist mental health professionals. (1st ed.). Oxford, UK: Oxford University Press.  
Bateman, A., O‘Connell, J., Lorenzini, N., Gardner, T., & Fonagy, P. (2016). A randomized 
controlled trial of mentalization-based treatment versus structured clinical management for 
patients with comorbid borderline personality disorder and antisocial personality disorder. 
Biomed Central Psychiatry, 16, 304–315. Doi:10.1186/s12888-016-1000-9  
 Bech, P. (2004). Measuring the dimensions of psychological general well-being by the WHO-5. 
QOL Newsletter, 32, 15–16. 
Beck, A. T., & Steer, R. A. (1990). Manual for the Beck anxiety inventory. San Antonio: 
Psychological Corporation. 
Beck, A.T., Steer, R.A., & Brown, G.K. (1996). Manual for the Beck Depression Inventory-II. 
San Antonio, TX: Psychological Corporation. 
Beck, J., Beck, A., & Jolly, J. (2005). Beck Youth Inventories for Children and Adolescents: 
Manual (2nd ed.) San Antonio, TX: Harcourt Assessment. 
Bernstein, E. M., & Putnam, F. W. (1986). Development, reliability and validity of a dissociation 
scale. Nervous Mental Disease, 174(12), 727–735.  
Bevington, D., Fuggle, P., Fonagy, P., Target, M., & Asen, E. (2013). Innovations in practice: 
Adolescent Mentalization-Based Integrative Therapy (AMBIT) – a new integrated approach 
to working with the most hard to reach adolescents with severe complex mental health needs. 
Child and Adolescent Mental Health, 18(1), 46–51. Doi:10.1111/j.1475-3588.2012.00666.x. 
Bo, S., Sharp, C., Beck, E., Pedersen, J., Gondan, M., & Simonsen, E. (2016). First empirical 
evaluation of outcomes for mentalization-based group therapy for adolescents with 
BPD. Personality Disorders: Theory, Research, and Treatment, 1–6. 





Bosc, M., Dubini, A., & Polin, V. (1997). Development and validation of a social functioning 
scale, the Social Adaptation Self-evaluation Scale. European Neuropsychopharmacology, 
7(1), 57–70.  
Brandt, J. (1991). The Hopkins verbal learning test: Development of a new memory test with six 
equivalent forms. Clinical Neuropsychologist, 5, 125–142.  
Calvert, R., & Kellett, S. (2014). Cognitive analytic therapy: A review of the outcome evidence 
base for treatment. Psychology and Psychotherapy: Theory, Research and Practice, 87(3), 
253–277. Doi:10.1111/papt.12020  
Chakraborty, R., & Chatterjee, A. (2006). Predictors of suicide attempt among those with 
depression in an Indian sample: A brief report. Internet Journal of Mental Health, 4(2), 1–6.  
Cicchetti, D. V. (1994). Guidelines, criteria, and rules of thumb for evaluating normed and 
standardized assessment instruments in psychology. Psychological Assessment, 6(4), 284–
290. Doi:10.1037/1040-3590.6.4.284 
Cohen, S., Kamarck, T., & Mermelstein, R. (1983). A global measure of perceived stress. Journal 
of Health and Social Behavior, 24(4), 386–396. 
Crick, N. R., Murray-Close, D., & Woods, K. (2005). Borderline personality features in 
childhood: A short-term longitudinal study. Development and Psychopathology, 17, 1051–
1070. Doi:10.1017/0S0954579405050492 
Cuzzolaro, M., Vetrone, G., Marano, G., & Garfinkel, P. E. (2006). The Body Uneasiness Test 
(BUT): Development and validation of a new body image assessment scale. Eating and 
Weight Disorders – Studies on Anorexia, Bulimia and Obesity, 11(1), 1–13. Doi: 
10.1007/BF03327738 
Davis, J., Lister, J., & Wrigley, D. (2015). NHS for sale (1st ed.). London: Merlin Press. 
Davies, P. T., Forman, E. M., Rasi, J. A., & Stevens, K.I. (2002). Assessing children‘s emotional 




security in the interparental relationship: The security in the interparental subsystem 
scales. Child Development, 73(2), 544–562. 
Deeks, J., Dinnes, J., D‘Amico, R., Sowden, A., Sakarovitch, C., Song, F.,…Altman, D. G., 
International Stroke Trial Intervention Group and European Carotid Surgery Trial 
Collaborative Group (2003). Evaluating non-randomized intervention studies. Health 
Technology Assessment, 7(27), 1–173. 
Denny, B. T., Kober, H., Wager, T. D., & Ochsner, K. N. (2012). A meta-analysis of functional 
neuroimaging studies of self and other judgments reveals a spatial gradient for mentalizing in 
medial prefrontal cortex. Journal of Cognitive Neuroscience, 24(8), 1742–1752. Doi: 
10.1162/jocn_a_00233 
Department of Health (2011). No health without mental health. Mental Health and Disability: 
Department of Health. Retrieved October 16, 2017, from 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/138253/dh_12
4058.pdf.  
Derogatis, L. R. (1975). Brief symptom inventory. Baltimore, MD: Clinical Psychometric 
Research. 
Derogatis, L. R. (1977). SCL-90-R: Administration, scoring & procedures manual-II for the 
revised version and other instruments of the psychopathology rating scale series. Baltimore, 
MD: Clinical Psychometric Research. 
Derogatis, L., & Melisaratos, N. (1983). The Brief Symptom Inventory: An introductory report. 
The Journal of Psychological Medicine, 13(3), 595–605. Doi: 10.1017/S0033291700048017  
Downs, S. H., & Black, N. (1998). The feasibility of creating a checklist for the assessment of the 
methodological quality both of randomised and non-randomised studies of health care 
interventions. Journal of Epidemiology and Community Health, 52, 377–384. 
Doi:10.1136/jech.52.6.377 








Egger, M., Zellweger-Zähner, T., Schneider, M., Junker, C., Lengeler, C., & Antes, G.  (1997). 
Language bias in randomised controlled trials published in English and German. The Lancet, 
350 (9074), 326–329. Doi: 10.1016/S0140-6736(97)02419-7 
EuroQol Group (1990). EuroQol – a new facility for the measurement of health-related quality of 
life. Health Policy, 16(3), 199–208. 
Fairburn, C. G., & Cooper, Z. (1993). The eating disorder examination. In C. G. Fairburn & G. T. 
Wilson (12
th
 ed.), Binge eating: Nature, assessment and treatment (pp. 317–360). New York: 
Guilford Press. 
Fairburn, C. G., Cooper, Z., Doll, H. A., O‘Connor, M. E., Bohn, K., Hawker, D. M,…Palmer, R. 
L. (2009). Transdiagnostic cognitive-behavioral therapy for patients with eating disorders: A 
two-site trial with 60-week follow-up. American Journal of Psychiatry,166 (3), 311–319. 
Fincham, F.D., & Bradbury, T.N. (1992). Assessing attributions in marriage: The Relationship 
Attribution Measure. Journal of Personality and Social Psychology, 62(3), 457–468. doi: 
10.1037/0022-3514.62.3.457 
Fischer-Kern, M., Fonagy, P., Kapusta, N.D., Luyten, P., Boss, S., Naderer, A.,…Leithner, K. 
(2013). Mentalizing in female inpatients with major depressive disorder. Journal of Nervous 
Mental Disease, 201, 202–7. Doi: 10.1097/NMD.0b013e3182845c0a  
Fray, P. J., & Robbins, T. W. (1999). CANTAB battery: Proposed utility in 
neurotoxicology. Neurotoxicology and Teratology, 18, 499–504. 
Fraley, R. C., Waller, N. G., & Brennan, K. A. (2000). An item-response theory analysis of self-
report measures of adult attachment. Journal of Personality and Social Psychology, 78(2), 




350–365. Doi: 10.1037/0022-3514.78.2.350 
Fonagy, P. (1989). On tolerating mental states: Theory of mind in borderline patients. Bulleting of 
the Anna Freud Centre, 12, 91–115.  
Fonagy P. (1998). An attachment theory approach to treatment of the difficult patient. Bulletin of 
the Menninger Clinic, 62, 147–169. 
Fonagy, P., & Luyten, P. (2009). A developmental, mentalization-based approach to the 
understanding and treatment of borderline personality disorder. Development and 
Psychopathology, 21(4), 1355–1381. Doi: 10.1017/S0954579409990198  
Frith, C. D., & Frith, U. (2006). The neural basis of mentalizing. Neuron, 50(4) 531–534. Doi: 
10.1016/j.neuron.2006.05.001 
Garner, D. M. (1991). Manual for eating disorder inventory. Odessa, FL: Psychological 
Assessment Resources, Inc.  
Gibbon, S., Duggan, C., Stoffers, J., Huband, N., Vllm, B., Ferriter, M., & Lieb, K. (2010). 
Psychological interventions for antisocial personality disorder. Cochrane Database of 
Systematic Reviews, (6). Doi: 10.1002/14651858.CD007668.pub2 
Goodman, R. (1997). Strengths and Difficulties Questionnaire: A research note. Journal of Child 
Psychology and Psychiatry, 38(5), 581–586. Doi: 10.1111/j.469-7610.1997.tb01545.x 
Gormally, J., Black, S., Daston, S., & Rardin, D. (1982). The assessment of binge eating severity 
among obese persons. Addictive Behaviours, 7, 47–55. Doi: 10.1016/0306-4603(82)90024-7 
Griffiths, H., Noble, A., Duffy, F., & Schwannauer, M. (2017). Innovations in practice: 
Evaluating clinical outcome and service utilization in an AMBIT‐ trained Tier 4 child and 
adolescent mental health service. Child and Adolescent Mental Health, 22(3), 170–174. 
Doi:10.1111/camh.12181  
Ha, C., Sharp, C., Ensink, K., Fonagy, P., & Cirino, P. (2013). The measurement of reflective 
function in adolescents with and without borderline traits. Journal of Adolescence, 36(6), 




1215–1223. Doi: 10.1016/j.adolescence.2013.09.008 
Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical 
Psychology, 32, 50–55. 
Hamilton M. A. (1960). Rating scale for depression. Journal of Neurology, Neurosurgery and 
Psychiatry, 23, 56–61. 
Health and Social Care Act (2012). The Health and Social Care Act. Retrieved August 28, 2017, 
from http://www.legislation.gov.uk/ukpga/2012/7/pdfs/ukpga_20120007_en.pdf  
Health and Social Care Information Centre (2013), Improving access to psychological therapies, 
key performance indicators (IAPT KPIs) – final Q3 2012–13 and provisional Q4 2012–13. 
Retrieved August 28, 2017, from 
http://www.hscic.gov.uk/searchcatalogue?productid=11773&topics=0/Mental+he 
alth&sort=Relevance&size=10&page=1#top  
Helsel,W. J., & Matson, J. L. (1984). The assessment of depression in children: The internal 
structure of the Child Depression Inventory (CDI). Behavior Research and Therapy, 22(3), 
289–298. Doi: 10.1016/005-7967(84)90009-3 
Hertzmann, L., Target, M., Hewison, D., Casey, P., Fearon, P., & Lassri, D. (2016). 
Mentalization-based therapy for parents in entrenched conflict: A random allocation 
feasibility study. Psychotherapy, 53(4), 388–401. Doi: 10.1037/pst0000092  
Higgins, J., & Green, S. (2011). Cochrane handbook for systematic reviews of interventions. 
Retrieved September, 20, 2017 from http://training.cochrane.org/handbook  
Hofmann, S. G., Asnaani, A., Vonk, I. J. J., Sawyer, A. T., & Fang, A. (2012). The efficacy of 
cognitive behavioral therapy: A review of meta-analyses. Cognitive Therapy and Research, 
36(5), 427–440. Doi:10.1007/s10608-012-9476-1 
Jakobsen, J., Simonsen, E., Rasmussen, K., & Gluud, C.. (2013). Is the total score of the Hamilton 
Depression Rating Scale associated with suicide attempts or suicides? British Journal of 




Medical Research, 3(1), 140–152.  
Jakobsen, J.C., Gluud, C., Kongerslev, M., Larsen, K. A., Sørensen, P., Winkel, P.,…Simonsen, 
E. (2014). Third-wave cognitive therapy versus mentalisation-based treatment for major 
depressive disorder: A randomised clinical trial. BMJ Open, 4, 1–12. Doi: 10.1136/bmjopen-
2014-004903  
John, O. P., Donahue, E. M., & Kentle, R. L. (1991). The Big Five Inventory –versions 4a and 54. 
Berkeley, CA: University of California, Berkeley, Institute of Personality and Social 
Research. 
Jørgensen, C. R., Freund, C., Bøye, R., Jordet, H., Andersen, D., & Kjølbye, M. (2013). Outcome 
of mentalization-based and supportive psychotherapy in patients with borderline personality 
disorder: A randomized trial. Acta Psychiatrica Scandinavica, 127, 305–317. Doi: 
10.1111/j.1600-0447.2012.01923.x 
Jørgensen, C., Bøye, R., Andersen, D., Døssing Blaabjerg, A., Freund, C., Jordet, H., & Kjølbye, 
M. (2014). Eighteen months post-treatment naturalistic follow-up study of mentalization-
based therapy and supportive group treatment of borderline personality disorder: Clinical 
outcomes and functioning. Nordic Psychology, 66(4), 254–273. Doi: 
10.1080/19012276.2014.963649 
Kadouri, A., Corruble, E., & Falissard, B. (2007). The improved Clinical Global Impression Scale 
(iCGI): Development and validation in depression. BMC Psychiatry, 7(1), 7. Doi: 
10.1186/1471-244s-7-7 
Karterud, S., & Bateman, A. (2010). Manual for mentaliseringsbasert terapi (MBT) og MBT 
vurderingsskala. Versjon individualterapi. Oslo, Norway: Gyldendal Akademisk. 
Kay, S.R., Fiszbein, A., & Opler, L.A. (1987). The Positive and Negative Syndrome Scale 
(PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261–276. 
Kerwin, M. E. (2005). Collaboration between child welfare and substance abuse fields: Combined 




treatment programs for mothers. Journal of Pediatric Psychology, 30, 581–597. Doi: 
10.1093/jpepsy/jsi045  
Kvarstein, E. H., Pedersen, G., Urnes, Ø., Hummelen, B., Wilberg, T., & Karterud, S. (2015). 
Changing from a traditional psychodynamic treatment programme to mentalization-based 
treatment for patients with borderline personality disorder – does it make a 
difference? Psychology and Psychotherapy, 88(1), 71–86. Doi: 10.1111/papt.12036 
Larsen, K. A. (2009). Mentalisation-based therapy. A treatment manual (in Danish). Retrieved 
November 30, 2017, from http://www.ctu.dk  
Laurenssen, E., Hutsebaut, J., Feenstra, D., Bales, D., Noom, M., Busschbach, J.,… Luyten, P. 
(2014). Feasibility of mentalization-based treatment for adolescents with borderline 
symptoms: A pilot study. Psychotherapy, 51(1), 159–166. Doi: 10.1037/a0033513   
Levy, R., Ablon, J. S., & Kächele, H. (2011). Psychodynamic psychotherapy research: Evidence-
based practice and practice-based evidence (1st ed.). New York: Humana Press. 
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A.,…Moher, 
D. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of 
studies that evaluate health care interventions: Explanation and elaboration. Annual 
International Medicine, 15 (4), W65. 
Lombardo, M. V., Chakrabarti, B., Bullmore, E. T., Wheelwright, S. J., Sadek, S. A., Suckling, J., 
& Baron-Cohen, S. (2010). Shared neural circuits for mentalizing about the self and 
others. Journal of Cognitive Neuroscience, 22(7), 1623–1635. Doi: 10.1162/jocn.2009.21287 
Lovibond, S. H., & Lovibond, P. F. (1995). Manual for the Depression Anxiety Stress Scales 
(DASS). New South Wales: Psychology Foundation Monograph. 
Luyten, P., Mayes, L. C., Nijssens, L., & Fonagy, P. (2017). The parental reflective functioning 
questionnaire: Development and preliminary validation. Plos One, 12(5), 1-28.  doi: 
10.1371/journal.pone.0176218 




Lymbery, M. (2010). A new vision for adult social care? Continuities and change in the care of 
older people. Critical Social Policy, 30(1), 5–26. Doi: 10.1177/0261018309350806  
Mayes, L., Carter, A., & Stubbe, D. (1993). Infant differences in exploratory behavior in the 
second year of life. Infant Behavior and Development, 16, 269–284. Doi: 10.1016/0163-
6383(93)80035-7  
MIND (2013). We still need to talk. A report on access to talking therapies. Retrieved August 28, 
2017, from https://www.mind.org.uk/media/494424/we-still-need-to-talk_report.pdf  
Mitchell, J. E, Agras, S., Crow, S., Halmi, K., Fairburn, C. G., Bryson, S., & Kraemer, H. (2011). 
Stepped care and cognitive-behavioural therapy for bulimia nervosa: Randomized trial. 
British Journal of Psychiatry, 198(5), 391–397. Doi: 10.1192/bjp.bp.110.082172 
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010). Preferred reporting items for 
systematic reviews and meta-analyses: The PRISMA statement. International Journal of 
Surgery, 8(1), 336–341.  
Morey, L. C., & Suman, A. (2008). The Personality Assessment Inventory. In:  G. J. Boyle, G. 
Matthews, & D. H. Saklofske (Eds). The SAGE handbook of personality theory and 
assessment, vol 2: Personality measurement and testing (pp. 626–645). Thousand Oaks, CA: 
Sage Publications. 
Morken, K., Karterud, S., & Arefjord, N. (2014). Transforming disorganized attachment through 
mentalization-based treatment. Journal of Contemporary Psychotherapy, 44(2), 117–126. 
Doi:10.1007/s10879-013-9246-8  
National Institute for Healthcare and Excellence (2004). Eating disorders: Core interventions in 
the treatment and management of anorexia nervosa, bulimia nervosa and related eating 
disorders. Clinical Guideline (GC9). Retrieved October 30, 2017, from 
https://www.nice.org.uk/guidance/cg9/evidence/full-guideline-243824221  
National Institute for Health and Clinical Excellence (2009). Borderline personality disorder: 




Treatment and management. CG78. London. Retrieved September, 20, 2017 from 
https://www.nice.org.uk/guidance/cg78  
Nolte, T., Bolling, D. Z., Hudac, C. M., Fonagy, P., Mayes, L., & Pelphrey, K. A. (2013). Brain 
mechanisms underlying the impact of attachment-related stress on social cognition. Frontiers 
in Human Neuroscience, 7, 816. Doi: 10.3389/fnhum.2013.00816 
O‘Connor, S., Tully, M., Ryan, B., Bradley, J., Baxter, G., & McDonough, S. (2015). Failure of a 
numerical quality assessment scale to identify potential risk of bias in a systematic review: A 
comparison study. BMC Research Notes, 8, 224. Doi: 10.1186/s13104-015-1181-1 
Ougrin, D., Tranah, T., Leigh, E., Taylor, L., & Asarnow, J. R. (2012). Practitioner review: Self-
harm in adolescents. Journal of Child Psychology and Psychiatry, 53(4), 337–350. Doi: 
10.1111/j.1469-7610.2012.02525.x   
Pitt, V. (2010) Are day centres outdated in the personalisation era? Community Care. Retrieved 
October 16, 2017, from http://www.communitycare.co.uk/2010/12/03/are-day-
centresoutdated-in-the-personalisation-era/ r  
Ramires, V., Schwan, S., & Midgley, N. (2012). Mentalization-based therapy with maltreated 
children living in shelters in southern Brazil: A single case study. Psychoanalytic 
Psychotherapy, 26(4), 308–326. Doi: 10.1080/02668734.2012.730546  
Robinson, P., Bateman, A., Roberts, A., Fonagy, P., Bogaardt, A., Clare, A.,… Skårderud, F. 
(2016). The NOURISHED randomised controlled trial comparing mentalisation based 
treatment for eating disorders (MBT-ED) with specialist supportive clinical management 
(SSCM-ED) for patients with eating disorders and symptoms of borderline personality 
disorder. Trials, 17(1), 1-15. Doi: 10.1186/s13063-016-1606-8  
Rossouw, T. I., & Fonagy, P. (2012). Mentalization-based treatment for self-harm in adolescents: 
A randomized controlled trial. Journal of the American Academy of Child & Adolescent 
Psychiatry, 51(12), 1304–1313.  Doi: 10.1016/j.jaac.2012.09.018 




Ryan, R. (2014). Heterogeneity and subgroup analyses in Cochrane Consumers and 
Communication Review Group reviews: Planning the analysis at protocol stage. Cochrane 
Consumer Community Review. Retrieved October 7, 2017, from http://cccrg.cochrane.org  
Salkovkis, P. M. (1995). Demonstrating specific effects in cognitive behavioural therapy. In: M. 
Aveline & D. A. Shapiro (Eds.), Research foundations for Psychotherapy Research (pp. 191–
228).  Chichester: Wiley & Sons.  
Sobell, L. C., & Sobell, M. B. (1992). Timeline follow-back: A technique for assessing self-
reported alcohol consumption. In: R. Z. Litten & J. Allen (Eds.), Measuring alcohol 
consumption: Psychosocial and biological methods (pp. 4–72). Totowa, NJ: Humana Press. 
Spielberger, C. D., Gorsuch, R. L., Lushene, R., Vagg, P. R., & Jacobs, G. A. (1983). Manual for 
the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press. 
Spielberger, C. D. (1996). State-Trait Anger Expression Inventory: Professional manual. Odessa, 
FL: Psychological Assessment Resources, Inc. 
 
Spitzer, R. L., Kroenke, K., & Williams, J. B. (1999). Validation and utility of a self-report 
version of PRIME-MD: The PHQ primary care study. Primary Care Evaluation of Mental 
Disorders. Patient Health Questionnaire. Journal of American Medical Association, 282(18), 
1737–1744. Doi: 10.1001/jama.282.18.1737  
Stoffers-Winterling, J. M., Völlm, B.A., Rücker, G., Timmer, A., Huband, N., & Lieb K (2012). 
Psychological therapies for people with borderline personality disorder. Cochrane Database 
of Systematic Reviews, (8) Art. No.: CD005652. Doi: 10.1002/14651858.CD005652.pub2 
Stuss, D. T., Alexander, M. P., & Gallup Jr., G. G. (2001). The frontal lobes are necessary for 
‗theory of mind‘. Brain, 124 (2), 279–286. 
Suchman, N. E., & Bers, S. A. (2015). Mothering from the inside out: A mentalization-based 
intervention for mothers in substance use treatment. New Haven, CT: Yale University School 





Suchman, N. E., DeCoste, C., Castiglioni, N., McMahon, T. J., Rounsaville, B., & Mayes, L. 
(2010). The Mothers and Toddlers Program, an attachment-based parenting intervention for 
substance using women: Post-treatment results from a randomized clinical pilot. Attachment 
& Human Development, 12(5), 483–504. Doi: 10.1080/14616734.2010.501983 
Suchman, N. E., DeCoste, C. L., McMahon, T. J., Dalton, R., Mayes L. C., & Borelli, J. (2017). 
Mothering from the inside out: Results of a second randomized clinical trial testing a 
mentalization-based intervention for mothers in addiction treatment. Development and 
Psychopathology, 29, 617–636. Doi: 10.1017/S0954579417000220 
Tajika, A., Ogawa, Y., Takeshima, N., Hayasaka, Y., & Furukawa, T. A. (2015). Replication and 
contradiction of highly cited research papers in psychiatry: 10-year follow-up. British 
Journal of Psychiatry 207, 357–362. Doi: 10.1192/bjp.bp.113.143701  
Thomsen, M., Ruocco, A., Uliaszek, A., Mathiesen, B., & Simonsen, E. (2017). Changes in 
neurocognitive functioning after 6 months of mentalization-based treatment for borderline 
personality disorder. Journal of Personality Disorders, 31(3), 306–324. Doi: 
10.1521/pedi_2016_30_250  
Trac, M. H., McArthur, E., Jandoc, R., Dixon, S. N., Nash, D. M., Hackam, D. G., & Garg, A. X. 
(2016). Macrolide antibiotics and the risk of ventricular arrhythmia in older adults. CMAJ : 
Canadian Medical Association Journal, 188(7), 120–129.  Doi:10.1503/cmaj.15090 
Verheul, R., Andrea, H., Berghout, C. C., Dolan, C., Busschbach, J. J. V., Van der Kroft, P. J. 
A.,…Fonagy, P. (2008). Severity Indices of Personality Problems (SIPP-118): Development, 
factor structure, reliability, and validity. Psychological Assessment, 20, 23–34. Doi: 
10.1037/1040-3590.20.1.23 
Viswanathan, M., Ansari, M. T., Berkman, N. D., Chang, S., Hartling, L., McPheeters, 
M.,…Treadwell, J. R. (2012). Assessing the risk of bias of individual studies in systematic 




reviews of health care interventions. In: Methods guide for effectiveness and comparative 
effectiveness reviews. Rockville (MD): Agency for Healthcare Research and Quality (US). 
Retrieved  September 20, 2017, from https://www.ncbi.nlm.nih.gov/books/NBK91433/  
Vrouva, I., Fonagy, P., Fearon, P. R., & Roussouw, T. (2010). The risk-taking and self-harm 
inventory for adolescents: Development and psychometric evaluation. Psychological 
Assessment, 22(4), 852–865. Doi: 10.1037/a0020583 
Walden, T. A., Harris, V. S., & Catron, T. F. (2003). How I feel: A self report measure of 
emotional arousal and regulation for children. Psychological Assessment, 15(3), 399–412. 
Doi: 10.1037/1040-3590.15.3.399 
Ware, J, E., Kosinski, M., & Keller, S. D. (1996). A 12-item short-form health survey: 
Construction of scales and preliminary tests of reliability and validity. Medical Care, 34(3), 
220–233. 
Web of Science (2017). Thomson Reuters search. Retrieved April 15, 2017, from 
https://apps.webofknowledge.com/Search.do?product=WOS&SID=P2KsEZZ4ddzVDbjhVP
2&search_mode=GeneralSearch&prID=c9cc0dfb-46e1-42b9-ab3a-43b2d62e6d5e  
Webster-Stratton, C., & Reid, M. J. (2010). The Incredible Years parents, teachers and children 
training series: A multifaceted treatment approach for young children with conduct problems. 
In: J. Weisz & A. Kazdin (Eds.), Evidence-based psychotherapies for children and 
adolescents (2nd ed.) (pp. 194–210). New York: Guilford Press. 
Wechsler, D. (2010). The measurement and appraisal of adult intelligence. (4th ed.). Baltimore: 
Williams & Wilkins. 
Weissman, M. (1999). Social Adjustment Scale – Self-report (SAS-SR) user’s manual. North 
Tonawanda, NY: Multi-Health Systems. 
WHOQOL Group (1998). Development of the World Health Organisation WHOQOL-BREF 
quality of life assessment. Psychological Medicine, 28, 551–558. 




Wood, L., Egger, M., Gluud, L. L., Schulz, K. F., Jüni, P., Altman, D. G.,…Sterne, J. A. C. 
(2008). Empirical evidence of bias in treatment effect estimates in controlled trials with 
different interventions and outcomes: Meta-epidemiological study. British Medical Journal, 
336(7644), 601–605.  
Yakeley, J., & Williams, A. (2014). Antisocial personality disorder: New directions. Advances in 
Psychiatric Treatment, 20(2), 132–143. Doi: 10.1192/apt.bp.113.011205 
Zanarini, M. C., Vujanovic, A. A., Parachini, E. A., Boulanger, J. L., & Frankenburg, F. R. 
(2003). Zanarini rating scale for borderline personality disorder (ZAN-BPD): A continuous 
measure of DSM-IV borderline psychopathology. Journal of Personality Disorders, 17, 233–
242.  
Zeanah, C. H., & Benoit, D. (1993). Clinical applications of a parent perception interview in 














Figure 1. PRISMA flow diagram Note. DBT=Dialectical Behavioural Therapy, MBT=Mentalisation based 
treatment, PRISMA=Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
 
 







































7-year old child 



















Substantial decline in depressive symptoms with CDI 
























    4 GAF scores changed by 15 points and SCL-90-R/GSI 
dropped from 1.50 to 0.68 











































Age= 30.3 (5.86) 
and 68% females 
in MBT and age= 
33.3 (6.60) and 

































Significantly greater decrease on suicide attempts (p<.01) 
and self-harm [Kendall´s W=.21, x2(3)=11.9,p<.008] in 
the MBT group as compared to SPC group posttreatment.  
After 18 months clients in the MBT group showed being 
significantly lower scores in the BDI [F (1,45)=32.6, 
p<.001], SCL-90-R [F (1,33)=30.2, p<.001], SAS [F 
(1,36)=25.2, p<.001] and in the IIP [Wilks´s lambda=.87, 
F (1,37)=5.4, p<.001] than SCU group  
After 5 years the MBT group showed less suicidality 
(23% vs 74%), less access to psychiatric services, 
medication use and higher GAF (45% above 60 vs 10%) 
than SCU group.  
 
 


























80% female, 76% 
white in MBT; 
age=30.9 (7.9) 
79% female, 68% 
white SCM.  















Self-harm (24% vs 44%) and suicide attempts (32% vs 
47%) were significantly lower in MBT posttreatment. 
The reduction symptomatology was greater in MBT, with 
substantial effect sizes for IIP (d=.95, 95% CI=0.59-1.3), 
SAS (d=.72, 95% CI=0.37-1.06) and modest for BDI 
(d=.45, 95%, CI=0.10-0.79). Anger (t=2.05, p<.05) 
paranoia (t=3.06, p<.01) and hostility (t=3.53, p<.001) 



















(1.2), 87% female 
and 75% 














24 Self-harm and depression reduced in both groups. Linear 
decrease was significantly greater in MBT-A for both 
self-harm (p<.001) and depression (p<.04). The reduction 
in self-reported BPD features (BPFS-C) was also greater 
for MBT-A (d=.36). Mentalisation (HIF) increased more 
in MBT-A (d=.38) and attachment avoidance decreased 




































94% female and 
82% white in 
MBT-ED; 
age=30.8 (10.0), 
91% female and 























21* 47% compliance in MBT-ED and 37% in SSCM-ED. No 
significant differences between interventions in the global 
EDE and ZAN-BPD at either 6, 12 or 18 months 
(p>0.05).  
Improvement at EDE global scores in the MBT-ED arm 
at 18 months with a -1.2 point reduction (95% CI -1.81 to 
0.56, p<.001). The global ZAN-BPD scores also 
decreased for both MBT-ED (95% CI -12.68 to -4.95, 
p<.001) and SSCM-ED (95% CI -12.49 to -2.55 p<.003) 






















for PG  
MBT-PT 1 hour 
weekly sessions 
between 6 and 
12 weeks  


























17 STAXI scores reduced at 3 months follow-up (ß =-2.94, 
SE=1.06, <=-2.77, p<..01) along with PSS scores (ß =-
1.21, SE=.53, <=-2.28, p<.05) and SDQ scores (ß =-1.97, 
SE=.61, z=-3.24, p<.01). There were no significant 
differences between treatments in the scores of the 
STAXI, PRFQ, PDI, PAM, RAM OR SDQ (p>.05).  











































19 MIO mothers had significantly (p<0.05) higher reflective 
functioning (PDI) (d=.56) and higher caregiving 
behaviour scores (d=.41). Small differences showed that 
MIO mothers had less psychiatric symptoms and 
substance misuse PE mother posttreatment.  Therapist 
fidelity to MIO model was associated with improvement 
in overall (R2 =0.41, ß =0.74), highest (R2 Δ=0.50, 
ß =0.81) and lowest reflective functioning scores 

































20 MIO mothers had higher reflective functioning (PDI) 
scores (d=.36), higher mental coherent representation 
scores (d=.41) and higher engagement with their children 
(d=.21) than PE mothers at 3 month follow-up. PE 
mothers had less psychiatric symptom than MIO mothers 
(d=.54) at 3-month follow-up. MIO mothers decreased 
heroin use moderately (d=-.29) whereas PE mothers 
increased (d=.21).  
 










































Age= 29.5 (6.5) 
97% females in 
MBT and 
age=29.7 (6.8) 
93% females in 
control/supportive 
therapy (ST) group 
 
 
MBT= 2 years 
individual and 

























Psychiatric symptoms decreased significantly at 2-year 
posttreatment for both groups (p<.0001). Pre-post effect 
sizes were large or very large (d=.5-2.1) and significant 
(p<.01) for depression, anxiety, social functioning and 
general level of functioning but the differences between 
the two treatments were not statistically significant 
(Fs<2.9, all ps>0.13).  Treatment gains were maintained 













Depression Age= 38.5 (8.9) 
and 82% female 
third-wave CT; 
age=40.3 (6.8) 
and 91% female 
MBT  
18 weeks MBT  
 
18 weeks third 






19 No significant differences were found between the two 
groups regarding BDI, SCL-90-R OR WHO-5 at 18 
weeks posttreatment. However, regarding HDRS scores, 





































































The BSI symptoms decreased significantly posttreatment 
(p<.001, d=1.46) and personality functioning improved 
with large effect sizes on self-control (p<.01, d=1.29), 
social concordance (p<.05, d=.70), identity integration 
(p<.01, d=1.42) and responsibility (p<.05, d=.58). 
Quality of life (EQ5D) scores also improved significantly 
(p<.05, d=1.11).  























17 Scores of symptom distress, depression and quality of all 
improved during 18 months (d=.68 to 1.26) and reaching 
statistical significance at the 12-month measurement 
(p<.05). Borderline symptoms also improved 
significantly after 18 months (p<.001) with an effect size 
of d=1.23.  
 
 


























BPD Age= 30.0 (6.17), 
69% females in 
MBT; 30.3 (7.76) 










Both groups improved in all outcome measures after 36 
months. Comparison of effect sizes showed greater 
improvements in the MBT group with large effects in the 
reduction of psychiatric symptoms (d=-.71 d=-.85 at 
posttreatment and follow-up respectively) and moderate 
effect sizes in improvement of personality functioning 





































14 Only one client in the MBT group and two in the SPT 
group maintained an eating disorder diagnosis (x2=.66; 
p<.042) posttreatment. Both treatments improved 
psychiatric symptoms in the HAM-D, HAM-A, TAS-20, 
GAF, SCL, CGI, SASS, DES, and BUT (ps<0.05). 
Analyses only differentiated between the two groups in 































BPD Age= 26.0 (6.0), 
84% females in 
MBT; 30.0 (7.0) 
83% females in 
OPD.  
 
3 year MBT 









15* Both groups showed reductions in self-harming (89% to 
27% in MBT) and suicide attempts (35% to 6% in MBT) 
posttreatment with no significant differences between 
groups (p>.05). BSI reductions were significantly 
(p<.001) better for MBT (reduction from M=2.0, SD=0.8 
to M=0.8, SD=0.8) than for psychodynamic (reduction 
from M=2.1, SD=0.8, to M=1.4, SD=0.7). GAF 
improvements and interpersonal problem reduction were 
also significantly greater for MBT (p<.001) 
posttreatment.  
 




































Significant reductions in borderline symptoms ([BPFS-
C], p<.001) as well as significant reductions in the 
internalising psychopathology ([YSR], p<.005), peer and 
parent attachment (IPPA-R, p<.001). No between groups 
differences in the externalising psychopathology or risk-
taking behaviour (RTSHI-A, p>.05) were found.  
 
 







































10 All clinical outcomes improved after discharge. The 
differences were significant for anxiety, depression 
(p<.05), psychological quality of life and all PANSS 
scores (p<.001). High attendance rates (80%) were 
reported and professionals were highly involved 
























diagnoses in MBT 
; age=30.59 (8.82)  



















Improvements in the ZAN-BPD t(17)=5.19, p<.05 and 
HDRS t(17)=2.71 p<.05 posttreatment. Main effect of 
time for processing speed F (1,31)=5.56, p<.03, n2p =.15 
with MBT improving posttreatment. Significant Time X 
Group interaction for sustained attention (1,44)=8.98, 
p<.01, n2p =0.17 and perceptual reasoning F(1,44)=19.92, 
p<.001, n2p=.31.MBT improved more in perceptual 
reasoning t(44)=2.09,p<.05, d=.61 and differences in 
attention were not significant posttreatment.  
 


























BPD Age=29.8 (6.3) 
and 70% female 
PRE-REORG; 
27.9 (5.7), 81% 
females REORG 
18-months day 




18 months BSI, SCL-90-
R, GSI, 
SIPP_118 
18 Psychiatric symptoms decreased (BSI, SCL-90-R) and 
improvements in personality functioning at 18 month 
follow up in both groups (ps<.05). Outcomes decreased 
by half in the REORG group, (18 months, PRE-REORG 
d=.81-1.22 vs d=.03-.71 REORG) and these differences 
were significant posttreatment and at 18 month follow-
up.  
Note. *Papers that were assessed by two independent raters, 1Downs and Black (1998) total score, 2CDI=Children‘s depression inventory (Helsel & Matson, 1984),3BPD=Borderline Personality 
Disorder, 4SPD=Schizotypal Personality Disorder, 5GAF=Global Assessment Functioning, 6SCL-90-R= Revised Symptom Checklist (Derogatis, 1977),7GSI=Global Severity Index (Derogatis 
& Melisaratos,1983), 8SPC=Standard Psychiatric Care, 9BDI=Beck Depression Inventory (Beck, Steer & Brown,1996), 10STAI=State Trait Anxiety Inventory (Spielberger et al., 1983), 
11SAS=Social Adjustment Scale (Weissman,1999), 12IIP-C=Inventory of Interpersonal Problems –Circumflex version (Alden et al., 1990), 13SCM=Structured Clinical Management (Bateman & 
Krawitz, 2013), 14APD=Antisocial Personality Disorder, 15TAU=Treatment as Usual, 16MBT-A=Mentalisation based treatment for adolescents, 17MBT-F=Mentalisation based family therapy, 
18RTSHI=Risk Taking and Self-Harm Inventory (Vrouva, Fonagy, Fearon & Roussouw, 2010), 19MFQ=Mood and Feelings Questionnaire (Angold et al., 1987), 20BPFS-C=Borderline 
Personality Features Scale for Children (Crick et al., 2005), 21HIF=How I Feel Questionnaire (Walden Harris & Catron, 2003), 22ECR=Experience of Close Relationships Inventory (Fraley, 
Waller & Brenan, 2000), 23MBT-ED= Mentalisation Based Treatment for Eating Disorders, 24SSCM-ED=Supportive Clinical Management for Eating Disorders, 25EDE=Eating Disorder 
Examination (Fariburn & Cooper, 1993), 26EQ-5D=EuroQol-5D (EuroQoL, 1990), 27DASS-21=Depression, Anxiety, Stress Scale-21 (Lovibond & Lovibond, 1995), 28BFI=Big Five Inventory 
(John, Donahue& Kentle, 1991), 29ZAN-BPD=Zanarini Rating for Borderline Personality Disorder (Zanarini et al., 2003), 30MBT-PT=Mentalisation based treatment for parental conflict, 
31PG=Parent´s Group, 32STAXI=State-Anger Expression Inventory (Spielberger, 1996), 33PRFQ-1=Parental Reflective Function Questionnaire (Luyten et al., 2017),34PDI=Parent Development 
Interview (Aber et al., 1985), 35PSS=Perceived Stress Scale (Cohen, Kamarck & Mermelstein,1983), 36PAM=Parenting Alliance Measure (Abidin & Konold, 1999), 37RAM=Relationship 
Attribution Measure (Finchman & Bradbury, 1992), 38SDQ=Strengths and Difficulties Questionnaire (Goodman, 1997), 39SIMS-PR=Security in the Marital-Subsystem Parent Report (Davies et 
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al, 2002), 40PHQ-9=Patient Health Questionnaire (Spitzer, Kroenke & Williams, 1999), 41MIO=Mothering from the Inside Out (Suchman & Bers, 2015), 42PE=Parent Education, 43BSI=Brief 
Symptom Inventory (Derogatis,1975),44WMCI=Working Model of the Child Interview (Zeanah & Benoit, 1993), 45NCAST=Nursing Child Assessment Satellite Training  (Barnard & Eyres, 
1979), 46SSP=Strange Situation Procedure (Ainsworth & Bell,1970), 47CBP=Curiosity Box Paradign (Mayes, Carter & Stubbe,1993),  48TFLB=Timeline Followback Interview (Sobell & 
Sobell,1992), BAI49=Beck Anxiety Inventory (Beck & Steer,1990) 50CT=Cognitive Therapy, 51HDRS=Hamilton Rating Scale for Depression (Hamilton, 1960), 52WHO-5=Who Five Well-
being Index (Bech, 2004),53SIPP-118=Severity Indices of Personality Problems (Verheur et al., 2008) 54BPDSI=Borderline Personality Disorder Severity Index (Arntz, 1999), 55OPD=Other 
Specialised Psychotherapeutic Treatment, 56SPT=Short-Term Psychodynamic Treatment 57 TAS-20= Toronto Alexythimia Scale (Bagby et al.,1994), 58HAM-A=Hamilton Anxiety Scale 
(Hamilton,1959) 59HAM-D=Hamilton Depression Scale (Hamilton, 1960) 60EDI=Eating Disorder Inventory (Garner,1991), 61BES=Binge Eating Scale (Gormally et al.,1982) 62BUT=Body 
Uneasiness test (Cuzzolaro et al.,2006) 63CGI=Clinical Global Impression (Kadouri, Corruble & Falissard, 2007), 64SASS=Social Adaptation Self-Evaluation Scale (Bosc, Dubini & Polin, 
1997),65SF-12=Short-form Survey (Ware, Kosinski & Keller, 1996), 66DES=Dissociative Experience Scale (Bernsteim & Putnam, 1986),67MBT-P=Mentalisation based treatment for parents, 
68MBT-I= Mentalisation based treatment (individual),  68PAI=Personality Assessment Inventory (Morey & Suman 2008),70YSR=Youth Self Report (Achenbach,1991), 71BDI-Y=Beck 
Depression Inventory for Youth (Beck, Beck & Jolly, 2005), 72IPPA-R=Inventory of Parent and Peer Attachment-Revised (Armsden & Greenberg, 1987),73RFQ-Y=Reflective Functioning 
Questionnaire for Youth (Ha et al., 2013), 74AMBIT=Adolescent Mentalisation-Based Integrative Treatment (Bevington et al., 2013), 75WHOQOL= World Health Organisation Quality of life 
questionnaire (WHOQOL Group,1998), 76PANSS=Positive and Negative Syndrome Scale (Kay, Fizbein & Opler, 1987), 77BYI=Beck Youth Inventory (Beck et al., 2005),  78WAIS-
IV=Wechsler Adult Intelligence Scale Fourth Edition (Wechsler, 2010), 79CANTAB=Cambridge Neuropsychological Test Automated Fray & Robbins,1998) 80HVLT=Hopkins Verbal 
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Table 1.1  
Summary of Primary Outcomes, Measures and Results 
Study Primary Outcomes Measure Results 
Ramires, Schwan & Midgley (2012) Depression Children‘s Depression Inventory (CDI) Reduction from 40 to 5 
Morken,Karterud & Arefjord (2014) General Psychopathology  Revised Symptom Checklist (SCL-90-R) Reduction from 1.68 to 0.5  
Bateman & Fonagy (1999;2008)  Depression Beck Depression Inventory (BDI) F (1,45)=32.6, p<.001 
Bateman & Fonagy (2009;2016)  Depression  Beck Depression Inventory (BDI) d=.45, 95%, CI=0.10-0.79 
Rossouw & Fonagy (2012)  Self-harm  Risk taking and self-harm inventory (RTSHI) Reduction favourable to MBT (p<.001) 
Robinson et al., (2016)  BPD features, Eating disorder features BPD Zanarini Scale, Eating Disorder 
Examination (EDE)  
No significant differences in any scale 
(p>0.05).  
Hertzmann et al., (2016)  Anger Stat Trait Anger Expression Inventory 
(STAXI) 
STAXI scores reduced at 3 months follow-up 
(ß =-2.94, SE=1.06, <=-2.77, p<..01) 
Suchman et al., (2010)  Reflective Functioning, Caregiving 
Behaviours 
Parent Development Interview (PDI) Significantly (p<0.05) higher reflective 
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Study Primary Outcomes Measure Results 
Suchman et al., (2017)  Reflective Functioning, Caregiving 
Behaviours 
Parent Development Interview (PDI) Higher reflective functioning scores (d=.36), 
mental coherent representation scores (d=.41) 
and engagement with their children (d=.21) 
Jørgensen et al., (2013;2014) General Psychopathology, Depression  Revised Symptom Checklist (SCL-90-R) and 
Beck Depression Inventory (BDI)  
Greater reduction of both in MBT (p<.0001). 
Jakobsen et al., (2014)  Depression Hamilton Depression Scale (HDRS) Significant difference (p<.03) favouring third 
wave-CT therapy. 
Laurenssen et al., (2014) General Psychopathology Brief Symptom Inventory (BSI) Symptoms decreased significantly 
posttreatment (p<.001, d=1.46) 
Bales et al., (2012)  Depression and General Psychopathology   Beck Depression Inventory (BDI) and Brief 
Symptom Inventory (BSI) 
All improved during 18 months (d=.68 to 
1.26) 
Bales et al., (2015) General Psychopathology Brief Symptom Inventory (BSI) and General 
Symptom Inventory (GSI) 
Large effects in the reduction of psychiatric 
symptoms (d=-.71 d=-.85 at posttreatment 
and follow-up respectively) 
Balestrieri et al., (2015) Eating Disorder Diagnosis  Structured Clinical Interview (SCID) Only one client in the MBT group and two in 
the SPT group maintained diagnosis (x2=.66; 
p<.042) 
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Study Primary Outcomes Measure Results 
Kvarstein et al., (2015) Self-harm and Suicide Attempts Medical Records, General Symptom 
Inventory (GSI) 
Both groups showed reductions in self-
harming (89% to 27% in MBT) and suicide 
attempts (35% to 6% in MBT).  
Bo et al., (2016) BPD features/symptoms  Borderline Personality Features Scale (BPFS)  Significant reductions in borderline 
symptoms ([BPFS-C], p<.001) 
Griffiths et al., (2017) Depression and Quality of Life Beck Depression Inventory (BDI), WHO 
quality of life questionnaire (WHOQL) 
Differences were significant for depression 
(p<.05), psychological quality of life 
Thomsen et al., (2017) BPD features Zanarini BPD scale (ZAN-BPD) Improvements in the ZAN-BPD t(17)=5.19, 
p<.05 
Bales et al., (2017) General Psychopathology   Brief Symptom Inventory (BSI), Revised 
Symptom Checklist (SCL-90-R)  
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Note. - Corresponds to a judgement of high risk; + corresponds to a judgement of low risk, ? 
represents that the judgement is unclear as there was not sufficient information, N/A corresponds to 
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Appendix 1-B: Quality Assessment Checklist 
2
(Downs & Black, 1998; Trac et al., 2016
3
) 
                                                     
Note Yes=1 point, except in question 5 is 2 points, Partially=1 point, Unable/No=0 points 
 
2
Further guidance on how to rate the Downs & Black (1998) scale can be found on http://jech.bmj.com/content/jech/52/6/377.full.pdf  
3
 Question 27 was the only modified item by Trac et al., (2016) from the original Downs & Black (1998) checklist tool. 
4












Fonagy (2009) 4 
 

























1. Is the hypothesis/aim/objective of the study clearly described? 
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2. Are the main outcomes to be measured clearly described in 
the Introduction or Methods section?  
Yes No Yes Yes Yes      Yes    Yes         Yes         Yes           Yes        Yes 
3.Are the characteristics of the patients included in the study 
clearly described ? 
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5. Are the distributions of principal confounders in each group 
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6. Are the main findings of the study clearly described? No Yes Yes Yes Yes Yes        Yes             Yes             Yes         Yes          Yes 
7. Does the study provide estimates of the random variability in 
the data for the main outcomes? 
No No No Yes Yes Yes        Yes          Yes           Yes        Yes           No 
8. Have all important adverse events that may be a consequence 
of the intervention been reported? 
No No No 
No 
No 
No Yes No           No                Yes          Yes           No 
9. Have the characteristics of patients lost to follow-up been 
described? 
No No No  Yes Yes Yes No     Yes Yes Yes     No 
10. Have actual probability values been reported (e.g. 0.035 
rather than <.05) for the main outcomes? 
No     No Yes   Yes Yes Yes   Yes       No       No            Yes               Yes 
External Validity            
11. Were the subjects asked to participate in the study 
representative of the entire population? 
No No Yes    No Yes No No        No No Unable Unable 
12. Were subjects prepared to participate representative of the 
population? 
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13. Were the staff, places, and facilities representative of the 
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15. Was an attempt made to blind those measuring the main 
outcomes of the intervention? 
No No No 
 
                  No 
Yes                   Yes Unable               Unable Unable Unable Yes 
16. If any of the results of were based on ―data dredging‖, was 
this made clear? 
N/A N/A Yes                     Yes No                   Yes Yes          Yes Yes Yes Yes 
17. In trials, do analyses adjust for different follow-ups, or in 
case-control, is the time period between the intervention and 
outcome the same? 
N/A N/A Yes 
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Yes        Yes Yes Yes Yes 
18. Were the statistical tests appropriate? No No Yes 
Yes 
 
               Yes Yes Yes         Yes Yes Yes Yes 
19. Was compliance with the intervention/s reliable? Yes Yes Unable Yes              Yes 
No 
 
Yes          Yes Yes Unable Yes 
20. Were the main outcome measures used valid and reliable? Yes Yes                   Yes Yes               Yes Yes Yes        Yes Yes Yes Yes 
Internal Validity            
21. Were the patients in different intervention groups or were 
the cases and controls recruited from the same population? 
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22. Were study subjects in different intervention groups or were 
the cases and controls recruited over the same period of time? 
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23. Were study subjects randomised to intervention groups? No No                Yes Yes Yes Yes Yes        Yes Yes No Yes 
24. Was the randomised intervention assignment concealed from 
both patients and health care staff? 
No No 
 
               No 
 
Yes Yes No No          No No Unable Unable 
25. Was there adequate adjustment for confounding in the 
analyses from which the main findings were drawn? 
No No Yes Yes                Yes Yes Unable       Yes Yes No No 
26. Were losses of patients to follow-up taken into account? No No               Yes Yes Yes Yes Yes        Yes Yes Yes Yes 
Power            
27. Did the study have sufficient power to detect a clinically 
important effect where the probability value for a difference 
being due to chance is less than 5%? 
No No      Unable Unable   Yes    No Unable               Unable Unable Unable No 
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Internal Validity-Bias          
14. Was an attempt made to blind study subjects to the intervention? 
 
 
No No No No     No No No No No 
15. Was an attempt made to blind those measuring the main outcomes of the intervention? No No No No   No No No No No 
16. If any of the results of were based on ―data dredging‖, was this made clear? Yes Yes Yes Yes    Yes Yes Unable Yes Yes 
17. In trials, do analyses adjust for different follow-ups, or in case-control, is the time period between the 
intervention and outcome the same? 
Unable Yes Unable Yes            Unable Yes Yes Yes Yes 









































20. Were the main outcome measures used valid and reliable? Unable Yes            Yes Yes        Yes Yes Yes Yes Yes 
Internal Validity  
21. Were the patients in different intervention groups or were the cases and controls recruited from the same 
population? 
Yes Unable No No        Yes Yes Yes No Yes 
22. Were study subjects in different intervention groups or were the cases and controls recruited over the same 
period of time? 
Yes  Yes No No      No Yes No Unable Yes 
23. Were study subjects randomised to intervention groups? No  No No No       No No No No No 
24. Was the randomised intervention assignment concealed from both patients and health care staff? No No No No       No No No No No 
25. Was there adequate adjustment for confounding in the analyses from which the main findings were drawn? Unable Yes Yes Unable            Unable No No No Yes 
26. Were losses of patients to follow-up taken into account?  No Yes Yes No          Yes No No Yes Yes 
Power  
27. Did the study have sufficient power to detect a clinically important effect where the probability value for a 
difference being due to chance is less than 5%? 
      Unable               Unable                Unable             Unable          Unable            Unable         Unable               Unable                  Unable 
Total Score         11       17          14           14       15 10           14       10           14 1            18 




               Quality Assessment Checklist: Scores from an Independent Rater 
 
  Bateman and 
Fonagy, 2009 
 




Robinson et al 2016 Thomsen et al. 2017 
1. Is the hypothesis/aim/objective of the study clearly described?  
                  1 
                1                1                1 1 
2. Are the main outcomes to be measured clearly described in the Introduction 
or Methods section?  
 
1 1 1 1 1 
3.Are the characteristics of the patients included in the study clearly 
described? 
1 1 1 1                 1 
4.Are the interventions of interest clearly described?                  1                   1                    1                  1                1 
5. Are the distributions of principal confounders in each group of subjects to 
be compared clearly described? 
2 1 0 2 1 
6. Are the main findings of the study clearly described? 1 1 1 1 1 
7. Does the study provide estimates of the random variability in the data for 
the main outcomes? 
0 0 0 1                 0 
8. Have all important adverse events that may be a consequence of the 
intervention been reported? 
0 0 0 1               0 
9. Have the characteristics of patients lost to follow-up been described? 1                1 0 1               1 
10. Have actual probability values been reported (e.g. 0.035 rather than <.05) 
for the main outcomes? 
1 0 0 1              1 
External Validity      
11. Were the subjects asked to participate in the study representative of the 
entire population? 
0 0 0 1            0 
12. Were subjects prepared to participate representative of the population? 1 1 1 1             1 
13. Were the staff, places, and facilities representative of the treatment the 
majority of patients? 
0 1 0 0            0 
Internal Validity-Bias      
14. Was an attempt made to blind study subjects to the intervention? 
 
 
0 0 0 0        0 
15. Was an attempt made to blind those measuring the main outcomes of the 
intervention? 
1                0         0                    1     0 
16. If any of the results of were based on ―data dredging‖, was this made 
clear? 
1  1 1 1 1 
17. In trials, do analyses adjust for different follow-ups, or in case-control, is 
the time period between the intervention and outcome the same? 
1 1 0 1 1 













18. Were the statistical tests appropriate?  
1 
1 1 1 1 
19. Was compliance with the intervention/s reliable? 0 0 0 1 0 
20. Were the main outcome measures used valid and reliable? 1 1 1 1 1 
Internal Validity 
21. Were the patients in different intervention groups or were the cases and 
controls recruited from the same population? 
1 1 1 1 1 
22. Were study subjects in different intervention groups or were the cases and 
controls recruited over the same period of time? 
1 1 0 1 1 
23. Were study subjects randomised to intervention groups? 1 1 0 1 0 
24. Was the randomised intervention assignment concealed from both patients 
and health care staff? 
0  0 0 0 0 
25. Was there adequate adjustment for confounding in the analyses from 
which the main findings were drawn? 
1 1 1 1 0 
26. Were losses of patients to follow-up taken into account? 1 1 0 1 0 
Power 
27. Did the study have sufficient power to detect a clinically important effect 
where the probability value for a difference being due to chance is less than 
5%? 
1    1 1 1 0 
Total Score 21 19 12 25  15 
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  Ramires et al., (2012) 
Risk of Bias Judgement Risk 
Selection Bias Randomisation: Non-randomised study 
Recruitment: Explained that it was one of 14 but not explained differences with other cases or why this case chosen. 




Performance Bias Intervention Fidelity: Therapy conducted by a trained therapist with 5 years of experience. Sessions were recorded and supervised by 
experienced therapists (>25 years) according to MBT principles. 




Attrition Bias No attrition Low 
Detection Bias Assessors blinded: Not reported 
Self-reported outcomes: The outcome used was valid and reliable and used in a wide range of countries. 




Reporting Bias Not applicable N/A 
Morken et al., (2014) 
Risk of Bias Judgement Risk 
Selection Bias Randomisation: Non-randomised study 
Recruitment: Criteria why this case was chosen is not specified 




Performance Bias Intervention Fidelity: Not reported 






                                                     
4
 Further guidance on how to judge risk of bias can be found on https://effectivehealthcare.ahrq.gov/topics/methods-guidance-bias-individual-
studies/methods/  
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Risk of Bias Judgement Risk 
Attrition Bias No attrition Low 
Detection Bias Assessors blinded: Not reported 
Self-reported outcomes: The outcome measures were valid and reliable  




Reporting Bias Not Applicable N/A 
Bateman & Fonagy (1999) 
Risk of Bias Judgement Risk 
Selection Bias Randomisation: Not described clearly 
Recruitment: All participants recruited from the same population. Source population described 




Performance Bias Intervention Fidelity: All interventions conducted by nurses with no formal psychotherapy qualifications. Did not follow manual.  
Concurrent Intervention: Participants could not receive any psychiatric or psychological intervention elsewhere.  
High 
Low 
Attrition Bias Three participants in treatment condition dropped out and three in the control group crossed over. Analyses showed non-significant 
differences compared with the rest of participants. Reasons were described. 
Low 
Detection Bias Assessors blinded: Not reported 
Self-reported outcomes: The self-report instruments were valid and reliable  




Reporting Bias Protocol for the trial not published Unclear 
Bateman & Fonagy (2009) 
Risk of Bias Judgement Risk 
Selection Bias Randomisation: Used stochastic minimisation program balancing for age, gender and presence of antisocial personality disorder 
Recruitment: All participants recruited from the same hospital 




Risk of Bias Judgement Risk 
Performance Bias Intervention Fidelity: Manualised MBT and adherence scales available upon request Low 
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Concurrent Intervention: No concurrent interventions described. Unclear 
Attrition Bias 99 participants of 134 completed treatment. Analyses were conducted following intention to treat principle. No significant differences 
between completers across the groups. 
Low  
Detection Bias Assessors blinded: Assessors were blinded 
Self-reported outcomes: The self-report instruments were valid and reliable  




Reporting Bias All outcomes reported Low 
Rossouw & Fonagy (2012) 
Risk of Bias Judgement Risk 
Selection Bias Randomisation: Independent statistician randomised participants using minimisation algorithm  
Recruitment: Consecutive service users who presented with self-harming in community mental health care 




Performance Bias Intervention Fidelity: Manualised MBT-A and adherence scales available online. 22 therapists received six days MBT adolescent (MBT-A) 
training.  




Attrition Bias 37 out of 80 participants completed treatment. No differences between groups. Analyses followed intention to treat principle. Low 
Detection Bias Assessors blinded: Blinded to allocation 
Self-reported outcomes: The self-report instruments were valid and reliable. 




Reporting Bias All outcomes reported Low 
 
Robinson et al., (2016) 
Risk of Bias Judgement Risk 
Selection Bias Randomisation: Block randomisation stratified by BMI. Randomly varying block sizes were also implemented 
Recruitment: Multi-centre study across three eating disorder and two personality disorder units. Strategy clearly described. 
Confounding: Participants with BMI of less than 15 were excluded, potential confounder. Offered financial incentive to those completing 
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Performance Bias Intervention Fidelity: Manualised MBT-ED and SCM-ED. Random recorded and transcribed sessions rated independently with MBT 
adherence scale.  
Concurrent Intervention: Not allowed 
Low 
Low 
Attrition Bias Out of 68 participants, 53 dropped out by 18 months High 
Detection Bias Assessors blinded: Single blind (researchers and statisticians are blind) 
Self-reported outcomes: The self-report instruments were valid and reliable.  




Reporting Bias All outcomes reported Low 
Hertzmann et al., (2016) 
Risk of Bias Judgement Risk 
Selection Bias Randomisation: Randomly allocated using minimisation criteria.  
Recruitment: Different sources of referral including, solicitors, court judges and mediators. Strategy of recruitment unclear. 
Confounding: No differences between groups in baseline characteristics. Ethnicity and socio-economic status were not reported. Number of 




Performance Bias Intervention Fidelity: Manualised MBT for parental conflict (MBT-PT). MBT adherence scales were used.  
Concurrent Intervention: More than half of the sample was receiving help or support elsewhere 
Low 
High 
Attrition Bias 3 participants out of 30 did not complete the post-treatment assessments.  Low 
Detection Bias Assessors blinded: Not reported 
Self-reported outcomes: The instruments were valid and reliable.  




Risk of Bias Judgement Risk 





Suchman et al., (2010) 
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Risk of Bias Judgement Risk 
Selection Bias Randomisation: Process not described  
Recruitment: Mothers enrolled in substance misuse treatment. Referrals from different professionals and recruited from same population.   
Confounding: No differences between groups in baseline demographic and psychiatric characteristics apart from marital status. Mothers that 




Performance Bias Intervention Fidelity: Manualised MBT for mothers with substance misuse difficulties and manualised parent education group (PE). 
Adherence scales were developed and used by independent raters. 4 therapists: 2 doctorate and 2 masters level provided therapy 
Concurrent Intervention: Participants had access to CBT, counselling and substance misuse treatment among others 
Low 
High 
Attrition Bias All analyses were conducted following intention to treat principle. 72% of the participants completed the intervention in both conditions.   Low 
Detection Bias Assessors blinded: Not reported 
Self-reported outcomes: The instruments were valid and reliable.  




Reporting Bias Not clear whether a prior outcomes were established Unclear 
Suchman et al., (2017) 
Risk of Bias Judgement Risk 
Selection Bias Randomisation: Process not described  
Recruitment: Mothers enrolled in substance misuse treatment. Both groups recruited from same population.  




Performance Bias Intervention Fidelity: Manualised MBT for mothers with substance misuse difficulties and manualised PE. Adherence scales were and by 
independent raters.  
Concurrent Intervention: Participants had access to substance misuse specialised treatment  
Low 
High 
Attrition Bias Analyses following intention to treat principle.17/87-randomised participants did not start treatment and 3 dropped out during treatment. Low 
Risk of Bias Judgement Risk 
Detection Bias Assessors blinded: Not reported 
Self-reported outcomes: The instruments were valid and reliable.  




Reporting Bias All outcomes reported Low 
MBT And Its Evidence Base Status   
 
1-79 
Jørgensen et al., (2013) 
Risk of Bias Judgement Risk 
Selection Bias Randomisation: Method not described  
Recruitment: All participants recruited from the same population.  
Confounding: Both treatments were conducted in the same clinic and by the same therapists.  Baseline significant differences between groups 




Performance Bias Intervention Fidelity: MBT and supportive psychotherapy were not manualised.  
Concurrent Intervention: No psychological intervention. All participants accessed a psycho educational program and medical treatment.   
High 
Low 
Attrition Bias 85 participants out of 111 initiated treatment and 58 finished it. At follow-up data of 43 participants was available High 
Detection Bias Assessors blinded: Not blinded 
Self-reported outcomes: The instruments were valid and reliable.  




Reporting Bias All outcomes reported Low 
Jakobsen et al., (2014) 
Risk of Bias Judgement Risk 
Selection Bias Randomisation: Generated block randomisation sequence unknown to the researchers.  
Recruitment: All participants recruited from the same public psychiatric outpatient clinic during the same period of time 
Confounding: One of the cognitive therapists was the principal investigator (researcher allegiance). Analyses adjusted for baseline differences 





Risk of Bias Judgement Risk 
Performance Bias Intervention Fidelity: External assessors for treatment adherence of both MBT and third-wave cognitive therapy  
Concurrent Intervention: Not reported   
Low 
Low 
Attrition Bias 0/22 participants dropped out of cognitive therapy and 2/22 participants were lost in the MBT group Low 
Detection Bias Assessors blinded: Interviewers were blinded 
Self-reported outcomes: The instruments were valid and reliable.  
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Reporting Bias All outcomes reported Low 
Laurenssen et al., (2014) 
Risk of Bias Judgement Risk 
Selection Bias Randomisation: Non-randomised study 
Recruitment: All participants recruited from the same hospital and referrals clearly described. 




Performance Bias Intervention Fidelity: Adherence not reported although adherence scale used 
Concurrent Intervention: Not reported   
Unclear 
Unclear 
Attrition Bias 2/15 dropped out of treatment and 2/13 did not complete posttreatment questionnaires. 4 out of 15 participants (26%) not included in analyses  High 
Detection Bias Assessors blinded: Unclear 
Self-reported outcomes: The instruments were valid and reliable.  




Reporting Bias A priori established outcomes not clear. Unclear 
 
 
Bales et al., (2012) 
 
Risk of Bias Judgement Risk 
Selection Bias Randomisation: Non-randomised study 
Recruitment: All participants recruited from the same hospital. Clinicians referred the most severe ―clients‖ to MBT program. 




Performance Bias Intervention Fidelity: Eight therapists with varying degree of experience, from junior psychologist to experienced clinical psychologists. 
Tapes sessions were regularly rated using MBT adherence scales 
Concurrent Intervention: Between 13% and 16% of participants had additional treatments but these were not specified.    
Low 
High 
Attrition Bias 7 participants dropped out. Four left the treatment prematurely and three were discharged due to criminal activities. Their data was included in 
the analyses. 
Low 
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Detection Bias Assessors blinded: Unclear 
Self-reported outcomes: The instruments were valid and reliable.  




Reporting Bias No information regarding a priori established outcomes  Unclear 
Bales et al., (2015) 
Risk of Bias Judgement Risk 
Selection Bias Randomisation: Non-randomised study 
Recruitment: Participants in the MBT and in the matched control group were recruited from different settings/hospitals. 
Confounding: Five participants of the 41 invited for assessment could not be interviewed due to staff problems and thus did not participate. 





Performance Bias Intervention Fidelity: Therapists ranging in experience from junior psychologists to experienced psychotherapists. MBT adherence scale used. 
Concurrent Intervention: No concurrent interventions were described.  
Low 
Unclear 
Attrition Bias Attrition not reported but analyses were performed on the intention to treat sample  Low 
Detection Bias Assessors blinded: Independent raters conducted assessments  
Self-reported outcomes: The outcome measures were valid and reliable. 




Risk of Bias Judgement Risk 
Reporting Bias No information regarding a priori established outcomes Unclear 
Balestrieri et al., (2015) 
Risk of Bias Judgement Risk 
Selection Bias Randomisation: Non-randomised study 
Recruitment: Participants in the MBT and in the short-term psychodynamic treatment group recruited from two different settings. 




Performance Bias Intervention Fidelity: Not reported 
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Attrition Bias 5/12 in MBT and 6/12 in short-term psychodynamic group dropped out the treatment. Those who drop out where not significantly different in 
demographic and clinical characteristics. 
Low 
Detection Bias Assessors blinded: Not described 
Self-reported outcomes: The outcome measures were valid and reliable. 




Reporting Bias No information regarding a priori published protocol  Unclear 
Kvarstein et al., (2015) 
Risk of Bias Judgement Risk 
Selection Bias Randomisation: Non-randomised study 
Recruitment: All participants recruited from the same setting but where recruited over different years. Exclusion criteria not described 





Performance Bias Intervention Fidelity: MBT was rated with adherence scale  





Risk of Bias Judgement Risk 
Attrition Bias Drop out defined as finishing treatment before the end of 3 months. 15% in psychodynamic group and 2% in MBT group dropped out. Drop 
outs continued as treatment advanced but characteristics of those who dropped out are not described.  
High 
Detection Bias Assessors blinded: Not described 
Self-reported outcomes: The outcome measures were valid and reliable. 




Reporting Bias No information regarding a priori established outcomes Unclear 
Bo et al., (2016) 
Risk of Bias Judgement Risk 
Selection Bias Randomisation: Non-randomised study 
Recruitment: Participants were recruited from three different clinics. 18 participants met criteria but chose not to participate. No reasons were 
given for this.  
N/A 
High 
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Confounding: Anorexia, substance misuse and parents who were not willing to be involved in family treatment were exclusion criteria, 
potential confounders. High 
Performance Bias Intervention Fidelity: No adherence scales were employed, but fidelity to the manual assessed through supervision 
Concurrent Intervention: No concurrent interventions were described.  
Unclear 
Unclear 
Attrition Bias 9 participants dropped out before completion. No significant differences between completers and non-completers in any measured variables. Low 
Detection Bias Assessors blinded: Not described 
Self-reported outcomes: The outcome measures were valid and reliable and translated into Danish.  




Reporting Bias All outcomes were reported.  Low 
 
 
Griffiths et al., (2017) 
 
Risk of Bias Judgement Risk 
Selection Bias Randomisation: Non-randomised study 
Recruitment: Source population described. All data corresponded to three different teams within the same service.  
Confounding: Baseline demographic characteristics were controlled for in the analyses. Different services used different self-report measures 




Performance Bias Intervention Fidelity: Staff trained in the MBT systemic model (AMBIT) for 4 days. Adherence was not reported.  
Concurrent Intervention: No concurrent interventions were described.  
Unclear 
Unclear 
Attrition Bias Data did not correspond to psychotherapy but to a multimodal organisational approach. 80% of attendance for the appointments offered. 
Clinical differences between those who engaged more and those who engaged less described. 
Unclear 
Detection Bias Assessors blinded: Not described 
Self-reported outcomes: The outcome measures were valid and reliable 




Reporting Bias Not applicable  N/A 
 
Thomsen et al., (2017) 
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Risk of Bias Judgement Risk 
Selection Bias Randomisation: Non-randomised study 
Recruitment: MBT participants and controls were recruited from different sources 
Confounding: MBT participants were matched to non-psychiatric controls on parental education. The intervention group was heterogeneous 





Performance Bias Intervention Fidelity: MBT intervention was conducted according to manualised principles. 
Concurrent Intervention: Parental group therapy and psychoeducation groups were offered 
Low 
Unclear 
Attrition Bias 4/18 participants in the MBT group did not finish the treatment. Only 28/56 controls were re-contacted and reasons were not described.  Unclear 
Detection Bias Assessors blinded: Not described 
Self-reported outcomes: The CANTABB might not measure adequately response inhibition  




Risk of Bias Judgement Risk 
Reporting Bias All outcomes are reported   Low 
Bales et al., (2017) 
Risk of Bias Judgement Risk 
Selection Bias Randomisation: Non-randomised study 
Recruitment: Both groups from the same service. Participants consecutively referred. 




Performance Bias Intervention Fidelity: Both cohorts received 18 months of manualised MBT. Adherence was monitored qualitatively. 
Concurrent Intervention: Not reported 
Unclear 
Unclear 
Attrition Bias 11 eligible participants did not take part. No dropouts during the treatment reported. Analyses performed following intention to treat principle.   Low 
Detection Bias Assessors blinded: Assessment conducted by treatment independent assessors 
Self-reported outcomes: The outcome measures were valid and reliable 




Reporting Bias Not clear if outcomes were a priori established  Unclear 
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Background: The burden of caregiving for a child with asthma has long been documented 
worldwide. Caregivers of asthmatic children often report depressive and anxiety symptoms, 
low quality of life, demoralisation or high stress. To date, no study has explored the 
relationship between mentalising capacity and the mental health of caregivers of asthmatic 
children. Method: Caregivers of children with asthma residing in the United Kingdom (UK) 
were recruited using an online-designed survey. Participants recruited from social media 
support groups and the Asthma UK charity research bulletin completed self-report measures 
of mentalising (Reflective Functioning Questionnaire,RFQ-8), family functioning (Family 
Assessment Device, FAD) mood (7up and 7Down questionnaire, 7U7D) and anxiety (Beck 
Anxiety Inventory, BAI) difficulties. Results: A total of 88 participants completed the full 
survey. Results indicated that poorer mentalising capacity was significantly associated with 
poorer family functioning and increased mood and anxiety symptomatology. Mentalising was 
a significant predictor in all the regression models for depression, hypomania and anxiety, 
explaining 16% of variance in depression and 10% of variance in anxiety, whereas family 
functioning was not a significant predictor in any of the regression models after mentalising 
was included. Greater mentalising capacity was significantly associated with a reduction in 
mood and anxiety scores. Conclusions: These findings suggest that mentalising capacity 
might be a better predictor of the mental health of caregivers of asthmatic children than 
previously identified factors such as family functioning, asthma severity or income. Further 
investigation into the role of mentalising in the mental health of this population is warranted.  
 
Key words: caregivers, asthma, children, mentalising, mental health 
 
 
Mentalisation, Caregiving and Asthma     
 
2-3 
Have you ever unexpectedly started coughing, struggled to breathe or felt a tight chest? 
These are common symptoms of an asthma attack (British Lung Foundation, 2016). Imagine 
that the person experiencing these symptoms is a child. This scary situation would probably 
mobilise the family environment, and its satisfactory resolution may depend on the resilience 
of the child and the ability of the caregivers to understand the problem and provide a reliable 
response. Paradoxically, the incessant repetition of such a situation could increase the stress 
in the family unit and affect caregivers‘ mood and morale (Fagnano, Berkman, Wiesenthal, 
Butz & Halterman, 2012; Reyes et al., 2011).  
Although its causes are still not well understood (Lazarus, 2010; Yangzong et al., 
2012), asthma is one of the most common chronic diseases worldwide and is characterised by 
inflammation of the air passages, which can lead to several recurring symptoms such as 
wheezing, shortness of breath or difficulties in sleeping, among others (Global Initiative for 
Asthma, 2017). During the last two decades, the prevalence of childhood asthma has 
increased globally (Manning, Goodman, O‘Sullivan & Clancy, 2007), and over one million 
children are currently receiving asthma treatment in the United Kingdom (UK) (National 
Health Service, 2017). The International Study of Asthma and Allergies in Childhood 
(ISAAC), the biggest epidemiological research study concerning asthma prevalence 
worldwide (Asher et al., 2006), showed that the prevalence of asthma in children living in the 
UK aged 13–14 was 24.7% and was 20.9% for children in the six to seven age group. This 
and further research have confirmed that the prevalence of childhood asthma in the UK 
constitutes one of the highest worldwide (British Lung Foundation, 2016; Mallol et al., 2013; 
Mukherjee et al., 2014).  
There is a significant burden associated with asthma in the UK and in other Western 
countries, such as the United States (US), with extensive literature reporting on the negative 
economic effects of asthma in relation to healthcare, research, early mortality and partial or 
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permanent disability, among others (Gupta, Sheikh, Strachan & Anderson, 2004; Nunes, 
Pereira & Morais-Almeida, 2017). In the UK, the treatment and management costs of the 
illness have been estimated to be as high as one billion pounds annually (Asthma UK, 2016; 
Mukherjee et al., 2014). Although both the direct (visit to emergency services, medication, 
health consultations, etc.) and indirect (work/school days missed, disability, mortality, etc.) 
financial costs of asthma have been systematically studied and reported, this has not been 
carried out with respect to intangible costs, such as quality of life or psychological distress 
(Nunes et al., 2017).  
Despite the scarce quantification of the intangible negative impact of asthma, previous 
research has identified that children with asthma are prone to experiencing psychological 
difficulties (McQuaid, Kopel & Nassau, 2001; Tibosch, Verhaak & Merkus, 2011). Similarly 
to other chronic diseases, asthma not only has an impact on those who experience it, but can 
also often pose a burden on caregivers (Easter, Sharp & Hunt, 2015). In fact, the mental 
health of asthma caregivers has captured the interest of researchers, as evidenced by the 
growing number of papers published on the topic in the last decade (Bellin et al., 2013; 
Fagnano et al., 2012; Halterman et al., 2004; Yamamoto & Nagano, 2015; Zhou, Yi, Zhang 
& Wang, 2014). In a recent systematic review and meta-analysis, Easter et al. (2015) 
concluded that caregivers of children with asthma reported higher prevalence of anxiety and 
depressive symptoms than caregivers of children without medical diagnoses. 
In fact, several cross-sectional studies have suggested that caregivers of asthmatic 
children report more depressive symptoms (Bartlett et al., 2001; Brehaut et al., 2009; 
Fagnano et al., 2012) than caregivers of children without physical or mental health 
difficulties. In addition, previous research has also reported that caregivers of asthmatic 
children can experience high levels of perceived stress (Lange et al., 2011), low quality of 
life (Cerdan, Alpert, Moonie, Cyrkiel, & Rue, 2012; Halterman et al., 2004), maternal 
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demoralisation (Reyes et al., 2011) and reduced family functioning (Zhou et al., 2014). Given 
that mental health difficulties among caregivers of children with asthma are associated with 
poorer asthma outcomes (Bartlett et al., 2001; Tibosch et al., 2011), understanding the nature 
of this phenomenon is highly relevant. In fact, previous research has showed that caregivers‘ 
anxiety and depression predicts the incidence of asthma symptoms in their children 
(Martínez, Pérez, Ramírez, Canino & Rand, 2009).  
As discussed earlier, family functioning would very likely impact on the resources 
available when responding to asthma episodes. Family functioning refers to the complex 
interaction between different qualities, such as family support, conflict resolution 
mechanisms, cohesion and adaptability (Lewandowski, Palermo, Stinson, Handley & 
Chambers, 2010). In fact, Sato et al. (2013) reported that children living in families who used 
ineffective responses to manage their asthma symptoms had poorer asthma outcomes. 
Furthermore, it has been suggested that family functioning can act as a mediator in the 
negative association between socio-economic status and the mental health of caregivers of 
asthmatic children (Zhou et al., 2014).  
Because childhood asthma requires that caregivers respond effectively to the medical 
and emotional demands of the illness (Gibson-Young, Turner-Henson, Gerald, Vance & 
Lozano, 2014), poor family functioning could hinder such caregiving responses. Conversely, 
high levels of family functioning could facilitate caregivers to be able to make the necessary 
psychological adjustments (Drotar, 1997; Thompson, Gustafson, Hamlett & Spock, 1992) to 
respond flexibly and adaptively to the demands of a chronic illness like asthma.  
Similarly, attachment theory (Bowlby, 1969) can offer an understanding of 
individual responses to stressful situations (Mikulincer & Shaver, 2012), such as 
caregiving for a child with asthma. Previous studies have suggested that mothers of 
children with asthma can display overprotective and anxious attachment styles 
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(Cassibba, van IJzendoorn, Bruno & Coppola, 2004; Hermanns, Florin, Dietrich, 
Rieger & Hahlweg, 1989; Madrid & Schwartz, 1991; Peri, Molinary & Taverna, 
1991; Ravaccia & Fiorentini, 1997; Scobinger, Florin, Reichbauer, Lindemann & 
Zimmer, 1993; Tambelli, Zavattini & Pradarelli, 1993), which are associated with a 
higher risk of developing mental health difficulties (Mikulincer & Shaver, 2012).  
In addition, there is some evidence that parental attachment style is a strong 
predictor of children‘s attachment style (Fonagy, Steele & Steele, 1995; Obegi, 
Morrison & Shaver, 2004; van IJzendoorn, 1995). Thus, understanding the ability of 
caregivers to model secure attachment patterns could have immediate and practical 
implications in supporting caregivers of asthmatic children, especially considering 
that they are responsible for dealing sensitively with the emotional and physical needs 
of their children (Easter et al., 2015; McQuaid et al., 2001). This necessary sensitivity 
of caregivers in order to promptly respond to their children‘s needs is closely linked 
with the concept of mentalisation (Meins, Fernyhough, Fradley & Tuckey, 2001; 
Sadler et al., 2013).  
Mentalisation emerged over two decades ago in the context of understanding 
attachment interactions between parents and babies (Camoirano, 2017; Fonagy, 
Steele, Steele, Moran & Higgit, 1991). Fonagy (1989) first described it as an ability 
that allows awareness of one‘s own and others‘ mental states, which in turn 
facilitates the understanding of behaviours, intentions, thoughts and feelings.  
Arguably, mentalisation and attachment are intertwined and cannot fully be 
separated. Mentalising is a key element of attachment interactions because it allows 
parents to develop alternative understandings of their children‘s needs, which in turn 
helps to provide them with attuned responses (Fonagy et al., 1991). Through this 
attachment process, and with the aid of mentalising ability, parents should be able to 
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provide their children with more insight into their internal world, including their 
emotional and physical needs. Caregivers‘ mentalising ability should be a tool that 
helps the children understand the connection between feelings, thoughts and 
behaviours (Claydon, Zerwas, Callinan & Smith, 2016). This enables 
contextualising behaviours as well as increasing their predictability. 
Thus, whilst robust mentalising is associated with secure attachment and 
resilient responses in the face of stress (Bateman & Fonagy, 2013; Fonagy, Gergely, 
Jurist & Target, 2002), difficulties in mentalising among caregivers has been 
associated with disruptive communications with their children (Grienenberger, Kelly 
& Slade, 2005). Therefore, higher levels of mentalising may help caregivers cope 
with the demands and the uncertainty that a chronic disease such as asthma poses. 
An enhanced ability to make sense of their children‘s feelings and desires could help 
caregivers respond sensitively to the physical and emotional needs of the disease, 
which could in turn alleviate the children‘s suffering and subsequently reduce the 
stress that asthma may pose in the family unit. In fact, Grienenberger et al. (2005) 
suggested that maternal mentalising could reduce the risk of affect dysregulation 
among caregivers when their children were feeling distressed. In contrast, reduced 
levels of mentalising could place caregivers at an increased risk of being 
overwhelmed by the demands of asthma, feeling anxious or experiencing mood 
difficulties, which could in turn reduce their ability to respond adequately to the 
physical and emotional needs of their children. Noteworthy research published to 
date has not explored this construct with respect to caregivers of asthmatic children. 
Given that mentalising is a malleable ability (Bateman & Fonagy, 2013), this 
has potential clinical implications. Previous literature has shown that mentalisation-
based parental interventions have been efficacious in enhancing mentalising as well 
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as improving mental health outcomes among mothers (Suchman et al., 2010; 2017). 
Therefore, the results of this study may help to clarify the relationship between 
mentalising and the psychological distress that caregivers of asthmatic children may 
experience. Understanding this association is paramount to informing clinicians and 
mental health providers of possible treatment targets when working with caregivers 
of asthmatic children, or other chronic health conditions, that experience 
psychological difficulties. 
Overall, previous research has identified that caregivers of asthmatic children 
are at risk of experiencing psychological distress and that family functioning might 
be a buffering agent (Zhou et al., 2014). To the best of our knowledge, previous 
literature has not explored the role of mentalising in the mental health and family 
functioning of caregivers of children with asthma.  
The aims of the study were to (a) further explore mood difficulties, anxiety 
symptoms, family functioning and mentalising ability in a sample of caregivers of 
asthmatic children residing in the UK; (b) examine whether there were statistically 
significant associations between caregivers‘ mentalising scores and family 
functioning scores, as well as with caregivers‘ anxiety and mood difficulties; and (c) 
explore whether mentalising was a significant predictor of anxiety and mood 
difficulties after controlling for family functioning, income level and child asthma 
severity. In line with previous research, it was hypothesised that the mentalising 
―certainty about mental states‖ subscale (RFQ-C) would show a significant negative 
correlation with family functioning, mood and anxiety difficulties, whereas the 
mentalising ―uncertainty about mental states‖ subscale (RFQ-U) would show a 
significant positive correlation with the same variables. Finally, it was predicted that 
mentalising would be significantly associated with caregivers‘ mood and anxiety 
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In order to meet inclusion criteria, participants were at least 18 years old, understood 
written English and were caregivers of a child or an adolescent with an asthma diagnosis 
residing in the UK. Given the absence of a currently established definition of caregiver 
(Hermanns & Mastel-Smith, 2012), this paper defined caregivers as adults (>18) who were 
providing unpaid support and were taking the main responsibility (>4 hours daily) in caring 
for a child or adolescent that was under 18 years of age.  
Design 
The current paper was a quantitative cross-sectional study using an online survey 
design.  
Measures 
Mentalising: The reflective functioning questionnaire (RFQ-8) (Fonagy et al., 2016) was 
used as a self-report measure of mentalising. This is an eight-item likert scale, which 
provides two scores: one for the subscale regarding hypomentalising, which assesses the 
―uncertainty about mental states‖ (RFQ-U), and one for the subscale regarding 
hypermentalising, which assesses the ―certainty about mental states‖ (RFQ-C). In the RFQ-C, 
very low scores (Mean <2.0) reflected difficulties in mentalising, with some agreement 
reflecting a more genuine mentalising. In contrast, in the RFQ-U, higher scores (Mean>4.0) 
reflected poor mentalising, with lower scores characterising greater ability to mentalise. This 
instrument has a 7-point Likert scale and has shown adequate internal consistency with 
Cronbach’s alphas, ranging from .70 to .65 in clinical populations and from .63 to .67 in non-
clinical populations (Fonagy et al., 2016). The test–retest reliability of the RFQ-8 is also 
good, with correlations ranging from r=.84 to .75 over a three-week period (Fonagy et al., 
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2016). In the current study, the reliability analyses showed excellent internal consistency for 
the RFQ-C (Cronbach’s alpha=.83) and poor internal consistency for the RFQ-U 
(Cronbach’s alpha=.52). Both the RFQ-C and RFQ-U were employed in descriptive and 
correlational analyses. For the purpose of the regression analyses, RFQ-C subscale was 
employed as a measure of mentalising. Regression models using RFQ-U can be found in 
Appendix 2-A.  
Family Functioning: The general functioning (GF) subscale of the Family Assessment 
Device (FAD) (Epstein, Baldwin & Bishop, 1983) was used as a measure of family 
functioning. This is a 12-item likert scale, where average scores above 2.2 indicate family 
disruption. Previous studies suggest that GF demonstrates high correlations with the overall 
FAD scores and can thus be used as an accurate measurement of family functioning on its 
own (Kabacoff, Miller, Bishop, Epstein & Keitner, 1990; Ridenour, Daley & Reich, 1999). 
This subscale has demonstrated adequate test–retest reliability (r=.71–.77) and internal 
consistency (Cronbach’s alpha=.78–.92) scores (Akister & Stevenson-Hinde, 1991; Bihun, 
Wamboldt, Gavin & Wamboldt, 2002; Epstein et al., 1983; Shek, 2001), and has been 
previously employed in studies with caregivers of asthmatic children (Zhou et al., 2014). GF 
has also been able to discriminate between clinical and non-clinical populations, which 
provides further support to its discriminant validity (Miller, Epstein, Bishop & Keitner, 
1985), and concurrent validity has been confirmed in a large epidemiological study (Byles, 
Byrne, Boyle & Offord, 1988). The FAD showed excellent internal consistency, with .91 
Cronbach’s alpha in the current sample.  
Anxiety: Caregiver anxiety was measured using the Beck Anxiety Inventory (BAI) (Beck, 
Epstein, Brown & Steer, 1988). This 21-item self-report questionnaire has been widely used 
in research and clinical settings. The clinical cutoff point is indicated at scores above 10. It 
has demonstrated strong internal consistency (Cronbach’s alpha=.92) as well as adequate 
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one-week test–retest reliability (r=.75) (Beck et al., 1988). The internal consistency of the 
BAI was excellent in the current sample (Cronbach’s alpha= .92).  
Mood Difficulties: The 7 Up 7 Down Inventory (7U7D) (Youngstrom, Murray, Johnson & 
Findling, 2013) was employed as a self-report measure of mood symptoms. Previous research 
has found clinical scores to be of Mean<5.0 in the 7U subscale and of Mean<6.5 in the 7 D 
subscale. This instrument was developed as a brief self-report questionnaire from the General 
Behaviour Inventory (GBI) (Depue et al., 1981), and measures depressive and hypomanic 
symptoms. The 7U7D has demonstrated high internal consistency (.83 to .95), high 
correlations with the original GBI scale and adequate construct validity (Youngstrom et al., 
2013). The 7U7D showed excellent internal consistency, with Cronbach’s alphas of .80 for 
the 7Up and .90 for the 7Down subscale in this sample.  
Clinical and Socio-demographic Information: An electronic questionnaire was designed for 
the purpose of this study. The scales had a Likert design and collected clinical and socio-
demographic characteristics of the participants, such as gender, ethnicity, age, number of 
children in the household and income, among others (see Appendix 4-D). The scale also 
collected information regarding asthma severity, using an adapted set of questions from the 
questionnaire of Halterman et al. (2004). For the purpose of the analyses, a caregiver report 
of the number of asthma-free days over the last two weeks was employed as a measure of 
asthma severity.  
Procedure 
Participants were recruited online between July and October 2017. The study was advertised 
on the Asthma Research UK bulletin, which is distributed monthly to the registered Research 
and Policy (RaP) patient volunteers. The study was also advertised on asthma support groups 
on Twitter and Facebook. The advert included a link to a REDCap (Harris et al., 2009) online 
platform. This is a secure online data-collection system licensed and approved by Lancaster 
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University. Following the link, a participant information sheet, containing a description of the 
study, its aims, exclusion and inclusion criteria, data management and confidentiality 
information, was displayed. Participants were then asked to provide consent by clicking a 
link at the end of the introductory section. Following completion of the online questionnaires, 
a debriefing section, with further information on the research team and sources of support, 
was displayed. The study received ethical approval by the University Research Ethics 
Committee (FHMREC). Copies of the information poster, participant information sheet, 
consent, questionnaires and debriefing section are included as appendices in the ethics section 
(Appendices 4-A, 4-B, 4-C & 4-D).  
Statistical Analyses 
All statistical analyses were conducted using IBM SPSS statistics software, version 22. 
Regarding missing data, comparisons on main demographic variables between caregivers 
with complete and non-complete survey data were conducted. Following traditional methods 
for handling missing data (Eekhout et al., 2014; Siddiqui, 2015), only cases with less than 
25% of items missing in the RFQ-8, 7U7D and FAD questionnaires were included in the 
final sample. For the BAI questionnaire, only cases with less than 10% of items missing were 
included, following the strategy adopted by a previous paper on handling missing data in the 
BAI (Wetherell & Areán, 1997). 
Descriptive analyses were conducted to explore and summarise the main demographic 
and clinical characteristics of the final sample. Correlation analyses were employed to assess 
the relationships between clinical and demographic variables. Sensitivity analyses were 
conducted to evaluate possible influential cases (multivariate outliers). The normal 
distribution of the data was confirmed through inspection of histograms. These analyses were 
followed by multiple linear regression analyses to examine whether candidate predictors (e.g. 
mentalising) were associated with mood difficulties and anxiety. Sequential linear regression 
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analyses were employed as the aim of the study was to examine whether previously identified 
predictors were still significant after introducing mentalising variable in the model. A priori 
sample size calculation indicated that in order to detect medium-to-large effect sizes in a 
multiple regression with four predictors at a probability of p=0.05 and with a power of 0.80, a 
minimum of 85 participants was required.  
Results 
A total of n=247 participants provided consent to take part in the current research, 
although only n=143 provided complete data in some of the survey sections. A final sample 
of n=88 participants fully completed the survey. When comparing those caregivers with 
complete data (n=88) with those with partial data not included in the final analyses (n=55), 
no significant differences were observed between groups in any of the variables (ps>.05) 
such as age, sex, ethnicity, income or qualifications among others  (Table 1).  
Insert Table 1 
 
In terms of the demographic and clinical characteristics of the final sample (n=88), 
the mean age of caregivers was 36 (SD=7.13), 97% were female and 94% described 
themselves as white. All participants were mother or father of the child and 85% were 
married or cohabiting. Sixty-nine per cent of the caregivers reported a yearly income of 
£26,000 or more, and 57% had completed university education. Regarding the children, the 
mean age was six (SD=3.72), 45% were female and 91% were white.  
In terms of clinical characteristics, the mean number of days over the past two weeks 
with daytime asthma symptoms was 5.92 (SD=3.93), the average number of days with night-
time symptoms was 5.42 (4.13), and the mean number of asthma-free days was 6.72 
(SD=5.09). Over the past two weeks, participants reported employing the rescue inhaler on 
an average of 5.68 (SD=4.41) days.  
In terms of mentalising, the mean score in the uncertainty about mental states 
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subscale (RFQ-U, potential score range 0–12) was 2.48 (SD=2.54) and the score in the 
certainty about mental states subscale (RFQ-C, potential score range 0–18) was 7.37 
(SD=5.13). The mean family functioning (FAD, potential score range 11–48) was 23.20 
(SD=8.11). The mean hypomania (7U, potential score range 0–17) and depression (7D, 
potential score range 0–21) scores were 3.46 (SD=3.27) and 6.53 (SD=5.17) respectively. 
Finally, the mean anxiety score (BAI, potential score range 20–84) was 36.62 (SD=11.50).  
Insert Table 2 
 
Regarding the level of association between clinical and demographic characteristics 
(Table 2), asthma severity (number of asthma-free days in the past two weeks) was not 
significantly correlated with caregivers‘ and children‘s demographic characteristics, with the 
exception of qualifications (r=.27, p<.01), showing that families with higher education levels 
experienced a greater number of asthma-free days than those with less education.  
Mentalising (RFQ-C or RFQ-U) did not show significant correlations with 
demographic variables (ps>.05). However, family functioning was significantly associated 
with income (r=.21, p<.05) and caregivers‘ qualifications (r=.22, p<.05), meaning that those 
with higher incomes and qualifications were more likely to experience greater family 
disruption.  
Self-reported hypomanic symptoms were significantly correlated with children‘s age 
(r=.27, p<.05), suggesting that having older children was associated with greater chances of 
experiencing hypomanic symptoms. Depression (7Down) did not show any significant 
association with the other variables (ps>.05). Caregiver‘s anxiety symptoms were 
significantly associated with children‘s gender (r=-.26, p<0.01), suggesting that those with a 
female child were more likely to report greater anxiety scores.  
Insert Table 3 
 
Information about clinical variables is provided in Table 3. In terms of correlations 
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between predictors (e.g. mentalising with family function), most of the correlations were 
statistically significant, showing small and moderate effect sizes (r=0.01to -0.65) and running 
in the expected direction.  
For example, certainty about mental states (RFQ-C) was negatively correlated with 
depression (r=-.49, p<.001), hypomania (r=-.24, p<.05), anxiety (r=-.44, p<.01) and family 
functioning (r=-.30, p<.01), whereas uncertainty about mental states (RFQ-U) was positively 
associated with depression (r=.50, p<.000) and anxiety (r=.28 p<.001). Given that low scores 
in the RFQ-C suggest poor mentalising (hypermentalising), and higher scores in the RFQ-U 
also suggest poor mentalising (hypomentalising), these correlations suggest that the poorer 
the mentalising scores, the more likely the reporting of family functioning difficulties, 
anxiety, and depressive and hypomanic symptoms. Similarly, family functioning (FAD) was 
positively correlated with self-reported depressive symptoms (r=.30, p<.01) and negatively 
with RFQ-C (r=-.30, p<.01), suggesting that those with higher difficulties in family 
functioning would be expected to report higher depressive symptoms and lower mentalising 
capacity.  
When studying the association between clinical variables and asthma severity (Table 
3), asthma-free days was negatively correlated with anxiety symptoms (r=-.22, p<=.05), 
whereas rescue inhaler use showed a positive correlation (r=.22, p<=0.05), meaning that 
caregivers who reported higher rescue inhaler use and fewer asthma-free days were more 
likely to report higher anxiety symptoms. In other words, high severity of asthma was 
associated with higher anxiety in caregivers. Moreover, asthma-free days showed a 
significant negative association with rescue inhaler use (r=-.65, p<=.001), as expected.  
Insert Table 4 
 
When exploring whether mentalising was significantly associated with anxiety and 
mood difficulties after controlling for confounders, mentalising (RFQ-C) was the only 
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variable significantly associated with caregivers‘ depressive symptoms.  In the most stringent 
model (step 4, when all candidate predictors were present) mentalising explained 16% of 
variance in depression by itself (b=-.44, p<.001).  
Insert Table 5 
In the case of hypomanic symptoms, mentalising (RFQ-C) was the only predictor 
with a marginally significant contribution to the model (b=-.13, p=.05) (Table 5). These 
results suggest that a unit increase in mentalising (RFQ-C) was associated with a reduction in 
the self-reported depression and hypomanic symptoms scores.  
Insert Table 6 
In the last regression model, both mentalising (b=.89, p<.001) and asthma severity 
(b=-.42, p<.05) were significantly associated with anxiety, although mentalising explained 
10% of the variance, compared with children‘s asthma severity, which only explained 3% of 
variance (Table 6). Similar to the regression models of depression and hypomania, increases 
in mentalising units (RFQ-C) were associated with reductions in anxiety scores. Moreover, 
increases in the number of asthma-free days were also associated with reductions in anxiety. 
When using RFQ-U as a predictor, similar results were observed (see Appendix 2-A).  
Discussion 
To our knowledge, this is the first study exploring mentalising ability in a sample of 
caregivers of asthmatic children. Overall, the findings show that poor mentalising was 
significantly associated with more disrupted family functioning and that it was significantly 
associated with anxiety and mood difficulties after controlling for other covariates.  
In detail, regarding the first aim about exploring participants‘ socio-demographic 
characteristics, descriptive analyses indicated that the sample was almost entirely comprised 
of mothers (97%). The absence of fathers as informant caregivers in the current sample is 
consistent with asthma literature (Yamamoto & Nagano, 2015), where participants are 
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usually mothers. Given that this study targeted caregivers in general, this overwhelming 
majority suggests that mothers might assume most caregiving duties. Similarly, over half of 
the sample had completed university education, the majority of caregivers and their children 
identified themselves as white and 69% of the families reported having a yearly household 
income of £26,000 or more. This average income is above the median yearly household 
disposable income in the UK (Office for National Statistics, 2016). These results suggest that 
the participants of this study were mostly well-educated, middle class, white British females. 
Therefore, caution should be taken when generalising these results to service users from more 
deprived backgrounds and/or from non-white ethnic groups.  
 Interestingly, participants with higher income and qualifications were more likely to 
report greater family disruption. These correlations were unexpected and inconsistent with 
previous research, which suggests that family disruption is significantly associated with 
lower income (Zhou et al., 2014). Consequently, consideration of this inconsistency in future 
research is required. 
 In terms of clinical characteristics, participants reported that over the last two weeks, 
an average of 6.52 days (SD=5.09) were asthma-symptom-free. These results suggest an 
asthma severity of between the mild and moderate ranges (National Institute of Health, 
2007). The results are also similar to a recent cross-sectional study (Gutiérrez, Fagnano, 
Wiesenthal, Koehler & Halterman, 2014) that reported an average of 7.67 asthma-free days 
(SD=5.0) in a sample of 194 asthma children attending primary care clinics. Moreover, the 
self-reported depression scores (mean=6.53, SD =5.17) were similar to those reported in a 
clinical sample using the same instrument (7D) (Youngstrom et al., 2013), and the average 
anxiety symptoms (mean=36.62, SD=11.50) level was in the moderate clinical range (Beck et 
al., 1988). These results are consistent with previous findings, which have indicated that 
caregivers of asthmatic children are prone to experiencing anxiety and depressive symptoms 
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(Easter et al., 2015; Fagnano et al., 2012; Zhou et al., 2014). However, caution is required 
when interpreting the results, as this study did not compare caregivers‘ scores with a control 
group, such as caregivers of non-asthmatic, healthy children.  
The second aim was to analyse whether there were significant associations between 
mentalising and both self-reported mental health symptoms and family functioning. Initially, 
it was hypothesised that certainty about mental states (RFQ-C) would negatively correlate 
with family functioning, mood and anxiety difficulties, and uncertainty about mental states 
(RFQ-U) would positively correlate with the same variables. The results were mostly 
consistent with these hypotheses, such as that those with poorer mentalising scores (lower 
RFQ-C) were more likely to experience greater family disruption and greater symptoms of 
depression, anxiety and hypomania. Regarding RFQ-U, those with poorer mentalising, as 
measured by this scale (higher scores), were more likely to report greater anxiety and 
depression, but these scores were not significantly associated with family functioning 
difficulties or hypomanic symptoms. It is important to highlight here the poor reliability 
showed by the RFQ-U (Cronbach’s alpha= .52), which warrants caution when interpreting 
these results. Nevertheless, these findings provide further support for the theoretical 
underpinnings of mentalising theory, such as that poor mentalising capacity is associated with 
greater mental health difficulties (Bouchard et al., 2008).  
Finally, the study sought to examine whether mentalising was a significantly 
associated with anxiety, depressive and hypomanic symptoms after controlling for income, 
child asthma severity and family functioning. The final hypotheses were also confirmed, as 
mentalising was significantly associated with caregivers‘ depression (16% of variance), 
anxiety (13% of variance) and hypomanic (4% of variance) symptoms after controlling for 
income, asthma severity and family functioning. Mentalising was the most significant 
variable to all the models.  After accounting for the contribution of the other variables, 
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mentalising alone showed a medium effect size for depressive (r=.40) and anxiety (r=.36) 
symptoms and a small effect size (r=.20) for hypomanic symptoms. These results indicated 
that higher levels of mentalising were significantly associated with a reduction in self-
reported anxiety and mood difficulties. Although causality cannot be inferred, this supports 
the idea that mentalising might be a buffering agent against caregivers‘ mental health 
difficulties, as previous literature has identified when looking at other client groups (Bateman 
& Fonagy, 2013; Fonagy & Bateman, 2016).  
Similarly, asthma severity was also able to contribute significantly to the final 
regression model of anxiety. However, asthma severity on its own only showed a small effect 
size (r=.17) suggesting that mentalising (r=.36) was the most important factor in 
understanding caregivers‘ mental health difficulties. This is important given that recent 
studies have focused on asthma severity as a significant predictor of poorer mental health 
outcomes amongst caregivers (Zaky, Fouda, Samir & Ahmed, 2016). In contrast, these results 
suggest that there are other significant factors, such as caregivers‘ mentalising ability, that 
require attention too. For instance, a mixed-method study suggested that losing control could 
be one of the significant dimensions associated with the burden of asthma (Guo, Gao, Guo, 
Wen & Zeng, 2015). It could be argued that losing control is intrinsically relevant to 
mentalising, which essentially supports affect regulation and helps in not ―losing control‖ 
(Fonagy et al., 2002).  
Furthermore, family functioning was not a significant variable in any of the final 
models. In fact, its contribution to the model of depressive and anxiety symptoms was no 
longer significant after mentalising was introduced to the model. This is particularly relevant 
given the extensive literature examining the significant association between disruptive family 
functioning and caregivers‘ mental health in both non-asthmatic (Brown, Lambert, Hsu & 
Eckman, 1998; Jackson, 1992; Kung, 2003) and asthmatic populations (Özkaya, Çetin, 
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Uğurad & Samanci, 2010; Schreier & Chen, 2010; Zhou et al., 2014).  
A possible explanation is that none of the previous studies conducted statistical 
analyses including both family functioning and mentalising. Given that it is hard to imagine 
that positive family functioning can be constructed in a family unit where caregivers have 
difficulties with mentalising, it is possible that mentalising acts a mediating factor in the 
relationship between family functioning and asthmatic caregivers‘ mental health difficulties. 
Thus, future longitudinal studies should aim to test this hypothesis through mediation 
analyses. In addition, it is also important to acknowledge how maternal anxiety and 
depressive symptoms have showed to contribute to the incidence of asthma (Martinez et al., 
2009), and how this might affect family functioning, thereby acting as a confounding factor. 
It is recommended that future studies further explore this issue.  
Overall, these results are promising, as they suggest that mentalising could be an 
important factor in understanding caregivers‘ difficulties, irrespective of their income, family 
functioning and the asthma severity of their children. Theoretically, this can be understood in 
the context of mentalising being an essential component of affect regulation in emotionally 
charged situations (Migdley & Vrouva, 2013), which are often present in the context of 
asthma caregiving duties (Bellin et al., 2013).  
Clinical Implications 
Taken together, these findings suggest that mentalising could be a protective factor that 
allows these families to negotiate the social, financial and emotional demands that asthma 
may pose on their homes, without having such a significant impact on their mental health. 
Moreover, the results indicate that when caregivers‘ mentalising capacity is compromised, 
the likelihood of experiencing mental health difficulties increases.  
Notably, most psychological interventions targeting asthmatic clients or caregivers of 
asthmatic children have focused on problem-solving, meditation, educational, family 
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functioning or environmental triggers, among other aspects (Canino et al., 2008; Ellis et al., 
2014; Paudyal, Jones, Grindey, Dawood & Smith, 2017; Walders et al., 2006). It could be 
argued that learning skills or understanding the nature of asthma might be necessary but not 
sufficient to reduce caregivers‘ anxiety and mood difficulties if their mentalising is 
compromised. Therefore, interventions oriented towards mentalising enhancement could be 
an additional option for this population. In fact, short-term parental-based mentalisation 
interventions have yielded promising results for both clinical (Suchman et al., 2010; 2017) 
and non-clinical populations (Hertzmann et al., 2016). This MBT based intervention could 
constitute a short-term manualised intervention, especially designed for this population.  It 
could contain elements of not knowing stance, mentalising dialogue and psychoeducation on 
asthma, responding to crisis, understanding asthma seasonal effects, as well as infant-
caregiver interactions. 
Limitations and Future Research 
Although novel, the study presents some limitations. First, the study employed an online 
cross-sectional design and only obtained self-reported data. This is particularly relevant for 
variables such as asthma severity, where the inherent memory bias of retrospective self-report 
(Schwarz, 2007) could have affected the results. Although the asthma control test (ACT, 
NIH, 2007) or other systematically validated measures of asthma severity were considered in 
this study, it was finally decided to use shorter, less time consuming assessment procedures 
of asthma severity. By doing this, the current paper possibly avoided greater attrition, but 
possibly compromised the validity of asthma severity, which should be addressed in future 
studies.   
Second, the study sample lacked diversity, especially regarding ethnicity and income. 
This suggests that the sample was not representative of the client group, which often affects 
people from minorities and deprived backgrounds. Given that asthma can pose significant 
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financial burdens in the family unit (Zhou et al., 2014) and that socio-economic status has 
been shown to predict worse anxiety, depression or quality of life outcomes in asthma 
caregivers (Annett, Bender, DuHamel & Lapidus, 2003; Celano et al., 2008; Erickson et al., 
2003; Zhou et al., 2014), future studies should attempt to include a more diverse sample.  
Third, the study was conducted in summer and autumn, whereas asthma seasonal 
effects have extensively documented that asthma severity increases in winter (NHS, 2017). 
This could have skewed our results and the impact of asthma severity on caregivers‘ 
symptoms. However, our results on asthma severity were very similar of those reported by 
Gutierrez et al., (2017) who recruited their sample over three years across different seasons, 
including winter.  
Fourth, mentalising was measured using the short version of the reflective functioning 
questionnaire (RFQ-8). The RFQ-8 is a short screening questionnaire originally developed 
for research studies assessing mentalising capacity in clinical samples with severe 
mentalising difficulties (Fonagy et al., 2016). The use of a clinical scale in a community 
sample could partially explain the low internal consistency scores of the RFQ-U. Ideally, this 
study would have employed the recently developed parental reflective functioning 
questionnaire (PRFQ) (Luyten, Mayes, Nijjssens & Fonagy, 2017), but the first validated 
version of the PRFQ was not published until the data collection for this study was already 
ongoing. Thus, future studies aiming to examine mentalising capacity in asthma caregivers 
should employ the PRFQ instead.  
Moreover, mentalising proponents have described the concept as a capacity that 
occurs largely at a more implicit or automatic level (Fonagy et al., 2002; Migdley & Vrouva, 
2013), and thus it could be argued that it is hard for people to access it through self-report 
questionnaires. Future studies should therefore include both self-report questionnaires and 
semi-structured interviews, such as the parent development interview (PDI) (Slade, Aber, 
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Bresgi, Berger & Kaplan, 2004), which allow clinicians to potentially assess more 
implicit/automatic mentalising processes.  
Conclusions 
Despite its limitations, this study is the first to examine mentalising capacity in a 
sample of caregivers of children with asthma. The findings of this study suggest that 
mentalising was the most important factor in understanding caregivers‘ self-reported anxiety 
and mood difficulties. These results alert researchers and clinicians to the possible existence 
of an overlooked psychological construct that may influence caregivers‘ mental health. This 
could also be relevant to caregivers of other chronic illnesses, as the prevalence of depressive 
symptoms in this population has been extensively documented (Easter et al., 2015). The 
study paves the way for future research to develop a more comprehensive exploration of 
mentalising and its possible interrelatedness with other elements of caregiving for asthmatic 
children. 
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    Demographic and clinical characteristics 
Caregivers Excluded Cases (N=55) Included Cases (N=88) x2/t 
Age, Mean (SD)  35.19 (6.24)a 36.68 (7.13) t=-.1.18 
Sex female, n (%)  53 (98)b 85 (97)  x2=.29 
Ethnicity White, n (%)  46 (85)b 83 (94) x2=3.35 
Relation to child (mother or father), n (%)  51 (94)b 87 (100) x2=4.93 
Income, n (%)c   x2=7.40 
6,000 to >26,000 18 (34) 27 (30)  
26,000 to >48,000 17 (32) 30 (34)  
48,000 and above 18 (34) 21 (35)  
Qualifications, University Studies, n (%) 26 (48)c 50 (57) x2=5.11 
Marital Status, Married or cohabiting, n (%) 34 (81)d 64 (84) x2=.20 
Clinical Variables    
Mentalising scores (RFQ-U), Mean (SD)  2.48 (2.54)  
Mentalising scores (RFQ-C), Mean (SD)  7.37 (5.13)  
Anxiety scores (BAI), Mean (SD)  36.62 (11.50)  
Family Functioning Scores (FD), Mean (SD)  23.09 (8.15)  
Hypomania Scores (7Up), Mean (SD)  3.46 (3.27)  
Depression Scores (7Down), Mean (SD)  6.53 (5.17)  
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 Children Excluded Cases (N=55) Included Cases (N=88) x2/t 
Age, Mean (SD) 5.94 (3.67)e 6.53 (3.72) t=-.89 
Sex female, n (%) 19 (36)c 39 (45) x2=1.09 
Ethnicity White, n (%)  44 (80) 80 (91) x2=3.49 
Asthma Severity    
Nº days with asthma daytime symptoms, M (SD) 5.93 (4.00)b 5.92 (3.93) t=.00 
Nº days with with asthma night-time symptoms, M (SD) 5.76 (4.03) 5.42 (4.13) t=.48 
Nº of asthma free days, M (SD) 6.20 (5.26)c 6.72 (5.09) t=-.58 
Nº days Use of rescue inhaler, M (SD) 5.51 (4.42) 5.68 (4.41) t=-.22 
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Table 2.  

















Caregiver Demographics, r        
Age .07 .15 .09 -.01 .03 (-.04)  .18  
Gender .01 .10 -.01 .08  .01 (-.16)  .15 
Ethnicity .00 -.05 -.17 -.16  -.06 (.18) -.04 
Relationship Status .01 .11 .07 -.10 .09 (.11) .08 
Employment -.19 .12  .02 .05 .08 (-.01) -.04 
Income .15 -.18 -.00 -.05 -.05 (.00) .21* 
Qualifications .27** -.13 .07 -.15 -.07 (.12) .22* 
Children Demographics, r        
Age .06 .27* .11  .13 .01 (-.12)  .04 






Note= *p<.05, **p<.01 ***p<.001, a=Refers to the amount of days without asthma symptoms over the last two weeks, bBAI=Beck Anxiety Inventory, cRFQ-C=Certainty About Mental States,RFQ-U=Uncertainty 














Gender -.02 -.15 -.03  -.26* -.19 (.11) -.05 
Ethnicity -.06 .01 .03  -.01  -.07 (.01) -.03  




Pearson´s r correlations between clinical variables  
 





Depression (7Down) Anxiety (BAI) Family Functioning 
(FAD) 
RFQ-U (RFQ-C) Asthma Free days Rescue Inhalera 
7Up, r   .33*** .49 *** .09 .20 (-.24*) -.09 .14 
7Down, r  .33***  .47 *** .30 ** .50*** (-.49***) -.02 .04 
BAI, r  .49*** .46***  .18 .28** (-.44**) -.22* .22* 
FAD, r  .09  .30** .18  .19 (-.30**) .05 .01 
RFQ-U (RFQ-C) .20 (-.24*) .50***(-.49***) .28**(-.44***) .19 (-.30**) -.61*** -.09 (0.08) .15 (-.10) 
Asthma Free 
Days 
-.09 -.02 -.22* .05 -.09 (.08)  -.65** 
Rescue Inhaler 
Use 
.14 .04 .22* .01 .15 (-.10) -.65**  
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Table 4  
        Sequential linear regression model of depressive symptoms (7D), asthma severity, family functioning and mentalising (N=88) 
 
Variable Step 1 Step 2 Step 3 Step 4 95% CI 









6.68*** 2.74 7.54*** 11.51 3.57  
Income
a
 -.01 .00 -.29 -0.17 .69 -1.05 .00 
Asthma Severity
a
  -.02 -.03 .01 .20 -.18 .00 
Family Functioning
a
   .20** .11 .24 -.15 .02 
Mentalising (RFQ-C)
a 
   -.44*** -.24 -.64 .16 
R
2
 .00 .00 .09** .27***    
F .01 .02 3.01* 7.71***    
R2 .00 .00 .09* .17***    
F .01 .04 9.00* 19.79***    
 















        Sequential linear regression model of hypomanic symptoms (7U), asthma severity, family functioning and mentalising (N=88) 
 
Variable Step 1 Step 2 Step 3 Step 4 95% CI 









4.88*** 3.77*** 5.27*** 8.06 2.48  
Income
a
 -.52 -.49 -.57 -.54 .07 -1.15 .03 
Asthma Severity
a
  -.04 -.04 -.03 .10 -.16 .00 
Family Functioning
a
   .05 .02 .11 -.06 .00 
Mentalising (RFQ-C)
a 
   -.13* .00 -.27 .04 
R
2
 .03 .03 .05 .09*    
F 2.97 1.66 1.69 2.28    
R2 .03 .00 .01 .04*    
F 2.97 .38 1.70 3.88*    
 














        Sequential linear regression model of anxiety symptoms (BAI), asthma severity, family functioning and mentalising (N=88) 
 
Variable Step 1 Step 2 Step 3 Step 4 95% CI 
Upper   Lower 
Semipartial Correlation
2 





40.42*** 34.53*** 44.17*** 53.19 35.15  
Income
a
 -.53 -.18 -.63 -.40 1.58 -2.38 .00 
Asthma Severity
a
  -.50* -.51** -.42* .01 -.86 .03 
Family Functioning
a
   .30* .12 .41 -.16 .00 
Mentalising (RFQ-C)
a 
   -.89 *** -.44 -1.34 0.13 
R
2
 .00 .05* .09* .24***    
F .24 2.28 2.93* 6.45***    
R2 .00 .04* .04* .14***    
F .24 4.30* 4.07* 15.47***    
 









Sequential linear regression models with RFQ-U as covariate 
Table 1 
        Sequential linear regression model of depressive symptoms (7D), asthma severity, family functioning and mentalising (N=88) 
 
Variable Step 1 Step 2 Step 3 Step 4 95% CI 









6.68*** 2.74 1.19 4.53 -2.15  
Income
a
 -.01 .00 -.29 -.10 .75 -.97 .00 
Asthma Severity
a
  -.02 -.03 .01 .19 -.17 .04 
Family Functioning
a
   .20** .13* .26 .01 .02 
Mentalising (RFQ-U)
a 
   .93*** -.24 -.64 .19 
R
2
 .00 .00 .09** .29***    
F .01 .02 3.01* 8.73***    
R2 .00 .00 .09** .19***    
F .00 .04 9.00** 23.48***    
 








       Sequential linear regression model of hypomanic symptoms (7U), asthma severity, family functioning and mentalising (N=88) 
 
Variable Step 1 Step 2 Step 3 Step 4 95% CI 









4.88*** 3.77*** 3.41*** 5.82 1.00  
Income
a
 -.52 -.49 -.57 -.53 .08 -1.15 .03 
Asthma Severity
a
  -0.04 -0.04 -0.03 .10 -.17 .00 
Family Functioning
a
   .05 .04 .13 -.04 .01 
Mentalising (RFQ-U)
a 
   .21 .49 -.05 .02 
R
2
 .03 .03 .05 .08    
F 2.97 1.66 1.69 1.90    
R2 .03 .04 .01 .02    
F 2.97 .38 1.70 2.46    
 











       Sequential linear regression model of anxiety symptoms (BAI), asthma severity, family functioning and mentalising (N=88) 
 
Variable Step 1 Step 2 Step 3 Step 4 95% CI 









40.42*** 34.53*** 32.82*** 41.01 24.63  
Income
a
 -.18 -.63 -.42 -.17 1.68 -2.53 .00 
Asthma Severity
a
  -.50* -.51* -.46* -.00 -.93 .04 
Family Functioning
a
   .30* .23 .53 -.06 .02 
Mentalising (RFQ-U)
a 
   1.02* 1.96 .08 .04 
R
2
 .00 .05* .09* .14*    
F .24 2.28 2.93* 3.48**    
R2 .00 .04* .04* .04*    
F .24 4.30* 4.07* 4.72*    
 
 Note= *p<.05, **p<.01 ***p<.001, aAll values are unstandardized Beta coefficients 
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This thesis initially provided a systematic review of the evidence regarding the efficacy 
and effectiveness of mentalisation-based treatment (MBT), followed by presentation of a 
study exploring mentalising ability in a sample of caregivers of asthmatic children. 
Mentalising is in essence a conceptualisation of the development of a sense of self and how 
this impacts on an individual‘s ability to cope with the overwhelming demands of their social 
environment. Bearing this in mind, this paper addresses the opportunities and challenges that 
such a theory poses in the understanding of a caregiving experience. First, the main findings, 
limitations and strengths of the research paper are summarised. Second, the impacts of the 
findings on clinical practice are presented. Third, the current research context is described, 
along with future research directions. Finally, how mentalisation corresponds with my 
clinical curiosity, as well as the development of my professional identity in the context of 
clinical psychology training, is discussed.  
Summary of Findings, Strengths and Limitations 
The research paper sought to examine the mental health of caregivers of asthmatic 
children as well its relationship to their mentalising capacity. The results showed that 
participants reported anxiety and depressive scores similar to those of clinical populations, 
suggesting that this population might be at risk of experiencing mental health difficulties. 
Most previous literature has focused extensively on psychosocial and environmental 
predictors of caregivers‘ mental health, such as asthma severity, education, asthma 
management or life stress (Bellin et al., 2011; Clougherty, Kubzansky, Spengler & Levy, 
2009; Halterman et al., 2004; Wood et al., 2002; Yamamoto & Nagano, 2015; Zhou, Yi, 
Zhang & Wang, 2014). These studies have contributed substantially to the understanding of 
the multiple factors involved in the mental health and quality of life of caregivers. This study 





The results showed that mentalising was significantly associated with depression, 
anxiety and hypomanic symptoms, explaining more variance than any other variable included 
in the model. The findings are important because they confirm that caregivers of asthmatic 
children may experience emotional distress and that mentalising ability contributes to the 
understanding of such difficulties. Moreover, the parental-based mentalising interventions 
included in the systematic review showed good outcomes in both clinical (Suchman et al., 
2010; 2017) and non-clinical populations (Hertzmann et al., 2016). Taken together, these 
findings might be especially attractive for policy-makers, clinicians and researchers who wish 
to further understand how mental health difficulties emerge in the context of caregiving and 
how it might be possible to prevent or treat them when necessary.  
A particular strength of this study is its limited exclusion criteria, as participation was 
open to residents in the United Kingdom (UK) over 18 years old who were currently 
caregiving (>4 daily hours) for an asthmatic child. The study employed well-validated 
questionnaires and provided an a priori sample size and power calculation. Furthermore, the 
sequential linear regression included variables that previous studies had identified as 
associated with caregivers‘ mental health and quality of life, such as asthma severity, family 
functioning or income (Erickson et al., 2002; Schreier & Chen, 2010; Zaky, Fouda, Samir & 
Ahmed, 2016; Zhou et al., 2014). The study was further strengthened because it recruited 
participants from ―Asthma UK‖, the biggest asthma charity in the UK, as well as from social 
media support groups.  
However, there are caveats that deserve attention. Similarly to any cross-sectional 
study, the findings and their interpretations are limited by methodological considerations. 




be disregarded as an explanation for the significant relationships between the variables. This 
is particularly relevant for the measurement of mentalising capacity. This is a complex, 
multifaceted and dynamic phenomenon, which is not static but rather fluctuates, especially 
under stressful circumstances (Fonagy, Gergely, Jurist & Target, 2002). In this research, 
mentalising was solely measured with a short self-report questionnaire, potentially 
significantly limiting the possibility of capturing its multidimensionality and dynamic 
components. This is particularly important in the context of difficulties obtaining internal 
consistency for the subscale measuring ―uncertainty about mental states‖ (RFQ-U), a 
subscale designed to capture hypomentalising, defined as a significant lack of awareness 
about one‘s own and others‘ mental states (Fonagy et al., 2016). One possible explanation is 
that this scale was originally created to assess mentalising scores in clients with a diagnosis 
of Borderline Personality Disorder (BPD), who previous literature argues are likely to 
experience severe mentalising difficulties (Bateman & Fonagy, 2016). When employing the 
scale with a non-clinical sample, some items might have not been relevant for respondents, 
therefore compromising internal consistency.  
Another possible limitation is that our regression model only included the mentalising 
subscale measuring ―certainty about mental states‖ (RFQ-C). When conducting the same 
sequential linear regression with the ―uncertainty about mental states‖ subscale (RFQ-U), the 
results were very similar but not identical (see Appendix 2-A). In the model using RFQ-U, 
both family functioning and mentalising were significant contributors to the final model of 
depression, whereas in the model using RFQ-C, only mentalising had a significant 
contribution. Nevertheless, whilst mentalising alone (RFQ-U) was associated with 19% of the 
depression symptoms, family functioning was only associated with 4%, suggesting that 
mentalising remained the strongest predictor in the model. Another significant difference is 




associated with hypomanic symptoms, the model was no longer significant when RFQ-U was 
used as a measure of mentalising. These inconsistencies suggest possible differences in the 
subtypes of mentalising difficulties (hypomentalising and hypermentalising), which may or 
may not be associated with caregivers‘ mental health difficulties. 
 Nevertheless, this was the first study examining the concept of mentalising in a 
sample of caregivers of asthmatic children. It was beyond the scope of this research to 
provide a detailed explanation of the differentiating effects that different subtypes of 
mentalising difficulties could have on the caregivers, and this should be further explored in 
future studies.  
Impact of the Study in Clinical Practice 
The findings indicate that consideration should be given to mentalising when understanding 
the distress that caregivers of asthmatic children might experience. In a recent study, Riddle, 
Smith and Jones (2016) identified the need for accessible psychological interventions for 
caregivers in the UK. In the case of asthma caregivers, clinical psychologists could be 
embedded within respiratory teams and contribute to increasing the presence of mentalising 
principles in formulations, assessments and psychological intervention programmes. Another 
possibility would be to design mentalising-based group interventions delivered in primary 
care settings, where the first contact with caregivers is likely to occur. Finally, clinical 
psychologist could provide consultation to asthma charities, where staff working for helplines 
or support groups would be able to integrate and employ mentalising principles.  
One of the main advantages of using a mentalising framework in the understanding of 
the mental health of asthma caregivers is its transdiagnostic nature. Mentalising is 
intrinsically related to the development of the sense of self (Migdley & Vrouva, 2013). 




outcomes, not only in specific symptoms but also in emotional regulation, positive self-
appraisal and a more balanced view of oneself (Bateman & Fonagy, 2016). By targeting 
mentalising, clinicians would not be limited to dealing with anxiety or mood difficulties, but 
could also support caregivers experiencing other types of mental health difficulties.  
Within my current clinical practice, this study has deepened my understanding of the 
importance of mentalising to construct secure attachment relationships, and the possible 
implications when this is absent or under threat. Moreover, this project has increased my 
awareness of the burden posed on my clients by caregiving, and how employing mentalising 
techniques might support them in dealing with such stressors.  
Current Research Context and Future Research Directions  
The application of mentalisation theory in understanding and treating mental health 
difficulties, personality development and caregiver–child interaction, among other areas, has 
rocketed over the past decade (Bateman & Fonagy, 2013; Kalland, Fagerlund, von Koskull & 
Pajulo, 2016; Hertzmann et al., 2016; Suchman et al., 2010). Concurrently, research 
exploring the mental health of caregivers of asthmatic children has also expanded rapidly 
over the past few years (Bellin et al., 2011; Easter, Sharpe & Hunt, 2015; Fagnano, Berkman, 
Wiesenthal, Butz & Halterman, 2012). Thus, it was only a matter of time until these two 
areas of research encountered each other.  
 To date, most psychological research examining asthma caregiving has focused on 
attachment (Yatsenko, Pizano & Nikolaidis, 2016), the impact of caregivers‘ mental health 
on children‘s asthma outcomes (Pak, 2012) or developing problem-solving and cognitive 
intervention programmes for families with asthma (Celano, Holsey & Kobrynski, 2012; 
Walders et al., 2006). Similarly, most asthma research exploring predictors associated with 
caregivers‘ mental health has taken a more sociological or medical perspective by focusing 




functioning or education. Both lines of research have been tremendously helpful in increasing 
the understanding of mental health among caregivers. Yet it could be argued that introducing 
mentalising, a psychological construct previously overlooked in asthma research, would 
possibly expand the current understanding of the mechanisms that interplay with caregivers‘ 
mental health. On the basis of the findings of this thesis and its limitations, future directions 
for research are proposed.  
 First, participation in the study was limited to those who had Internet access. The 
sample mainly comprised white, female, well-educated participants, with a minimal 
representation from ethnic minorities. Future studies should aim to recruit a more diverse 
sample. A possible strategy would be to recruit participants from the National Health Service 
(NHS) by contacting general practitioners (GPs) and paediatric surgeries. 
Second, the outcome study used a general mentalising ability measure (RFQ-8). 
Although parental and general mentalising are strongly correlated (Steele et al., 2008), 
authors have argued that these abilities are not exactly the same (Luyten, Mayes, Nikssenss & 
Fonagy, 2017). Thus, future studies should employ the recently developed parental reflective 
questionnaire (PRFQ) (Luyten et al., 2017) as a more accurate measure of assessing the 
mentalising capacity of caregivers.  
Third, the sample size of the outcome paper was not big enough to detect significant 
differences in a regression with another independent variable, and thus RFQ-U and RFQ-C 
could not be included together. To examine the influence of different mentalising capacities 
on caregivers‘ mental health, future studies should aim to include different mentalising 
subscales in the regression analyses.  
Fourth, the mental health of the children was not assessed in the current research. It is 
possible that caregiving for children who have both asthma and other mental health 




risk of emotional distress among caregivers. Future studies should therefore collect 
information regarding children‘s mental health in order to rule it out as a possible 
confounder.  
Finally, future studies should aim to collect validated medical information regarding 
asthma. The outcome paper relied on participants‘ self-report to establish the severity of 
asthma. Incorporating confirmed medical diagnoses and information from medical records 
would increase the validity of the construct ―asthma severity‖.  
Mentalisation Theory and my Clinical Interests 
What led me to develop a thesis on this subject? 
Since childhood, I have questioned how human personality develops. Growing up 
with both parents trained in the area of psychiatry and psychotherapy, it is clear why this 
question accompanied me throughout my youth and possibly contributed to my decision to 
train as a clinical psychologist. In fact, one of the main premises when deciding on the topic 
of my thesis was to include a psychological theory relevant to personality development.   
During a teaching session in the first year of training, the high prevalence of mental 
health difficulties and reduced quality of life amongst caregivers of chronic conditions were 
highlighted. Personally knowing several people with longstanding chronic health conditions, 
it had always struck me how illnesses like asthma were often examined and researched from 
purely medical lenses, even though, to date, medical science has not been able to clarify its 
causes (British Lung Foundation, 2016; Lazarus, 2010). Thus, I was genuinely interested in 
further understanding the psychological struggles that caregivers of children with such an 
illness may face.  What could make the task of caregiving for asthma a less burdensome 
experience?  
In attempting to answer this question, my mind travelled back to the start of my 




psychoanalytic theories. I remembered the lectures where we discussed the work of John 
Bowlby (1969), who demonstrated that early experiences play a fundamental role in shaping 
our sense of self. Attachment theory and the idea of an internal working model (Ainsworth, 
Blehar, Waters & Wall, 1978) that influences our behaviours, needs for intimacy and 
separation, loss and grief was not only very attractive, but also provided a wide range of 
research opportunities to understand caregiving experiences. Nevertheless, several studies 
had already examined the attachment experiences of caregivers of children with asthma 
(Cassiba, van IJzendoorn, Bruno & Coppola, 2004; Ravaccia & Fiorentini, 1997; Tambelli, 
Zavattini & Pradarelli, 1993) and thus I shifted my attention to mentalisation, which I 
considered a third-wave element of attachment theory.  
As a clinician with a profound interest in psychoanalysis, the work of Bion (1962) and 
Winnicott (1971), on the role of caregivers who mirror and contain babies‘ feelings, has 
always inspired me. Nevertheless, psychoanalytic theories are often dense and more difficult 
to examine through quantitative research methodologies. Over the last two decades, Dr 
Fonagy and his collaborators have been able to expand on and deepen Winnicot‘s and Bion‘s 
concepts, incorporating them into the theory of mentalisation (Wallin, 2015). The integrative 
nature of mentalisation and its emphasis on the experience of early relationships in laying the 
foundations of the personality were what drew me to use mentalising as a key concept for my 
thesis.  
Developing my Clinical Identity 
The journey of conducting this research is an excellent representation of the science–
practitioner model of clinical psychology. This model has not only contributed to developing 
an outstanding research-based culture but has also allowed professionals to make clinical 
decisions supported by the findings of a wide range of studies. Throughout my thesis journey, 




and results interpretation, skills that will be of incalculable value for my professional 
development and identity, allowing me to critically understand quantitative research, its 
underlying assumptions and limitations, and the tremendous influence, both positive and 
negative, that research has in policy-making and service delivery.  
Although very positive, this learning process has made me aware of an existing 
ethical dilemma between clinical psychology and research, which I believe has impacted on 
my clinical identity, and which I will try to address in the following pages. The dilemma 
concerns the allegiance of clinical psychology towards positivist paradigms of mental health.  
For instance, when conducting my outcome paper, I realised that the interventions 
mostly studied for supporting families with asthmatic children were problem-solving and 
cognitive. Similarly, the literature appraised during the systematic review suggested that most 
clients who had accessed talking therapies in England were only offered cognitive 
behavioural therapy (CBT) (Mind, 2013). Although CBT has proven to be useful for some 
people with different mental health presentations (Hofman, Asnaani, Vonk, Sawyer & Fang, 
2012), a significant amount of clients experience little or no benefit from this approach 
(Shedler, 2015). Furthermore, research conducted on predictors of therapeutic change has 
suggested that specific therapeutic models are not accurate predictors of positive therapy 
outcomes (Lambert, 2007; Martin, Garske & Davis, 2000; Wampold, 2001). Thus, 
overrelying on a limited number of therapeutic methods could suggest a misinterpretation of 
the clinical utility of the different available psychological therapies.  
Conducting a quantitative thesis has made me more aware of the predominantly 
positivist epistemological position in clinical psychology and how this affects the identity of 
trainees like myself. Worryingly, I seem to have automatically incorporated some of the 
vocabulary belonging to a purely positivist approach, finding myself describing efficacy and 




questioning the underlying assumptions of such terms. These automatisms have been 
acquired after extensive hours devoted to understanding quantitative research and developing 
outcome papers written to a publishable standard.  
One catchphrase that I have been regularly exposed to, both during training and 
throughout my thesis, has been ―evidence-based‖. Originating from the field of medicine, this 
is often a synonym for manualised brief psychotherapies (Shedler, 2015) tested under 
stringent settings (i.e. randomised controlled trials [RCTs]). The appeal of evidence-based 
therapies is that they are meant to be the vehicle for providing the best quality of care for 
service-users. In theory, this is something that every clinician, including myself, would agree 
with. However, when looking closely at how the ―evidence base‖ is constructed, one can start 
to understand some of the ambitious assumptions involved.  
Publication bias or research allegiance, suggested by some authors to account for up 
to 40% of results of published trials (Duncan & Miller, 2006), are often unnoticed. In a 
significant number of research trials, a priori-established exclusion criteria can preclude up to 
66% of clients from taking part (Westen, Novonty & Thompson-Brenner, 2004). This 
suggests that the clients whom clinical psychologists would see in their everyday practice are 
often excluded from such trials. In fact, psychotherapy research is currently experiencing a 
―replicability crisis‖, as most findings from RCTs are not translated into routine clinical 
practice (Tajika, Ogawa, Takeshima, Hayasaka & Furukawa, 2015). Replicating findings 
from high-controlled settings into naturalistic settings is an essential component of science 
(Rosenthal, 1990), yet this is not often acknowledged when discussing the evidence of 
―evidence-based therapies‖ (Shedler, 2015).  
In the current context, it is often hard to challenge the ―evidence-based‖ practice 
within clinical psychology settings (Mollon, 2009). Clinical psychologists have spent years 




practitioner model. This is admirable, but it remains unclear whether acquiring the status of 
science–practitioners has come with associated costs. Is equating ―evidence-based‖ to RCTs 
freezing the ability of clinical psychologists to think and reflect on the limitations of such 
research?  
Luckily, Lancaster‘s clinical training programme holds a more balanced perspective, 
welcoming different paradigms and acknowledging the limitations of dominant discourses. 
Yet over the past 18 months, I have experienced a sense of deflation and disappointment with 
some of the pathways taken by other clinical training programmes in understanding 
emotional distress. Almost mirroring the primary task crisis of the NHS, where providing 
quick-fix, cheap interventions seems to be the current priority, some clinical psychology 
circles seem to be moving towards a business model, where service-users are clients who 
―purchase‖ the seemingly best available (―evidence-based‖) approach in the market. The 
allegiance towards the National Institute for Clinical Excellence (NICE) guidelines can often 
produce a contradictory and confusing scramble of paradigms where, on the one hand, we tell 
ourselves that clinical psychologists employ a person-centred approach and, on the other 
hand, NICE guidelines are considered the bible of the profession, even though they blindly 
rely on psychiatric diagnostic categories that often lack adequate validity and utility 
(Jablensky, 2016).    
Moreover, the tendency of our profession to rely excessively on p values when 
making clinical decisions can deceive professionals, service-users and policy-makers, as it 
can be used as discouragement from thinking, reflecting and acknowledging that 
psychotherapy is, in essence, a human relationship, and thus its complexity and multifaceted 
nature cannot be solely captured by statistical values. As Jacques Lacan put it in an interview 
in 1974 (Skinner, 2014): 




fiction. There are individuals, and that is all. When I hear people talking about the 
guy in the street, studies of public opinion, mass phenomena, and so on, I think of 
all the patients that I‘ve seen on the couch in forty years of listening. None of them 
in any measure resembled the others, none of them had the same phobias and 
anxieties, the same way of talking, the same fear of not understanding. Who is the 
average Joe: me, you, my concierge, the president of the Republic? (p.3) 
It is important to acknowledge that I do not fully agree with Lacan‘s position, and that I 
believe that research is essential to progress in understanding how to best help our clients.  
That being said, I consider that Lacan‘s reflection touches on the identity crisis that I have 
experienced whilst developing my thesis. On the one hand, I value the attempt of clinical 
psychology to conduct research that helps to improve mental health care. This is the reason 
that I decided to conduct a quantitative project, as I believed that it could have a positive 
impact on caregivers of children with asthma who were struggling, and who had, to some 
extent, been overlooked by research.  On the other hand, I disagree with the neglect of 
alternative mental health paradigms mainly because they have emerged from different 
epistemological positions, such as social constructionism, and therefore do not fit in easily 
with RCTs. 
In fact, I consider that the currently established science–practitioner model in clinical 
psychology has become complacent. Under the umbrella of RCTs, too many questions have 
been foreclosed. Even though the mechanisms of therapeutic change are still largely 
unknown, certain therapies are being widely recommended (Mind, 2013), whilst others are 
largely disregarded. If the aim is for science to advance, neuroscientific evidence should be 
more readily incorporated into both routine decision-making and NICE guidelines. In fact, 
emerging evidence has suggested that psychotherapy can produce positive outcomes that are 




Wiswede et al., 2014).  
Overall, the realisation that clinical psychology is, in my opinion, experiencing an 
identity crisis has been painful. However, this process has shaped my professional identity 
and allowed me to take on board the immense amount of skills, opportunities and knowledge 
that the thesis and training have offered me, whilst also preserving the values of clinical 
intuition, innovation and constructive criticism. In fact, I am grateful for the opportunity that 
clinical training and this thesis have provided me in terms of developing an independent 
judgement. Moreover, I highly value the opportunity that this process has granted in learning 
what research has allowed us to discover but also in reconnecting with the feelings of not 
understanding, which I believe are essential to help those in distress. 
 It is my hope that as my professional career develops, I am able to reconcile these 
disappointments and develop a practice that is transparent, honest and shaped by research, 
clinical judgement and clients‘ personal needs. The capacity of combining all these elements 
in an NHS that is often overstretched, risk-averse and strongly influenced by economic and 
political interests may seem utopic. However, as Fernando Birri, Argentinian filmmaker, said 
(Galeano, 2003):   
Utopia is on the horizon. I move two steps closer; it moves two steps further away. I 
walk another ten steps and the horizon then runs ten steps further away. As much as 
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Applicant: Javier Malda Castillo Supervisor: Guillermo Perez Algorta  
Department: Health Research FHMREC Reference: FHMREC16112 
 





Re: Examining mentalization ability in caregivers of asthmatic children 
 
Thank you for submitting your research ethics application for the above project for review by 
the Faculty of Health and Medicine Research Ethics Committee (FHMREC). The 
application was recommended for approval by FHMREC, and on behalf of the Chair of the 
Committee, I can confirm that approval has been granted for this research project. 
 
As principal investigator your responsibilities include: 
- ensuring that (where applicable) all the necessary legal and regulatory requirements in 
order to conduct the research are met, and the necessary licenses and approvals have been 
obtained; 
- reporting any ethics-related issues that occur during the course of the research or arising 
from the research to the Research Ethics Officer at the email address below (e.g. unforeseen 
ethical issues, complaints about the conduct of the research, adverse reactions such as 
extreme distress); 
- submitting details of proposed substantive amendments to the protocol to the Research 
Ethics Officer for approval. 






Dr Diane Hopkins 
Research Integrity and Governance Officer, Secretary to FHMREC.
Faculty of Health and Medicine Research Ethics Committee 
(FHMREC) Lancaster University 
 
Application for Ethical Approval for Research[guidance1]   
  
for additional advice on completing this form, hover cursor over 
´guidance´ 















Title of Project guidance 2]: Examining mentalisation ability in caregivers of asthmatic children 
 
Name of applicant/researcher:  JAVIER MALDA CASTILLO 
ACP ID number (if applicable)*: Funding source (if applicable) 
Grant code (if applicable): 
 
*If your project has not been costed on ACP, you will also need to complete the Governance Checklist [link]. 
Type of study 
Involves existing documents/data only, or the evaluation of an existing project with no direct contact with 
human participants.  Complete sections one, two and four of this form 
 Includes direct involvement by human subjects. Complete sections one, three and four of this form 
1. Appointment/position held by applicant and Division within FHM   Trainee Clinical Psychologist 
2. Contact information for applicant: 
E-mail: j.maldacastillo@lancaster.ac.uk 
which you can be contacted at short notice) 
Telephone:  07514267419  (please give a number on 
Address: Clinical Psychology, Faculty of Health and Medicine, Furness Building, Lancaster University, Lancaster, 
LA1 4YG 
 
3. Names and appointments of all members of the research team (including degree where applicable) 
 
Principle Investigator (PI). Javier Malda Castillo Trainee in Clinical Psychology, Lancaster DclinPsych Research team 
Dr Guillermo Pérez-Algorta:Lecturer in Mental Health, Lancaster DclinPsych Research team 
Dr Claire Browne (field supervisor): Consultant Clinical Psychologist Central Manchester University Hospitals NHS 
Foundation Trust 







SECTION TWO---Not relevant section for this project 
Complete this section if your project involves existing documents/data only, or the 
evaluation of an existing project with no direct contact with human participants 
 
1. Anticipated project dates  (month and year [guidance 3]) 
3. If this is a student project, please indicate what type of project by marking the relevant 
box/deleting as 
appropriate: (please note that UG and taught masters projects should complete FHMREC form 


















4. Project supervisor(s), if different from applicant:   Dr Guillermo Pérez-Algorta 
 
5. Appointment held by supervisor(s) and institution(s) where based (if applicable): Lecturer 
in Mental Health, Lancaster University, DClinpsych Research team. 
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Start date: End date: 
 
 
2. Please state the aims and objectives of the project (no more than 150 




For additional guidance on data management, please go to Research Data Management 
webpage, or email the RDM support email: rdm@lancaster.ac.uk 
3. Please describe briefly the data or records to be studied, or the evaluation to be undertaken. 
 
 
4a. How will any data or records be obtained? 
 
4b. Will you be gathering data from websites, discussion forums and online chats no  
4c. If yes, where relevant has the  permission been secured from the website moderator? no  
4d. If you are only using those sites that are open access and do not require registration, 
have you made your intentions clear to other site users? no  
 
4e. If no, please give your reasons 
 
 
5. What plans are in place for the storage, back-up, security and documentation of data 
(electronic, digital, paper, etc[guidance5])? Note who will be responsible for deleting the data at 




6a. Is the secondary data you will be using in the public domain? no  
6b. If NO, please indicate the original purpose for which the data was collected, and 
comment on whether consent was gathered for additional later use of the data. 
 
Please answer the following question only if you have not completed a Data Management 













Complete this section if your project includes direct involvement by human subjects 
 
1. Summary of research protocol in lay terms (indicative maximum length 150 words[guidance 9]): 
 
The UK has one of the highest prevalence rates of asthma in children worldwide; with one in 
every 11 children suffering from asthma (Asthma UK, 2016). It has been suggested that caring 
for a child with a chronic illness can have a significant impact on the wellbeing of their 
caregivers (Julian et al. 2015) as well as increase their risk of experiencing mental health 
difficulties (Easter et al., 2015; Frankel & Wamboldt, 1998; Kaugars, Klinnert, & Bender,2004). 
In order to increase the understanding of the burden that asthma may have on caregivers of 
asthmatic children, we plan to collect online data using anxiety, mood disturbance, 
mentalisation and family functioning questionnaires. Overall, this research project will 
attempt to respond to three research questions: 
 
1) Explore the levels of mentalisation in a sample of caregivers of asthmatic children 
 
2) Is there an association between caregivers’ mentalisation ability and family functioning? 
 
3)I s there an association between caregivers’ mentalisation levels and anxiety and mood 
difficulties (depression and/or hypomanic) symptoms? 
 
2. Anticipated project dates (month and year only[guidance 10]) 
 
Start date: 20/08/2017 End date10/05/2018 
 
Data Collection and Management 
For additional guidance on data management, please go to Research Data Management 
webpage, or email the RDM support email: rdm@lancaster.ac.uk 
7a. How will you share and preserve the data underpinning your publications for at 
least 10 years e.g. PURE[guidance6]? 
 
7b. Are there any restrictions on sharing your data[guidance7]? 
 
 
8. Confidentiality and Anonymity 
a. Will you take the necessary steps to assure the anonymity of subjects, including in    
subsequent publications? yes 




9. What are the plans for dissemination of findings from the research[guidance 8]? 
 
 
10. What other ethical considerations (if any), not previously noted on this application, do you 
think there are in the proposed study?  How will these issues be addressed? 
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3. Please describe the sample of participants to be studied (including maximum & 
minimum number, age, gender[guidance 11]): 
 
Inclusion criteria: Be a caregiver (>18 years old) of a children or an adolescent with a confirmed 
asthma diagnosis in the United Kingdom. Currently there is not a consistent and agreed 
definition of caregiver (Hermanns & Mastel- Smith, 2012). This project will define caregiver as 
the adult who provides unpaid support and takes most responsibility (i.e. at least 4 hours per 
day) in caring for the wellbeing and health of the child. This can also include grandparents, 
relatives or legal guardians among others. 
 
There is no specific exclusion criteria although participants who are unable to understand 
written English will not be able to take part in the study given that there will not be 
translators/interpreters available for the current research. 
 
4. How will participants be recruited and from where? Be as specific as possible [guidance 
12]. Ensure that you provide the full versions of all recruitment materials you intend to use 
with this application (eg adverts, flyers, posters). 
 
The recruiting will be initially across the third sector, charitable organisations and online support 
groups of the United Kingdom. We plan to contact organisations such as: Asthma UK, British 
Lung foundation, or Allergy Uk and children centres such as Balmoral Children's Centre or 
Poulton Children's Centre. We also plan to contact asthma online support groups such as 
https://www.dailystrength.org/group/asthma or http://www.healthfulchat.org/asthma-chat-
room.html. In addition, contacts of the supervisory team will support in the selection of 
participants through advertising the project in non-NHS special interest social media groups (i.e. 
Facebook or twitter). An official Facebook and Twitter account will be created for the purpose of 
this study. In order to advertise the research, potential participants will receive an information 
poster (see protocol), which outlines the research aims and contact details of the research team. 
 
5. Briefly describe your data collection and analysis methods, and the rationale for their use. 
 
The selection of the instruments to collect the information was made on the basis of previous 
literature around measuring anxiety, family functioning, mentalisation and mood disturbance in 
research settings. The selection of the questionnaires was also based on previous literature 
exploring mental health difficulties among caregivers of asthmatic children. The instruments 
that will be employed include the general functioning scale of the Family Assessment device, 
the reflective functioning questionnaire (RFQ-8), the 7up 7 down inventory (7U7D) and the 
Beck Anxiety Inventory (BAI). This research will also collect sociodemographic information (i.e. 
employment status, education etc.) with the aim of characterizing the sample, which would aid 
in understanding the generalizability of the results. These instruments will be included in an 
online e-survery that participants will be able to access through a link shared by the research 
team. 
 
The independent variable in the current study will be the ability to mentalise and the three 
dependent variables will be anxiety , mood disturbance and family functioning. The aim of the 
current study is to clarify the possible effects of mentalisation in family functioning, anxiety 
levels and mood disturbances. Thus, correlation analyses between mentalisation and the three 
independent variables will be conducted. Descriptive statistics of sociodemographic (i.e. 
gender, ethnicity) and clinical characteristics (i.e. asthma severity) of the participants will also 
be conducted.  
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In order to control for potential confounders regression analyses will be conducted. 
Mentalisation will be included as predictor of family functioning, anxiety and mood disturbances 
and confounders will be caregivers´ gender, asthma severity (measured by adapted scale from 
Haterman et al., 2004) and income. These confounders were selected on the basis of previous 
research, which has suggested that there is a relationship between maternal demoralization, 
stress, depression and their children´s asthma (Yamamoto & Nagano, 2015). However, the 
interactions between paternal figures and asthmatic children have been overlooked. In 
addition, previous research has suggested that asthma severity of the child may impact on 
caregivers‘ quality of life (Haterman et al., 2004), which could then have effect on their mental 
health. Furthermore, income and health are strongly associated such as those from less 
privileged backgrounds are at increased risk of physical and mental health difficulties.  
The current research hypothesizes that higher mentalisation levels will predict less anxiety and 
mood disturbance symptoms and better family functioning after controlling for these 
confounders. However  of 0.80 and four predictors (mentalisation, gender, asthma severity 
and socio-economic status), a minimum sample size of 85 families will be required. Thus the 
minimum sample required will be of 85 and the maximum of 100.  
 
6. What plan is in place for the storage, back-up, security and documentation of data 
(electronic, digital, paper, etc.)? Note who will be responsible for deleting the data at the end 
of the storage period. Please ensure that your plans comply with the Data Protection Act 
1998[guidance 13]. 
 
 Data will be collected via Redcap, which is a secure online system to build and manage online 
questionnaires. Redcap use is approved by Lancaster university (https://redcap.lancaster.ac.uk/ 
and one of its advantages compared to other programs such as Qualtrix is that you can provide 
access to your profile to other staff involved in the research. The data will be stored in the 
password protected Lancaster University internal server. During this time, the data will be 
anonymous and will only be available to the research team within a password-protected 
environment. When the data collection processes finishes, these data will be transferred into an 
excel database and stored in Javier Malda Castillo's personal password protected box system.  
This is an encrypted online support storage system. Participants will be able to withdraw their 
consent up until 15th February 2018. If participants withdraw their consent, their data will be 
destroyed. The investigators will be able to identify which participants have decided to 
withdraw their consent by using their date of birth as identifying information. Participants´ 
identifying information (their date of birth) will be kept in a separate password protected excel 
document and will be deleted after the thesis has been assessed. The database will be 
accessible to all members of the research team through box. After Javier Malda Castillo 
completes the course, Dr Guillermo Pérez-Algorta will be responsible for the storage and 
deletion of the data.  
 
7. Will audio or video recording take place?   no audio video 
a. Please confirm that portable devices (laptop, USB drive etc) will be encrypted where they are 
used for identifiable data. If it is not possible to encrypt your portable devices, please comment 
on the steps you will take to protect the data.[guidance14] 
 
b What arrangements have been made for audio/video data storage? At what point in 
the research will tapes/digital recordings/files be destroyed[guidance 15]? 
 
No audio or video recording will take place. 
Please answer the following questions only if you have not completed a Data Management 
Plan for an external funder 
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8a. How will you share and preserve the data underpinning your publications for at 
least 10 years e.g. [guidance16]PURE? 
Once the thesis has been approved and the piece has been finished, the stored data will be 
transferred to the secure Lancaster University Server. As this is the last year of Javier Malda 
Castillo as a student, following his departure, maintenance of the data will be the responsibility 
of Dr Guillermo Perez-Algorta (supervisor). The data collected will be retained for 10 years as 
standard. 
8b. Are there any restrictions on sharing your data [guidance17]? 
We do not expect any restrictions in sharing the data and secondary analyses based on 
this data could be conducted. Information about this possibility will be provided to 
participants when obtaining consent . 
 
9. Consent 
a. Will you take all necessary steps to obtain the voluntary and informed consent of the 
prospective participant(s) or, in the case of individual(s) not capable of giving informed consent, 
the permission of a legally authorised representative in accordance with applicable law? yes 
 
b. Detail the procedure you will use for obtaining consent[guidance 18]? 
Participants will complete an online survey. Before starting to complete the questionnaires an 
introductory cover sheet will clearly inform participants that by completing the survey they 
consent to the use of the data for research purposes. However, this cover sheet will not require 
them to sign or type identifying information. 
Therefore, participants will be asked to click into a link at the end of the introductory cover in 
order to provide consent. After they click on the link, they will be redirected to the 
completion of the online questionnaires. 
 
10. What discomfort (including psychological e.g distressing or sensitive topics), inconvenience 
or danger could be caused by participation in the project? Please indicate plans to address these 
potential risks[guidance 19]. State the timescales within which participants may withdraw from 
the study, noting your reasons.[guidance 20] 
 
It is possible that participants feel distressed when responding questions related to anxiety, 
mood disturbance or family functioning. At the end of the study, participants will be able to 
read a debriefing sheet and they will be informed about how to access emotional support if 
they need to. Participants will be given the opportunity to receive support from the PI and will 
be signposted to the appropriate service (i.e. mental health charity such as MIND) if further 
support is required. The field supervisor, Dr Clare Browne (Clinical Psychologist) will provide 
supervision and guidance to the PI on this matter. 
 
11. What potential risks may exist for the researcher(s)? Please indicate plans to address such 
risks (for example, noting the support available to you; counselling considerations arising from 
the sensitive or distressing nature of the research/topic; details of the lone worker plan you will 
follow, and the steps you will take[guidance 21]) 
 
There are no potential risks identified for the principal investigator (PI). However, should the 
researcher feel distressed it will be agreed that he can have a conversation with his research 
supervisor. If this support is not sufficient, the research supervisor will guide the PI to access 
appropriate support. In fact, the Lancaster Doctorate in Clinical Psychology course offers 6 
sessions of free Cognitive-Analytic therapy that the PI could access if he feels that he needs 
additional support. 
12. Whilst we do not generally expect direct benefits to participants as a result of this research, 
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Javier Malda Castillo 
please state here any that result from completion of the study[guidance 22]. 
 
Participants will not gain any direct benefit from this study. However, this study will increase the 
understanding of the difficulties that caregivers of asthmatic children may experience. By 
exploring an overlooked construct in the area, this study will provide an opportunity for further 
research to develop in the area. 
13. Details of any incentives/payments (including out-of-pocket expenses) made to 
participants[guidance 23]: No incentives/payments will be made to participants. 
 
14. Confidentiality and Anonymity 
a. Will you take the necessary steps to assure the anonymity of subjects, including in 
subsequent publications? yes 
b. Please include details of how the confidentiality and anonymity of participants will be 
ensured, and the limits to confidentiality[guidance 24]. 
All information will be collected and stored anonymously. Participants will be informed about 
this prior to taking part in the study. No identifiable information will be collected for the current 
research. 
 
15. If relevant, describe the involvement of your target participant group in the design 
and conduct of your research[guidance 25]. 
 
The project has consulted with two professionals with broad experience working with 
population with physical and mental health difficulties. The field supervisor has broad 
experience in working with children with chronic health conditions. An experienced 
stakeholder working in a children's hospital has also provided consultation on possible 
recruitment strategy. 
 
16. What are the plans for dissemination of findings from the research? If you are a student, 
include here your thesis[guidance 26]. 
The results of this study will be part of a thesis in the Doctorate in Clinical Psychology 
program. Following the submission of the thesis, the results of this research will be 
submitted to an academic peer-reviewed journal. 
17. What particular ethical considerations, not previously noted on this application, do you think 
there are in the proposed study[guidance 27]? Are there any matters about which you wish to 
seek guidance from the FHMREC? The current study will recruit participants primarily through 
online resources. Thus, caregivers who do not have access to the internet or who are not 
comfortable in providing online information may not take part in the study. This would mean 
that the current research may exclude a segment of the caregivers of asthmatic children. This is a 
potential ethical issue as this research aims to produce information that is generalizable for 
asthmatic caregivers in the UK. However, this will be acknowledged in the research paper and 




SECTION FOUR: signature 
 




Student applicants: please tick to confirm that you have discussed this application with your 




supervisor, and that they are happy for the application to proceed to ethical review  
 





1. Submit your FHMREC application by email to Diane Hopkins (d.hopkins@lancaster.ac.uk) 
as two separate documents: 
i. FHMREC application form. 
Before submitting, ensure all guidance comments are hidden by going into 
‘Review’ in the menu above then choosing show markup>balloons>show all 
revisions in line. 
ii. Supporting materials. 
Collate the following materials for your study, if relevant, into a single word 
document: 
a. Your full research proposal (background, literature review, 
methodology/methods, ethical considerations). 
b. Advertising materials (posters, e-mails) 
c. Letters/emails of invitation to participate 
d. Participant information sheets[guidance 29] 
e. Consent forms 
f. Questionnaires, surveys, demographic sheets 
g. Interview schedules, interview question guides, focus group scripts 
h. Debriefing sheets, resource lists 
 
Please note that you DO NOT need to submit pre-existing measures or handbooks 
which support your work, but which cannot be amended following ethical review. 
These should simply be referred to in your application form. 
2. Submission deadlines: 
i. Projects including direct involvement of human subjects [section 3 of the form 
was completed]. The electronic version of your application should be submitted 
to Diane Hopkins by the committee deadline date. Committee meeting dates and 
application submission dates are listed on the FHMREC website.  Prior to the 
FHMREC meeting you may be contacted by the lead reviewer for further 
clarification of your application. Please ensure you are available to attend the 
committee meeting (either in person or via telephone) on the day that your 
application is considered, if required to do so. 
ii. The following projects will normally be dealt with via chair’s action, and may be 
submitted at any time. [Section 3 of the form has not been completed, and is 
not required]. Those involving: 
a. existing documents/data only; 
b. the evaluation of an existing project with no direct contact with human 
participants; 
c. service evaluations. 
3. You must submit this application from your Lancaster University email 
address, and copy your supervisor in to the email in which you submit this 
application 
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Have you ever found yourself struggling to breath and being unable to speak or ask for 
help? That is what an asthma attack looks like. Asthma is the commonest long-term illness of 
childhood worldwide with prevalence rates ranging from 7-10% (Lazarus, 2010). The United 
Kingdom (UK) has one of the highest prevalence rates of asthma worldwide with over 8 
million people currently experiencing this condition (British Lung Foundation, 2016) and the 
National Health Service (NHS) spends over a billion pounds every year in treating and 
supporting people with asthma (Asthma Uk, 2016). 
The impact of this chronic illness is not limited to the children who suffer it, but has an 
effect in the family system, especially among caregivers (Easter, Sharp & Hunt, 2015). 
Previous literature has suggested that caring for a child with asthma can adversely affect 
parental mental health (Frankel & Wamboldt, 1998; Kaugars, Klinnert, & Bender,2004) and 
quality of life (Halterman et al., 2004). In fact, recent literature indicated that anxiety and 
mood difficulties (i.e. depressive symptoms) were higher in caregivers of asthmatic children 
than in caregivers of children without physical or mental health diagnoses (Easter et al., 
2015) and other studies have reported that maternal demoralization (Reyes et al., 2011); 
perceived stress (Lange et al., 2011) and reduced quality of life (Halterman et al., 2004) are 
frequent among caregivers of asthmatic children. 
Furthermore, it seems that family functioning is an important resource for caring for an 
asthmatic child (Drotar, 1997; Thompson, Gustafson, Hamlett & Spock, 1992). Family 
functioning refers to the interpersonal relationships within the family, including levels of 
cohesion, adaptability, conflict resolution and quality of communication 
(Lewandowski,Palermo, Stinson, Handley & Chambers, 2010). Families with higher levels of 
functioning can make flexible changes to deal with the stressors and uncertainties of a 
chronic illness like asthma (Zhou, Yi, Zhang & Wang, 2014). Although it has not been 
examined in the specific context of asthma, previous literature suggests that adequate family 
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functioning can help in reducing the effects of parental depressive symptoms related to 
childcare stress (Brown, Lambert, Hsu & Eckman, 1998). In contrast, families with lower 
levels of functioning can increase the stressors associated to having children with asthma and 
in turn impact on caregivers ‗mental health (Zhou et al., 2014). 
In contrast, the currently available literature has failed to explore mentalisation in this 
population, a concept originally developed by Fonagy (1991), defined as ―the capacity to 
differentiate self from the other and to ascribe mental states to others so their behaviour can 
make sense and be predictable‖ (Roussow, 2012, p. 89). In interactions between caregivers 
and asthmatic children, mentalisation could help caregivers understand their children‘s 
emotional states, the potential stress of dealing with a chronic condition and how this could 
influence their behaviours. Understanding their children‘s mental states would help them 
support not only with the chronic condition but also with the emotional impact of it. 
Since its origin, mentalisation has captured the interest of clinical research as is reflected 
by the wide array of clinical research papers that have explored it (Bateman & Fonagy, 
2013). Although the concept was first introduced in the context of a treatment for personality 
disorders (Choi-Kain & Gunderson, 2008), its usage rapidly expanded into a wide array of 
clinical areas, including the treatment of families (Fearon et al., 2006), eating disorders 
(Skarderud, 2007), parent-infant dyads (Sadler, Slade & Mayes, 2006) and school-based 
community interventions (Twemlaw & Fonagy, 2006). Furthermore, robust mentalisation has 
been associated to secure attachment (Fonagy et al., 2002) and individuals with high levels of 
mentalisation show high significant resilience in the face of stressful situations (Bateman & 
Fonagy, 2013). In contrast, lack of mentalisation has been associated with different mental 
health difficulties (Roussow, 2012). Therefore, caregivers with greater levels of mentalisation 
may respond more adaptively to the demands of asthma and may experience higher levels of 
positive family functioning, whereas caregivers with lower mentalisation may be at risk of 
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experiencing mood difficulties, anxiety and reduced family functioning. This has potential 
clinical implications because mentalisation is not a static unitary trait, but instead a dynamic 
ability that can be enhanced through therapy (Bateman & Fonagy, 2013). Hence, exploring 
caregivers‘ ability to understand their own and their children´s feelings, desires and thoughts 
could contribute to the understanding of the impact that asthma has on the family unit. 
Furthermore, given that caregivers are primary responsible for monitoring children´s health 
and for making medical decisions regarding their asthma (McQuaid et al., 2003), 
understanding their possible mental distress is paramount both in terms of caregiver 
wellbeing and asthma outcomes (Easter, Sharp & Hunt, 2015). 
Overall, previously available literature has suggested that caregivers of children with 
asthma may be at risk of experiencing mental health difficulties. However, the currently 
available literature has largely ignored a widely researched construct in clinical practice such 
as mentalisation. Therefore, this study aims to expand the currently available literature by 
exploring the mentalisation ability of the caregivers and its possible association with their 
mental health and family functioning. The results of the study could increase the 
understanding of the burden that caregivers of children with asthma may experience, which 






Participants will be caregivers (>18 years old) of asthmatic children that in the United 
Kingdom. Currently there is not a consistent and agreed definition of caregiver in the 
literature (Hermanns & Mastel-Smith, 2012). This study will define caregiver as the adult 
who provides unpaid support and assumes most responsibility (i.e. at least 4 hours per day) in 
caring for the wellbeing and health of the child. This can also include grandparents, relatives 
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or legal guardians among others. 
Sample Selection. Professional contacts of the supervisory team will help in 
identifying potential participants. In addition, participants will be recruited through 
advertising the project in non- NHS special interest social media groups (i.e. Facebook or 
twitter), online support groups, third sector organisations and charities. An official Facebook 
and Twitter account will be created for the purpose of this study. In order to advertise the 
research, potential participants will receive an information poster (see appendix 4-A), which 
outlines the research aims and contact details of the research team. 
Design 
 
The current study will follow a cross-sectional quantitative between subjects design. 
A quantitative survey design will be designed using the online secure survey design 
management system ―Redcap‖. 
Materials 
 
-Clinical and sociodemographic information: An e-survey with forced response and Likert-
scales will be employed to collect clinical and sociodemographic information such as: age, 
ethnicity, gender and asthma severity (adapted from Halterman et al., 2004) among others 
(see appendix 4-D). This will help characterizing the sample, which would aid in 
understanding the generalizability of the results. 
-Family Functioning: The functioning of families in the current study will be assessed using 
the general functioning scale of the Family Assessment Device (Epstein, Baldwin & Bishop, 
1983). This is a 12 item self-report questionnaire that provides rating of the overall 
functioning of a family. The score on this questionnaire can range from 0 to 4 with higher 
scores indicating more impaired family functioning. The average test-retest reliability of the 
scale is 0.71 and the average internal consistency is 0.78 (Akister and Stevenson-Hinde, 
1991; Bihun et al., 2002). In addition, the concurrent validity was confirmed in a large 
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epidemiological study of children (Byles, Byrne & Boyle, 1998), as scores on the scale were 
significantly associated with other variables associated with impaired family functioning (e.g. 
alcoholism). 
- Mentalisation: Reflective Functioning Questionnaire (Fonagy et al., 2016): The reflective 
functioning questionnaire (RFQ-8) is short screening 8-item version of the original RFQ 
which has 56 items . This is the most recently developed self-report screening measure for 
mentalizing, with a 7-point type Likert scale. Internal consistency of the scale ranged from 
0.70 to 0.65 in a clinical sample and from 0.63 to 0.67 in a non-clinical sample. The test–
retest reliability over a period of 3 weeks ranged from r= 0.84 to 0.75 (Fonagy et al., 2016). 
This questionnaire has been chosen because is easy to administer and because the aim of this 
research is not to capture the different dimensions of mentalizing, but rather explore the 
general ability of mentalisation of the participants. 
-Mood difficulties: The 7 Up 7 Down Inventory (7U7D) is a recently developed self-report 
questionnaire that consists of 14 items (Youngstrom, Murray, Johnson and Findling, 2013). 
This scale measures hypomanic and depressive tendencies and has demonstrated high internal 
reliability ranging from .83 to .95 as well as adequate construct validity (Youngstrom et al., 
2013). 
-Anxiety: Beck Anxiety Inventory (BAI). This is a 21 item self-report questionnaire that can 
be used as a screening instrument for anxiety in research setting. The internal consistency for 
the BAI is as high as .92 and test-retest reliability scores of .75 have been reported after one 
week (Beck, Epstein and Brown, 1988). 
Procedure 
 
The recruiting will be initially across the third sector, charitable organisations and 
online support groups of the United Kingdom. We plan to contact organisations such as: 
Asthma Uk, British Lung foundation, or Allergy Uk and children centres in such as Balmoral 
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Children's Centre or Poulton Children's Centre. We also plan to contact asthma online 
support groups such as: https://www.dailystrength.org/group/asthma or 
http://www.healthfulchat.org/asthma-chat-room.html. 
The study will be conducted online through the platform Redcap. Therefore, informed 
consent will be gained online (Appendix 4-B). Prior to completing the questionnaires, 
participants will be presented with an online participant information sheet. Informed consent 
will be gained by explaining to participants what are they consenting to such as: what will 
they be asked to do, what will their data be used for, how will the data be stored and what 
would they need to do if they wanted to withdraw from the study. Following consent, 
participants will be instructed on how to complete the online questionnaires. The order of the 
questionnaires will be the same that is described in the materials section above. After 




In the current study, mentalisation will be the independent variable and anxiety, mood 
disturbances and family functioning will be the dependent variables. The aim of the current 
study is to clarify the possible effects of mentalisation in family functioning, anxiety levels 
and mood disturbances. Thus, correlation analyses between mentalisation and the three 
independent variables will be conducted. In order to control for potential confounders, 
regression analyses will be conducted in which mentalisation will be included as predictor of 
family functioning, anxiety and mood disturbances and caregivers‘ gender, income and 
child´s asthma severity will be included as confounders. These confounders were selected on 
the basis of previous research, which has suggested that there is a relationship between 
maternal demoralization, stress, depression and their children´s asthma (Yamamoto & 
Nagano, 2015). However, the interactions between paternal figures (male gender) and 
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asthmatic children have been overlooked. In addition, previous research has suggested that 
asthma severity of the child may impact on caregivers´quality of life (Haterman et al., 2004), 
which could then have an effect on their mental health. Furthermore, income and health are 
strongly associated such as those from less privileged backgrounds are at increased risk of 
physical and mental health difficulties (Marmot, 2010).The current research hypothesizes that 
higher mentalisation levels will be associated with less anxiety and mood disturbance 
symptoms and better family functioning after controlling for confounders. Therefore, 
according to power analysis guidelines (Miles & Shelvin, 2001) for a medium effect size, an 
alpha significance level of 0.05 and power of 0.80 and three predictors, this study will require 
a minimum sample size of 85 and a maximum sample size of 100. 




The data will be collected online through Redcap, which is an online secure e-survey 
design system. The data will be transferred to an excel document, which will be stored in a 
password-protected online secure system. 
Storage, backup and security 
 
The database will not contain any identifiable information from the participants. The 
principal investigator (PI) will be responsible for the data. The database will be held on the 
PI‘s Lancaster University personal file store. The PI personal file store is equipped with 
password-protected access. Field and research supervisor will be able to access the database 
using Lancaster University´s ―Box system‖. This is a high-grade encryption online storage 
system. Participants will be able to withdraw their consent up until 15
th
 February 2018. If 
participants withdraw their consent, their data will be destroyed. In order to be able to find 
out which participant has decided to withdraw their consent, their date of birth will be 
employed. Participants´ identifying information (their date of birth) will be kept in a separate 
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password protected excel document and will be deleted after the thesis has been assessed. 
After the thesis has been assessed and Javier completes the course, Dr Guillermo Pérez-
Algorta will be responsible for the storage and deletion of the data. The data will be retained 
for ten years as standard.  
Data Sharing 
 
We do not expect any data restrictions to be necessary. Lancaster University 
Doctorate in Clinical Psychology administration team will store the data resulting from this 
project in an encrypted environment. Potential users will find out about the data through 
publication and/or other dissemination activities. 
Ethical concerns 
 
In the process of collecting information about anxiety or mood disturbance symptoms, 
caregiver may be in touch with distressing memories, feelings, emotions or thoughts. Thus, 
participants of the current research will be provided with the opportunity of receiving support 
from the principal investigator who is a trainee in Clinical Psychology. If this is not enough, 
they will be signposted to an appropriate service. Participants will be informed about the 
























June 2017: Ethical Approval 
July 2017: Start data collection 
November 2017: Systematic Literature Review  
January 2018: Finish data collection 
January 2018: Introduction and methods  
February 2018: Statistical analysis and results  
March 2018: Discussion 
April 2018: Draft 
 
May 2018: Final submission 
 
July 2018: Inform the participants about the results 
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Appendix 4-A: Information Poster 
 
Exploring the wellbeing of caregivers of asthmatic children 
 
 
My name is Javier Malda Castillo and I am a Trainee Clinical Psychologist at Lancaster 
University. As part of my doctorate I am conducting a research project about how caregiving 
for a child or an adolescent with an asthma diagnosis can have an effect on mental health. 
 
Who can participate? 
 
We are looking for caregivers who have children with an asthma diagnosis. By caregivers we 
mean parents, grandparents, step parents or any individual over 18 who has the main 
responsibility of caring for a child or an adolescent with an asthma diagnosis. 
What is involved? 
 





If you would like to participate please click on this link 
_________________________________ 
or alternatively  contact Javier Malda Castillo  




























Appendix 4-B: Participant Information Sheet 
Exploring the Wellbeing of Caregivers of Asthmatic Children 
 
My name is Javier Malda Castillo and I am conducting this research as a student in the 
Doctorate in Clinical Psychology course at Lancaster University, Lancaster, United 
Kingdom. 
What is the study about? 
The purpose of this study is to explore the mental health and the family relationships of 
caregivers 
of asthmatic children. 
Why have I been approached? 
You have been approached because the study requires information from caregivers of 
asthmatic children. 
Do I have to take part? 
No.  It‘s completely up to you to decide whether or not you take part in this study. 
 
What will I be asked to do if I take part? 
If you decide you would like to take part, you would be asked to complete an online 
questionnaire that will take between 10 and 20 minutes. 
 
Will my data be identifiable? 
The information you provide is anonymous. The data collected for this study will be stored 
securely and researchers conducting this study will have access to this data. In addition, other 
researchers could use this data to develop more studies. 
The files on the computer will be encrypted (that is no-one other than the research team will 
be able to access them) and the computer itself password protected. 
Can I withdraw my consent? 
Your participation is voluntary and you will be able to withdraw your consent up until 15
th
 
February 2018. This means that up until that date you can contact me to let me know that you 
no longer want to participate in the study. I will then delete all your data. In order to be able 
to find your anonymous data, we will use your date of birth and the child´s date of birth, 
which will be linked to your questionnaire responses. 
 
 
What will happen to the results? 
The results will be summarised and reported in a thesis and will be submitted for publication 
in an academic or professional journal. 
 
Are there any risks? 
There are no risks anticipated with participating in this study. However, if you experience 
any distress following participation you are encouraged to inform the researcher and contact 
the resources provided at the end of this sheet. 




Are there any benefits to taking part? 
Although you may find participating interesting, there are no direct benefits in taking part. 
 
 
Who has reviewed the project? 
This study has been reviewed and approved by the Faculty of Health and Medicine Research 
Ethics Committee at Lancaster University. 
 
Where can I obtain further information about the study if I need it? 
If you have any questions about the study, please contact the main researcher: 
 
 
JAVIER MALDA CASTILLO 
 
Clinical Psychology, Div. Of Health Research, Furness Building C34  Lancaster University, 
Lancaster, 
LA1 4YG 
aldacastillo@lancaster.ac.uk  01524 592754 
 
Supervisors: 
Dr Guillermo Pérez-Algorta 
Clinical Psychology, Div. Of Health Research, Furness Building C73 ,Lancaster University, 
Lancaster, LA1 4YG 
01524594711 g.perezalgorta@lancaster.ac.uk 
Dr Claire Browne 
Central Manchester University Hospitals NHS Foundation Trust 0161 701 0850 
claire.browne@cmft.nhs.uk 
Complaints 
If you wish to make a complaint or raise concerns about any aspect of this study and do not 
want to speak to the researcher, you can contact: 
 
Dr Bill Sellwood Tel: +44 1524 593998 
Email: b.sellwood@lancaster.ac.uk Health Research Division, Lancaster University, 
Lancaster LA14YG 
 
If you wish to speak to someone outside of the Doctorate Programme, you may also contact: 
 
Professor Roger Pickup Tel: +44 (0)1524 593746 
Associate Dean for Research Email: r.pickup@lancaster.ac.uk Faculty of Health and 
Medicine 
(Division of Biomedical and Life Sciences) Lancaster University, LANCASTER LA14YG 
 
Thank you for taking the time to read this information sheet. 
 Resources in the event of distress 
Should you feel distressed either as a result of taking part, or in the future, you can contact a 
member of the research team who will provide you with support and guidance. If you do not 
feel comfortable about contacting the research team you can access free mental health 
support via your General Practitioner (GP) or MIND, which is a mental health charity 
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providing advice and support to anyone experiencing mental health problems.You can get in 
touch with MIND and find your nearest MIND service at https://www.mind.org.uk/about-
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Appendix 4-C: Participant Consent 
 
 
Study Title: Exploring the wellbeing of caregivers of asthmatic children  
 
We are asking if you would like to take part in a research project that aims to increase the 
understanding of mental health and family relationships of caregivers of asthmatic children 
 
Before you consent to participating in the study we ask that you read the participant 
information sheet. By clicking on the link below you will be consenting to take part in the 
current study.   If you have any questions or queries before signing the consent form please 
speak to the principal investigator, Javier Malda Castillo. 
 
 
By proceeding to the survey you confirm that: 
 
1. I have read the information sheet and fully understand what is expected of me within this 
study 
2. I have had the opportunity to ask any questions and to have them answered. 
3. I understand that my participation is voluntary and that I am free to withdraw my consent up 
until 15
th
 February 2018 without giving any reason, without my medical care or legal rights 
being affected. 
4. I consent to information from my questionnaire responses being used in reports, conferences 
and training events. 
5. I understand that the researcher will discuss data with their supervisor as needed. 
6. I consent to Lancaster University keeping questionnaire responses for 10 years after the study 
has finished. 
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Appendix 4-D: Questionnaires 
 
Clinical and Socio-demographic Information 
 
1) Your relationship to the child: 
a) Mother or father 
b) Grandmother or grandfather 
c) Stepfather or stepmother 
d) Legal guardian 
e) Other 
2) Your date of birth_______________________ 
 
3) How many hours do you approximately spend with the child over the course of a day?  
 
 





5) What is your ethnicity? 
a) White 
b) Mixed/multiple ethnic groups 
c) Asian/Asian British 
d) Black/African/Caribbean/Black British 
e) Other Ethnic group 
Please specify_______ 






f) In a registered same sex civil partnership 
g) Never married and never registered in a same sex civil partnership  
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6) Please tell us the total annual income of your household (before tax and deductions but including 
benefits/allowances) 
 
a) £6.000 to less than £13,000 GBP  
b) £13,000 to less than £19,000 GBP  
c) £19,000 to less than £26,000 GBP  
d) £26,000 to less than £32,000 GBP  
e) £32,000 to less than £48,000 GBP  
f) £48,000 to less than £64,000 GBP  
g) £64,000 or more GBP  
 
7) What is the highest qualification that you currently have? 
 





f) Masters´degree (Msc) 
g) Doctorate 
 









9) How many people are there in your household including yourself? (Please write in)  
 
a) Children 4 years and under  
b) Children 5 to 16  
c) Adults 17-64  
d) Adults Over 65 
 
11)What is the Child´s month and year of birth?  
 






13) Child‘s race/ethnicity 
 
a) White 
b) Mixed/multiple ethnic groups 
c) Asian/Asian British 
d) Black/African/Caribbean/Black British 
e) Other Ethnic group 
Please specify_______ 




14) In the last two weeks, on how many days did the child experience the following symptoms? 
a) Daytime asthma symptoms (i.e. coughing, wheezing, shortness of breath)_____ 
b) Nighttime asthma symptoms (i.e. coughing, wheezing, shortness of breath)_____ 
c) The need for rescue inhaler use 
15)   In the last two weeks, how many symptom free days did the child experience? (A symptom free day is a) a) 24 
day-hour period with no symptoms of asthma  

















Family Assessment Device - General Functioning Scale 
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1. Planning family activities is difficult because we misunderstand each other. 
Strongly agree      Agree      Disagree    Strongly Disagree___   
 
2. In times of crisis we can turn to each other for support. 
Strongly Agree     Agree     Disagree   Strongly disagree_  
 
3. We cannot talk to each other about the sadness we feel. 
Strongly Agree     Agree     Disagree    Strongly Disagree   
 
4. Individuals are accepted for what they are. 
Strongly Agree     Agree     Disagree    Strongly Disagree  __ 
 
5. We avoid discussing our fears and concerns. 
Strongly Agree     Agree     Disagree    Strongly Disagree  _ 
 
6. We can express feelings to each other. 
Strongly Agree     Agree    Disagree    Strongly Disagree  _ 
 
7. There are lots of bad feelings in the family. 
Strongly Agree     Agree     Disagree    Strongly Disagree   
 
8. We feel accepted for what we are. 
Strongly Agree     Agree     Disagree    Strongly Disagree__  
 
9. Making decisions is a problem for our family. 
Strongly Agree    Agree    Disagree    Strongly Disagree   
 
10. We are able to make decisions about how to solve problems. 
Strongly Agree     Agree     Disagree    Strongly Disagree   
 
11. We don't get along well together. 
Strongly Agree      Agree    Disagree   Strongly Disagree   
 
12. We confide in each other. 










The Reflective Functioning Questionnaire 
 
Please work through the next 8 statements. For each statement, choose a number between 1 and 7 to say how 
much you disagree or agree with the statement, and write it beside the statement. Do not think too much about it 
– your initial responses are usually the best. Thank you. 
 




Strongly 1 2 3 4 5 6 7 Strongly 




1. People´s thoughts are a mystery to me 
 
2. I don´t always know why I do what I do 
 
3.When I get angry I say things without really know why I am saying them 
 
4. When I get angry I say things I later regret 
 
5. If I feel insecure I can behave in ways that put others ‗back up 
 
6. Sometimes I do things without really knowing why 
 
7. I always know what I feel 
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The 7 Up 7 Down Inventory 
Below are some questions about behaviours that occur in the general population. Using the scale below, select 
the number that best describes how often you experience these behaviours. 
 
 
1. Have you had periods of extreme happiness and intense energy lasting several days or more when you also felt 
much more anxious or tense (jittery, nervous. uptight) than usual (other than related to the menstrual cycle)? 
0 1 2 3 
 
Never or hardly ever Sometimes Often Very often 
 
2. Have there been times of several days or more when you were so sad that it was quite painful or you felt that 
you couldn't stand it? 
 
0 1 2 3 
 
Never or Sometimes Often Very often hardly ever 
 hardly ever 
3. Have there been times lasting several days or more when you felt you must have lots of excitement, and you 
actually did a lot of new or different things? 
 
0 1 2 3 
 
Never or Sometimes Often Very often hardly ever 
hardly ever 
 
4. Have you had periods of extreme happiness and intense energy (clearly more than your usual self) when, for 
several days or more, it took you over an hour to get to sleep at night? 
 
0 1 2 3 
 
Never or hardly Sometimes Often Very often ever 
hardly ever 
5. Have there been long periods in your life when you felt sad, depressed, or irritable most of the time? 
 
0 1 2 3 
 





6. Have you had periods of extreme happiness and high energy lasting several days or more when what you saw, 
heard, smelled, tasted, or touched seemed vivid or intense? 
 
0 1 2 3 
 
Never or Sometimes Often Very often hardly ever 
hardly ever 
7. Have there been periods of several days or more when your thinking was so clear and quick that it was much 
better than most other people's? 




0 1 2 3 
 
Never or Sometimes Often Very often hardly ever 
hardly ever 
8. Have there been times of a couple days or more when you felt that you were a very important person or that your 
abilities or talents were better than most other people's? 
 
 
0 1 2 3 
 
Never or Sometimes Often Very often hardly ever 
hardly ever 
9. Have them been times when you have hated yourself or felt that you were stupid, ugly, unlovable, or useless? 
 
0 1 2 3 
 
Never or Sometimes Often Very often hardly ever 
hardly ever 
10. Have there been times of several days or more when you really got down on yourself and felt worthless? 
 
 
0 1 2 3 
 




11. Have you had periods when it seemed that the future was hopeless and things could not improve? 
0 1 2 3 
 
Never or Sometimes Often Very often hardly ever 
 
 hardly ever 
12. Have there been periods lasting several days or more when you were so down in the dumps that you thought you 
might never snap out of it? 
0 1 2 3 
 
Never or Sometimes Often Very often hardly ever 
hardly ever 
13. Have you had times when your thoughts and ideas came so fast that you couldn't get them all out, or they came 
so quickly that others complained that they couldn't keep up with your ideas? 
0 1 2 3 
 
Never or Sometimes Often Very often hardly ever 
hardly ever 
14. Have there been times when you have felt that you would be better off dead? 
 




0 1 2 3 
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4-40 
Beck Anxiety Inventory (BAI) 
 
Below is a list of common symptoms of anxiety. Please carefully read each item in the list. Indicate how 
much you have been bothered by that symptom during the past month, including today, by circling the 




Not At All Mildly but it 
didn’t bother me 
much 
Moderately - it 
wasn’t pleasant at 
times 
Severely – it bothered 
me a lot 
Numbness or 
tingling 
□ □ □ □ 
Feeling hot □ □ □ □ 
Wobbliness in 
legs 
□ □ □ □ 
Unable to relax □ □ □ □ 
Fear of worst 
happening 
□ □ □ □ 
Dizzy or 
lightheaded 
□ □ □ □ 
Heart 
pounding/racing 
□ □ □ □ 
Unsteady □ □ □ □ 
Terrified or 
afraid 
□ □ □ □ 
Nervous □ □ □ □ 
Feeling of 
choking 
□ □ □ □ 
Hands trembling □ □ □ □ 
Shaky / unsteady □ □ □ □ 
Fear of losing 
control 
□ □ □ □ 
Difficulty in 
breathing 
□ □ □ □ 
Fear of dying □ □ □ □ 
Scared □ □ □ □ 
Indigestion □ □ □ □ 
Faint / 
lightheaded 
□ □ □ □ 
Face flushed □ □ □ □ 








    Appendix 4-E: Debrief 
 
Thank you for taking the time to participate in this study. It has been suggested that 
caregivers of asthmatic children might be at increased risk of experiencing mental health 
difficulties. Thus, the purpose of this study is to explore whether caregivers of asthmatic 
children experience mental health difficulties and to better understand their family relationships.  
 
The study also intends to explore the level of mentalisation among caregivers of asthmatic 
children. Mentalisation is the ability to understand others' emotions and be able to respond 
accordingly. For instance, understanding when someone is upset. High levels of mentalisation 
could be helpful when dealing with stressful situations. An example of mentalisation ability 
could be to understand when someone is upset and responding to it (i.e. nodding sympathetically 
if someone is describing an stressful experience or soothing a child if his/her non-verbal 
communication indicates that he/she is upset about something).  
 
All the information that is collected for this study will be anonymous and there will be no 
way of identifying your responses in the dataset. If you have any questions about the study do 
not hesitate to contact me via email on j.maldacastillo@lancaster.ac.uk or my supervisor Dr 
Guillermo Perez-Algorta on g.perezalgorta@lancaster.ac.uk and we will be happy to answer 
any of your queries.  
 
 
Sources of support 
If you feel distressed as a result of participating in the study you can contact a member of the 
research team, who will provide you with support and guidance. Alternatively, you can also 
access free mental health support through your GP. You can also access free mental health 
support through the charity MIND. You can get in touch with MIND and find your nearest 
MIND service at https://www.mind.org.uk/about-us/local-minds/ or by phoning their central 
office at 020 8519 2122.  
 
 
Javier Malda-Castillo  
Trainee Clinical Psychologist 
